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Background
Everyone makes decisions about their health, and
many healthcare interventions aim to encourage
this. An informed decision is one where a reasoned
choice is made by a reasonable individual using
relevant information about the advantages and
disadvantages of all the possible courses of action,
in accord with the individual’s beliefs.
Objectives
• To provide an unbiased bibliography of
controlled studies evaluating interventions that
may affect informed patient decision making.
• To classify studies by research design, decision-
making theory, type of intervention and 
health setting.
• To describe the measures of informed patient
decision making and other outcomes reported.
• To identify under-reported areas and direct
future research.
Methods
Data sources
The electronic databases MEDLINE, BIDS (social
science), and PsycLIT were searched for 1991–96.
The journals Medical Decision Making, Patient
Education and Counseling, and Preventive Medicine
were handsearched for 1986–96.
Inclusion criteria
Studies were included if they reported the results 
of a controlled study of any intervention using real
patients making a health decision. Specifically, ran-
domised controlled trials (RCTs), non-randomised
concurrent studies, historical studies, and same
subject ‘before and after’ studies were included.
Health decisions were defined to include any re-
ported health behaviour change as well as explicit
decisions. Interventions were defined broadly to
include any that could reasonably be expected to
affect informed decision making, such as changes
in information provision, cost, or service provision.
Patients were defined as any individual making a
decision about health care. Experimental studies
on healthy student volunteers, studies of health
professionals making decisions about another
individual’s care, and articles not published in
English were excluded.
Data extraction
This was performed using coding forms by a
member of the project group and checked by a
team member, with disagreements resolved by
discussion. Abstracts were assessed and the articles
retrieved if the review criteria were met. Final
inclusion decisions were made by the first author 
of this report and verified by another member of
the project group.
Articles were classified by study quality according to
the hierarchy of evidence, underlying theory, the
domain of health care, and the health decision.
The comparison groups, other factors associated
with the decision-making process, reported
measures, and a summary of the findings were
recorded.
Data synthesis
Descriptive summaries and qualitative analysis were
performed. The health domains and decisions were
too diverse for meaningful quantitative meta-
analysis.
Results
Following handsearching and abstract evaluation
825 articles were distributed to the project group
members and 547 were subsequently included
within the bibliography.
Study quality
There were 336 RCTs, 114 non-randomised
concurrent studies, 34 historical, and 63 ‘before
and after’ same-sample studies. Only 51 of the 
RCTs were classified as having a low risk of bias. 
A total of 267 studies claimed to have approached 
a representative sample of participants, but only
243 reported the number invited to take part. 
Few studies provided adequate descriptions of 
the intervention materials.
Theoretical context
A total of 206 studies referred to an underlying
theory. Of these, 101 referred to theories explain-
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ing decision making such as expected 
utility theory, prospect theory or social 
cognition models.
Health domain and the decision
A total of 251 studies were in general medicine, 
114 cancer, 108 genitourinary medicine, 61 
primary care, 31 paediatrics; 15 mental health, 
10 dentistry, 11 surgery, seven genetics, and 31
obstetrics and gynaecology, and midwifery. The
decision was classified as a life-style change in 
357 studies, a screening decision in 114, a
treatment decision in 107, a decision to participate
in the consultation in 51, and as another type of
decision in 26 studies.
Interventions
A total of 301 interventions were of information
provision itself, 273 varied the delivery of inform-
ation, 208 provided patient feedback, 94 manipu-
lated information in some other way, 55 prompted
active patient participation, and 89 of another
intervention altogether.
Decision-making factors
A total of 512 studies assessed actual rather 
than hypothetical decisions, 476 involved 
decisions affecting the participant rather than
a third party and in 525 studies the decision 
was made without time pressure. Only 26 
studies explicitly made patients aware of 
their involvement in the decision-making 
process.
Measures assessed
Demographic details were recorded in 515 studies,
knowledge in 181, decision-making measures in
169, measures of affect in 69, satisfaction in 60, 
self-efficacy in 75, personality trait in 20 and other
variables in 111 studies. 
Summary result
Only five studies were theory driven, assessed
measures associated with informed decision
making, and used a low risk of bias design.
Although of disparate design these five studies
suggest that information and education are
relatively ineffective ways of facilitating informed
decision making, compared with the context 
and social influences. Studies reporting
manipulation of information, and provision 
of feedback, were the most likely to report 
an effect.
Conclusions
There is a paucity of well-designed, theoretically
driven and adequately operationalised research
assessing informed patient decision making. 
Given the small number of high-quality studies 
and the relatively slow increase in research in this
area there is no need for the NHS to revisit this
topic as a review for 5 years. Resources should be
concentrated on better primary research.
Recommendations for research
Future primary research should work under an
explicit theory of decision making, record process
measures to permit evaluation of whether the
decision was informed, and if evaluating experi-
mental interventions use randomised trials with 
a low risk of bias.
A booklet describing the main decision-making
theories, and an inventory of suitable outcome
measures could be developed to help clinical
researchers design appropriate studies.
Complementary systematic reviews would 
be valuable.
• The effect of interventions on patient
preferences. (At least 50 trials were excluded
from the present bibliography because no
behaviour change was recorded.)
• Observational studies of real patient decision
making. Studies using tape-recorded
consultations, verbal thinking aloud protocols,
and other written or computer-based process-
tracing methods will predominate.
• Assessing the effect of additional information,
manipulation of information, provision of
feedback, and group delivery of information on
informed patient decision making.
Primary research is a priority in areas such as
genetics, prenatal diagnosis and where decisions
are often made by proxy, such as paediatrics and
mental health.
Primary research is required to evaluate the
following types of interventions:
• decision aids, such as graphical and computer-
based devices
• information manipulation, such as decision
analysis, prompts, and feedback.
Executive summaryHealth Technology Assessment 1999; Vol. 3: No.1
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E
veryone makes decisions about their health
care, such as whether to brush their teeth,
smoke, or take headache pills, and some have to
make difficult decisions, such as whether to under-
go a prenatal diagnosis test, or choosing between
chemotherapy or surgery for cancer. Generally
people want to make these decisions for themselves
and to be given the information required to make
them wisely. Many healthcare interventions aim to
encourage this.
However, there is no agreed definition of an
informed decision because it depends on the
theoretical predisposition of the researcher. For
some an informed decision is one where the final
choice accords with an underlying theory, such as
expected utility theory. For others it is the process
that matters, and whether this follows a particular
theory, that defines an informed decision. The two
approaches cannot easily be reconciled, and the
following is a compromise definition: an informed
decision is one where a reasoned choice is made by
a reasonable individual, using relevant information
about the advantages and disadvantages of all the
possible courses of action, in accord with the
individual’s beliefs. In practice individuals rarely
make decisions this way. They have a limited
processing capacity and overcome these by using
modes of thinking and reasoning that simplify the
issues. These heuristic modes of thinking deter-
mine which aspects are attended to and how they
are interpreted. 
Several models and theories have been developed
to explain how individuals make decisions and 
how decision making may be facilitated. Some 
of the factors that affect an individual’s ability 
to make an informed decision and theories 
of decision making are discussed in more 
detail below.
Factors associated with informed
decision making 
The factors associated with an individual’s ability to
make an informed health decision can be grouped
into those pertaining to a) the decision context, b)
the decision maker, and c) other influences. Only
the last are directly alterable.
Decision context
The following features of the health decision
suggest that different psychological evaluations are
required, which may alter the extent to which an
individual makes an informed decision.
• Type of health decision, for example, smoking
or drinking alcohol; attending a physician
appointment; adhering to medication; having 
a diagnostic test; participating in choice 
of treatment.
• Seriousness of the outcome, for example,
choosing to take a headache pill, deciding
whether to donate an organ or not.
• Familiarity with the decision, for example,
deciding whether or not to exercise is more
commonly experienced by people than deciding
whether or not to have a genetic test.
• Level of certainty, for example, declining 
insulin always makes diabetic people ill, whereas
declining prenatal screening only carries a risk
of giving birth to a Down’s syndrome child. 
• Health domain, for example, making choices 
in medicine, in surgery or in primary care.
• Recipient, for example, deciding for yourself 
or for your child.
Decision maker
People vary in their preferred degree of involve-
ment in health decisions.
1 Some want all possible
information whereas others are happy to rely on a
physician’s recommendation or a more intuitive,
‘gut reaction’. Personality traits, need for control,
beliefs about the doctor–patient role, current state
of health or illness, and the degree of anxiety or
depression and an individual’s ability to understand
health information vary widely.
2 It is likely that
these individual differences will affect the degree 
to which informed decisions are made.
Other influences
Individuals are often unable to deal systematically
with large amounts of information, and employ
heuristics to reduce the processing required. These
often result in decisions being made from the
context rather than the content of the information.
Decisions may change when the same factual
information is presented in slightly different ways,
for example, by framing the information either
positively or negatively, expressing figures as
Chapter 1
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percentages, risk, inverse risk, or verbally.
3,4 The
context also affects whether a reasoned decision is
made. For example, individuals under time pres-
sure or experiencing extreme affect (e.g. frighten-
ed or angry), are more likely to use an heuristic,
whereas those who perceive a need to justify the
decision outcome or who are only moderately
anxious are more likely to use all the information. 
Decision aids such as memory prompts, repeating
information, reducing the quantity or improving
the clarity of information, and presenting inform-
ation in different mediums may also affect decision
making. It is likely that extra relevant prompt
information will reduce the cognitive load and
promote informed decision making. However, too
much information may make people rely on an
established heuristic and lead to worse decisions.
Finally, extraneous factors such as charging for 
a service, the availability of transport, the shape 
of an inhaler or the presence of a no-smoking
policy will alter an individual’s evaluation of the
available information.
Measures of informed 
decision making
The most frequently used measures of informed
decision making and their limitations are 
discussed below.
• Noting the health behaviour indicates a decision
was made but no more than this.
• Knowledge assesses the individual’s ability to
recall information. Although, better-informed
decision makers probably recall more, this does
not mean the information was used.
• Utilities measure individual’s values or attitudes
towards the choices available rather than the
decision outcome. Proponents of expected 
utility theory argue that a good decision is 
one consistent with the choice derived from an
equation that integrates an individual’s values 
for each outcome with the likelihood of the
outcome occurring. As an informed decision
should accord with a patient’s attitudes, it is
likely that an informed decision will be consist-
ent with a decision derived from expected 
utility theory. However, deciding in accord 
with personal utilities is not sufficient for a 
decision to be classified as informed.
• Affect measures anxiety, satisfaction and regret,
which are often reported. Although reduced
affect may be desirable it is not necessarily
associated with informed decision making. 
For example, moderately raised anxiety is
associated with a more systematic evaluation 
of the information but great anxiety is associ-
ated with the application of heuristics.
5 Equally
an individual is as likely to be satisfied with
health care if the decision was made following 
a health professional’s recommendation or 
after an in-depth evaluation of all the 
available information.
Most of these measures focus on the outcomes
following the making of the health decision. It is
likely that the effects of memory and the need to
continue with the same healthcare team will affect
their validity. Equally, few of these measures evalu-
ate the decision-making process, that is, the type
and way information was used by the individual
when making the decision. It is also necessary to
ensure that the final decision was based on an
unbiased evaluation of all the available information
including the risks and alternatives. A number of
process-tracing techniques are available. These
include: verbal protocols; analysis of tape-recorded
consultations following the application of a
technique like content analysis to the transcripts;
and the use of information boards or computer
programmes to track the information used. 
Perhaps because of these issues of measurement,
little is known about the impact of encouraging
informed decision making on the individual. There
is some evidence to suggest that too much
evaluation of the available information leads to
reduced post-decision satisfaction.
6 However, the
application of heuristics is more likely to lead to
poorer outcomes than adequately surveying all the
alternatives.
7 Such conflicts can be resolved only in
the light of an underlying theory.
Decision-making theory
There are three broad types of decision-making
theory.
8 The first, normative theory describes 
what people ought to do if they wish to be rational
decision makers. These axiomatic theories are
based on mathematical and statistical proofs.
9
The most important, classical decision theory,
assumes that people are perfectly informed, and
are familiar with all the alternatives that are
available to them, as well as their beliefs and
preferences associated with these alternatives. 
The rational or best course of action is the one 
that maximises expected utility.
7
Descriptive theories, in contrast, describe how
people actually make decisions.
10 At least since Health Technology Assessment 1999; Vol. 3: No.1
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the early 1950s it has been clear that people 
rarely do this in accord with normative theories.
11
Simon suggested that because of their limited
processing capacity, or bounded rationality,
individuals adopted more simplistic modes of
thinking that are generally good, but can lead 
to poor decision making.
12,13
The third type of decision-making theory,
prescriptive theory, recognises that human beings
can be poor decision makers and is concerned with
the development of decision aids to help them.
14
Early approaches were based on a modified norm-
ative theory, taking into consideration evidence
from how people actually make decisions unaided.
For example, social cognition models
15 and
prospect theory
4 maintain that an individual’s
behaviour is logically related to their values and
beliefs. However, by describing the underlying
cognitive processes such as attitudes, biases or
schemas, they permit the development of more
effective decision aids.
An understanding of informed decision making in
patients depends, in part, on knowing how patients
currently make decisions (descriptive theory) and
how they can be assisted to make better decisions
(prescriptive theory). There are many descriptive
theories relevant to this issue. One concerns the
simplistic modes of thinking (heuristics) used when
judging risk and uncertainty,
7,12,16 which can lead to
misperceptions of risk and poor decisions. Similarly
framing, the way a problem is presented, for
example, emphasising gains rather than losses,
affects risk-taking propensity (preference for a safe
over an equivalent risky option).
4,17 Another sub-
optimal way in which people tend to gather and
interpret information is illustrated by the confirm-
ation bias, involving the selective processing of
information that confirms initial expectations.
7
Both professionals and the lay-population are
subject to these simplistic modes of thinking.
18,19
People’s commitments to different courses of
action are affected by the procedure used to
establish their preferences. They often judge one
alternative as more attractive but select another
when asked to choose between them.
16 This
suggests that preferences are not necessarily a 
good guide to final choices, and challenges the
view that people have stable preferences for
decision outcomes. 
People adopt a range of different underlying
information processing strategies for different
problems, with each strategy differentiated in 
terms of the mental effort required and the
accuracy/quality of the decision.
13 Many factors,
such as fatigue, time pressure, stress and other
emotional states, and lack of engagement with the
problem, induce the use of simpler sub-optimal
strategies.
5,20,21 Similarly the school of naturalistic
decision making has shown that people make
decisions in very different ways when they have
expertise and experience to draw on.
23
Not surprisingly such theories have given rise to
many different ways to improve decision making.
One approach has involved specifying a structured
sequence of activities similar to those specified by
normative theories, for example, decision analysis
and the use of decision trees for risky decisions, or
Analytical Hierarchy Process for riskless ones.
14,24
A second approach, scenario planning
25 has 
been developed for strategic decisions involving
outcomes that occur only in the medium-to-long
term, and which cannot be ascribed probabilities.
This involves developing positive and negative
scenarios that describe how the future could
unfold, and choosing the action that is best,
regardless of which does occur. A third approach
involves training people to reason more effectively
such that they follow rules based on formal 
models from statistics, logic and probability
theory.
26 All such approaches recognise that 
different types of decision require different 
types of prescriptive solution.
27
Taken together, this body of theory provides a rich
source of information for judging patient decision
making, and the development of evidence-based
medicine has provided the impetus for a critical
evaluation of decision aids. Interventions aimed at
supporting patient decision making should be
developed in the context of these bodies of theory,
and a primary function of this review is to assess 
the extent to which the published literature on
informed decision making in patients achieves 
this. In addition, this body of knowledge provides 
a base for evaluating the existing research on
informed decision making, and to determine
whether the implicit and explicit models of
decision making underlying this research are
coherent and appropriate. 
Aims of review
The aim is to provide a comprehensive, annotated
bibliography of controlled studies of interventions
that might plausibly inform patient healthcare
decision making. Studies have been classified by
the hierarchy of evidence and by theoretical con-
text. Information about the type of intervention,Introduction
4
health setting, measures reported and main
research findings are recorded. The bibliography
provides a summary of the evidence describing
patient decision making, factors associated with
decision making, evaluated interventions and
theory-driven research. Such a review will enable
identification of under-reported areas and aim to
provide answers to the following questions.
• Can decision making be facilitated?
• Do people who have more information make
better decisions?
• Does the way in which we present information
change the effectiveness of the decision?
• Does the context affect decision making?
• Does the effectiveness of information on
decision making vary by medical setting?Health Technology Assessment 1999; Vol. 3: No.1
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Search strategy
Studies considered for inclusion within the
systematic review were first identified from 
abstracts generated from one of two sources:
electronic databases and handsearches of com-
plete sets of journals. Articles were retrieved if 
the review criteria were met or the abstract
contained insufficient information to assess 
the review criteria.
Electronic databases
Over 6 months a search strategy was developed for
the electronic databases MEDLINE, PsycLIT, and
BIDS (social science). A pilot strategy had been
developed for inclusion within the initial protocol
from a set of keywords chosen by the project group.
Additional keywords were included within the
strategy derived from: 17 articles considered
relevant to the field of informed patient decision
making (appendix 1); and 100 articles considered
for inclusion within the review following appli-
cation of the pilot strategy to MEDLINE and hand-
searching of the journal Medical Decision Making.
The keywords of the final strategy were modified
and expanded within each of the electronic
databases by the research officer experienced 
in electronic searches and systematic reviews
(appendix 2). The final strategy included terms
from three categories: decision making field or
healthcare users and comparative study designs
(appendix 3).
The sensitivity of the search strategy was 
evaluated by comparing the number of articles
identified by handsearching a second journal,
Patient Education and Counseling. The pilot strategy
identified 7% of articles considered for inclusion
while the final strategy identified 62%. This
sensitivity figure was considered satisfactory as
electronic searches identify between 17–82% 
of relevant articles.
28 However, these efforts to
increase sensitivity resulted in significantly 
reducing the specificity of the final strategy, 
as 17,860 abstracts were generated for the 
years 1991–96 alone. Consequently, the appli-
cation of the strategy was limited to articles 
published between these years to ensure
completion of a review considering the 
resources available.
Handsearching
Three journals were selected for handsearching
because of their relevance to the healthcare users
decision making area: Medical Decision Making,
Patient Education and Counseling, and Preventive
Medicine. In the handsearch, every abstract 
within every volume was read and considered 
for inclusion. All volumes were handsearched 
for the years 1986–96 inclusive.
Inclusion criteria
The review inclusion criteria were developed 
over 4 months, during which over 300 abstracts
downloaded from the pilot MEDLINE and PsycLIT 
search strategies were circulated to all project 
group members. At monthly meetings, each group
member fed back the inclusion or exclusion status 
of each abstract. When members disagreed a
discussion took place until a set of working rules 
was developed. At the end of this development
phase, agreement between group members on 
the inclusion and exclusion criteria was reached.
Nevertheless, in this area there are no pre-defined
or obvious boundaries to be used for selection
criteria, and some of the cut-off categories may
appear arbitrary. For inclusion, each study published
within an article had to fulfil the following criteria.
• Study participants must be patients. A patient
was defined as any individual making a health
decision. Studies using university student
participants were excluded. Studies assessing
health professional decision making about
another individual’s care were excluded.
• A study must report a behavioural measure 
of the health decision made. This measure 
of reported or observed behaviour assesses
decision making, a more inclusive category than
informed decisions. This broad health behaviour
outcome measure incorporates many decisions
including: smoking; adherence to medication;
attendance for screening; and choices between
treatments like chemotherapy or surgery. The
issue of whether to include such lifestyle
decisions was debated extensively by the group.
Some members considered these to be often
affected more by other factors than the inform-
Chapter 2
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ation and decision process itself; others argued
that this is only a qualitative difference from
other health decisions and an arbitrary line
would have to be drawn if they were to be ex-
cluded. We decided to include such studies. The
health behaviour included real, in the sense that
an event happened, intended or hypothetical
outcomes. Studies were excluded if the health
behaviour measure assessed the effectiveness of a
pharmacological treatment such as one compar-
ing the effects of placebo gum with nicotine gum
on smoking cessation. Additionally, studies that
did not assess actual or reported behaviour were
excluded, such as those that only reported bio-
physiological measures, knowledge, satisfaction,
preferences or utilities, and changes in affect.
• A study must assess an experimental
intervention. The definition of an experimental
study was interpreted broadly to include any
design that evaluated an experimental group
with a comparison group. Studies with one of six
designs were included: randomised controlled
trial (RCT) with a low risk of bias (RCTa); RCT
with an unknown risk of bias (RCTb); RCT with
a high risk of bias (RCTc); non-randomised
concurrent; historical studies or ‘before and
after’ intervention with different samples; and,
‘before and after’ intervention with the same
sample. Studies assessing predictors of a behavi-
our such as factors associated with breast screen-
ing attendance, were excluded. The definition 
of an intervention was broad to incorporate the
many factors that may alter decision making:
offering additional information; framing figures
in different ways; patient use of a decision aid;
comparison of information mediums; offers of
free transportation; introduction of fluoride 
to water supplies; and so on.
• The study must be published in English.
All abstracts generated from the search strategies
were assessed for inclusion by the first author of
this report. Articles were retrieved if the review
criteria were met or the abstract contained
insufficient information. Batches of ten articles
were sent in rotation to each member of the project
group. The inclusion criteria were again assessed by
that member of the project group and, if included,
a data extraction coding form was completed for
each study of each article. Completed forms were
returned to the first author of this report and
checked. Classification disagreements were
resolved by discussion. All review details and
extracted information were entered into the
project electronic database.
Data extraction
To ensure consistent information was extracted from
each study of each article, a data extraction sheet or
coding form was developed over a 6-month period
(appendix 4). The categories within the coding
form were informed with reference to the decision
making and integration of research literature, and
the expertise of members of the project group. Each
draft coding frame was piloted on articles derived
from the search strategies and modifications agreed
within the group monthly meetings. Following
piloting, several categories were simplified or omit-
ted because it proved impossible to achieve consist-
ency between articles, as the information published
was not described or presented in a format
compatible with the review’s research question.
There follows a brief explanation of the inform-
ation extracted from each article. 
Study identification number 
Each study was allocated a unique number. If more
than one study was reported in one article, each
study was given a separate identification number
and coding form. If a study was published more
than once in different articles, this too was treated
as a separate study.
Location of research 
This meant the country where the study 
was undertaken.
Domain of health care 
The area of health in which the decision was made
was recorded. Responses within this free-text box
were later categorised into 11 medical domains:
dentistry; cancer; general medicine and infectious
diseases; HIV and sexually transmitted diseases
(STDs); mental health; paediatrics; genetics;
obstetrics and gynaecology, and midwifery; surgery
and accident and emergency (A&E); primary care;
other (alternative medicine, marital counselling).
Participants 
The person making the health decision whom may
or may not receive the health care was recorded.
Age groups 
Participants were classified as child, adult, or
elderly by the reviewer.
Health status 
Participants were classified by the reviewer as well,
physically impaired, or mentally impaired by the
reviewer. For example, participants attending for:
health promotion programmes were classified asHealth Technology Assessment 1999; Vol. 3: No.1
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‘well’; athletes foot, cancer follow-up, and surgery
were classified as ‘physically impaired’; depression,
anxiety, and schizophrenia were classified as
‘mentally impaired’. If the decision maker was a
spouse or relative, the health status recorded was
that of the person making the decision not the
recipient of the decision. So, the decision maker
carer of a person with Alzheimer’s disease was
classified as ‘well’.
Decision associated factor 1 
Decisions were classified as real, hypothetical or
intended. Real decisions were those health actions
carried out by the participant such as attending for
mammography or using an inhaler. Hypothetical
and intended decisions were later combined and
included decisions made based on an option
becoming available in the future, a vignette based
on imaginary decisions and intentions about future
behaviours. For example, a non-pregnant woman
making a decision to have a test for Down’s
syndrome in a future pregnancy, or an individual
intending to use a condom during the next 
sexual encounter.
Decision associated factor 2 
Decisions were classified as implicit or explicit
according to whether the researchers and decision
makers were aware that they were making a 
health decision.
Decision associated factor 3 
Studies were classified into those where the
decision maker was the recipient of the decision
outcome or those where the recipient was a third
party. For example, a decision to be immunised
compared with having a child immunised. Some
decisions were more difficult to classify and minor
rules were established: decisions made by pregnant
women were classified as participant even though
decisions about amniocentesis and termination
would impact on a foetus; and use of condoms was
said to affect both the participant and other.
Decision associated factor 4 
Studies were classified into those where the
decision was time restrained, made at the same
time as the intervention, and those that were not
time restrained, made some while after the
intervention. The important difference being
whether the participant was given the opportunity
to reflect on, and change, the decision.
Health decision 
A free-text box was provided to write the type of
health decision made. These decision types were
then classified into one of six decision categories:
• to use a health service
• to make a lifestyle change
• to attend for testing (screening and diagnostic)
• to adhere to treatment regimens
• to actively participate within the consultation
(e.g. question asking and research)
• other (e.g. organ donation and willingness to pay).
Theoretical context 
This noted the authors’ references to a theoretical
framework that informed the study design or
intervention. Any type of theory alluded to was
noted in the free-text box and subsequently
classified into one of the following four categories:
• no theory
• explanation decision-making theory (social
cognition models, prospect theory and expected
utility theory)
• health-promotion theories (social learning
theory and skill acquisition theories)
• other psychological models (illness
representation, attribution theory and stress
coping models).
The project group did not assess the adequacy of
the operationalisation of theories nor infer whether
the research was theory driven if the authors did
not explicitly mention a theory.
Measures described 
This table was used to record any measure
described within the published paper other than
the health behaviour outcome measure. As noted
in the introduction, several measures have been
used to assess informed patient decision making,
and others are associated with the process of
decision making. A free-text box was used to list all
the measures the authors described. Before
piloting, the project group aimed to note the type
of analysis associated with each measure. However,
little consistency was achieved across papers in the
type of measures used and the reporting of results.
Subsequently, only the description of the type of
measures referred to was classified and grouped 
as follows:
• demographic variables: age, sex, level of
education, social class, marital status, religion
• personal history: sexual orientation, medical
history, law infringements, health insurance,
reproductive history, physiological assessment
• decision-making process measures: attitudes,
utilities, reasons, preferences, variables 
of operationalised models, perception of 
risk, perception of severity, autonomy, 
intention, motivationMethods
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• efficacy: efficacy and self-efficacy
• knowledge measures
• satisfaction: usefulness of information,
satisfaction with information
• affect: anxiety, depression, regret, worry
• personality factors: need for cognition, need 
for cognitive closure, locus of control
• other variables: perception of well being,
perception of disability, social support,
alienation, memory, willingness to pay.
Intervention groups 
This table provided a description of the main
components of each group assessed within the
experimental intervention. It was assumed that a
routine health encounter would include the
provision of verbal information by a health
professional to a patient. Any variation from this
norm was noted in the free-text box. For example,
comparison group: routine care; Group 1: routine
care plus leaflet; Group 2: routine care plus leaflet
plus free test. The main components were subse-
quently categorised within the following groups:
• additional information (leaflet, video, 
computer, posters)
• group-delivery information (media, classroom
based, group counselling)
• information manipulation (framing,
directiveness, more/less information)
• patient-prompted information (decision 
aid, memory prompt, pre-consultation 
rehearsal questions)
• service change (additional contact by health
professional, free service)
• environmental change (introduction of 
no-smoking policy, shops altering food displays)
• other (incentives, alternative treatment offered).
Quality of the study 1 
Study designs were classified according to the
hierarchy of evidence (Cochrane handbook) 
as follows:
• RCTa (e.g. randomisation from serially
numbered, opaque sealed envelopes, third party
or computer; low risk of bias)
• RCTb (e.g. unclear how randomised; unknown
risk of bias)
• RCTc (e.g. tossed coins or approached patients
on alternate days; high risk of bias)
• non-randomised concurrent (e.g. intervention
community compared with comparative
community)
• non-randomised historic (e.g. assessed uptake 
of cervical screening before and after
remuneration of doctors)
• ‘before and after’ studies with same sample 
(e.g. assessed cessation smoking before and 
after a workplace intervention).
Quality of the study 2 
This assessed the level of intervention. Studies 
were classified into those where the unit of inter-
vention was the individual patient, and those 
where some other unit of allocation such as
hospitals, communities, or patients allocated 
by health professional.
Quality of the study 3 
Where possible, details of the sample approached
were recorded in order to collect details on the
representativeness of the sample. First, whether 
the sample invited to participate included: all avail-
able participants; a systematic sample; a volunteer
or convenience sample; or, not adequately
described. Second, the actual number of partic-
ipants was recorded: those who were invited to
participate, those who participated, and those who
were included within the final analysis. The latter
was often difficult to extract from the published
information.
Quality of the study 4 
A free-text box was provided for reviewers to
highlight additional causes for concern, such 
as inappropriate use of statistics, confounds
between group allocation, and so on. However, 
as there was so much diversity between the types 
of study designs and application of analyses, the
comments within this box became meaningless,
and it was subsequently omitted from the 
final bibliography.
Quality of the study 5 
Within the area of informed patient decision
making, the issue of the readability and accessibility
of intervention materials is of particular import-
ance when aiming to explain variations in
understanding. In an attempt to describe the
quality of intervention materials a category was
created to document whether or not the inter-
vention materials had been piloted or evaluated 
for readability. Unfortunately the information
pertaining to this extraction was inconsistently
reported, if mentioned at all, and was omitted 
from the final coding of articles. 
Data synthesis
Four new variables were calculated to encourage
integration of the research findings with the 
review objectives.Health Technology Assessment 1999; Vol. 3: No.1
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• The theoretical context variable combined
information on reference to a theory-driven
study with reference to a decision-making
measure. Four classifications were created:
theory and decision-making measure; theory
only; decision-making measure only; neither
theory nor decision-making measure.
• The summary of reported effects variable was a
crude record of whether the authors reported an
effect size between the intervention and health
behaviour outcome measure: effect reported; no
effect reported; mixed effects reported (e.g.
different interventions did not show differential
effects but an effect over time or some behaviour
changes showed an effect and others did not).
• The single variable for health domain was
created to maximise the efficiency of subsequent
chi-square analysis. A few studies classified as
being associated with more than one area of
health were modified to force this information
into one mutually exclusive category.
• The single variable for health decision was
created to maximise the efficiency of subsequent
chi-square analysis. A few studies classified as
being associated with more than one type of
decision were modified to force this information
into one mutually exclusive category.
First, the results were presented as descriptive
summaries and listings of articles by study number,
grouped by health domain, decision and
theoretical context.
Second, the review identified five studies that 
were described as ‘good’ studies because they
fulfilled the following criteria: design reported 
as RCTa; referred to a theory when designing 
the study or intervention; and assessed at least 
one decision-making measure. The findings of
these studies are discussed in detail with refer-
ence to the reviews objectives. However, no
meaningful quantitative meta-analysis have 
been applied as the reported information 
was too diverse.
Third, non-parametric analyses were used in an
attempt to answer the five questions outlined within
the aims. The associations between the reported
effect of the intervention on the health behaviour
and health domain, health decision, and type of
intervention were assessed.
The trajectory of knowledge
The number of studies using different types of
methodology, using a decision-making theory, and
recording an informed decision outcome were
analysed by publication year. Results were plotted
for the 5 years 1991, 1992, 1993, 1994 and 1995, for
which both a full-year computer-based search and
handsearch had been done.Health Technology Assessment 1999; Vol. 3: No.1
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A
total of 547 reports fulfilled the inclusion
criteria and formed the bibliography. They 
are listed by study number in appendix 5 and
alphabetically by author in appendix 6.
As the amount of extracted information is large,
there are several ways to synthesise and present 
the results. The remaining format of this section
summarises the information in accordance with 
the research aim of this review. The bibliography is
available in electronic format from JG Thornton,
Centre for Reproduction, Growth and Develop-
ment, 34 Hyde Terrace, Leeds, LS2 9LN. 
Summaries of extracted
information by study
Appendices 7 and 8 summarise all the information
extracted following application of the coding form.
Appendix 7 includes information on: health
decisions; domain of health care; health status 
and age of participants; reported theoretical
context; intervention groups; and, reported
measures. Appendix 8 includes: level of inter-
vention; sample size; representativeness of 
sample; and summary of reported results.
Both tables follow the order of: study design 
(RCTa, RCTb, RCTc, non-randomised concurrent,
non-randomised historical, and ‘before and after’
same sample); theory (did or did not report a
theory); and health domain.
Summary by frequency tables
The following tables describe the number of 
studies within each of the following coding frame
categories: study design; type of intervention; health
decision; health area; theory; decision associated
factors; reported measures; theoretical context; and,
reported effects. Two tables are reported for each
category. The first table shows the number of studies
within each level of the category. As this review has
referred to the hierarchy of evidence as a means of
quality assessment, the second table reports the
number of studies within each level of category by 
study design.
Study design
Table 1 describes the number of studies by one of
six study designs.
Type of intervention
Tables 2 and 3 describe the number of studies using
a particular type of intervention such as written
leaflet or the provision of free transport. Note that
these categories are not mutually exclusive. For
example, one study may have assessed a number 
of written leaflets framed in different ways, or 
a media intervention compared with leaflet
distribution in clinics. For example, 67% of 
RCTa studies compared the effects of additional
information with the health decision whereas only
10% evaluated the impact of patient prompt.
Health decision
Tables 4 and 5 describe the number of studies looking
at a particular health decision or health behaviour.
Note that these categories are not mutually exclusive
and a study may be classified more than once. For
example, a healthy diet programme may have two
stages involving cholesterol screening and change 
in food choice resulting in both the lifestyle and
testing health-promotion categories being recorded.
Seventy-one per cent of concurrent studies looked 
at lifestyle change decisions.
The frequencies for the modified, mutually
exclusive health decision variable were: lifestyle
change, 275 (50%); attendance testing, 103 (19%);
adherence treatment, 92 (17%); utilisation of
services, 51 (9%); and, other, 26 (5%).
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TABLE 1  Frequency of study design (n = 547)
RCTa RCTb RCTc Concurrent Historical Before/after 
low-risk bias unknown bias high-risk bias same sample
Number of studies 51 208 77 114 34 63Results
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TABLE 2  Frequency of intervention type
Type of intervention Examples  n
Used additional information Written leaflet,audio-tape,video-tape,computer 301
Manipulated information Illustrations,framing,graphics 94
Changed delivery of information Letter,telephone,physicians versus nurse 273
Provided feedback Demonstrate learnt skills,results of screening test 208
Used patient prompt Decision aid,memory  55
Used group-delivery information Media,classroom,community programmes 273
Manipulated environment No-smoking policy,design inhaler,free service 109
Other Patient incentives,health professional prompt 89
TABLE 3  Frequency of studies by type of interventions and design
RCTa RCTb RCTc Concurrent Historical Before/after
same sample
Used additional information 34 105 52 58 16 36
Manipulated information 15 50 17 11 0 1
Changed delivery of information 27 111 47 50 10 28
Provided feedback 14 81 33 47 5 28
Used patient prompt 5 19 15 9 2 5
Used group-delivery information 11 48 21 63 14 31
Manipulated environment 12 29 11 30 13 14
Other 4 38 9 20 7 11
TABLE 4  Frequency of studies by type of health decision
Type of decision Examples  n
Utilisation of services Attendance at appointment,use call-out service 51
Health promotion – changes lifestyle Smoking,drinking,exercise,substance use,safe sex 357
Health promotion – attendance testing Breast,colorectal,cervical screening 114
Adherence to treatment Medication,surgery,behavioural therapy 107
Active participation Question asking within consultation,taking part in research 20
Other Organ donation,willingness to pay 6
TABLE 5  Frequency of studies by health decision and study design
RCTa RCTb RCTc Concurrent Historical Before/after
same sample
Utilisation of services 8 20 9 7 4 3
Health promotion – changes lifestyle 28 128 47 81 21 52
Health promotion – attendance testing 14 39 18 22 10 11
Adherence to treatment 12 46 14 18 6 11
Active participation 3 11 3 0 1 2
Other 0 3 1 2 0 0Health Technology Assessment 1999; Vol. 3: No.1
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Health domain
Tables 6 and 7 describe the number of studies within
a particular health domain. Note that these cate-
gories are not mutually exclusive and a study may 
be classified more than once. For example, a study
looking at postnatal depression may be classified 
as both midwifery and mental health, or a smoking
study may come under both general medicine and
cancer. Eighteen per cent of ‘before and after’ 
same-sample studies assessed an intervention
associated with cancer care or prevention.
The frequencies for the modified, mutually
exclusive health domain variable were: general
medicine, 189 (35%); cancer, 109 (20%); the
human immunodeficiency virus (HIV) and STDs,
103 (19%); primary care, 55 (10%); obstetrics, 
29 (5%); and, other, 62 (11%).
Theory
Tables 8 and 9 describe the number of studies 
that referred to a theory to drive the research.
These show that 85% of historical studies were 
not theory driven.
Decision associated factors
As there was little variation between studies on
these four variables, the frequencies are reported
within the text, and no ‘by design’ frequencies 
are given.
TABLE 6  Frequencies of studies by health domain
Health domain Examples n
Cancer Breast,testicular,colorectal,cervical 114
Dentistry Oral hygiene 10
Genetics Huntington’s chorea,cystic fibrosis (CF),sickle cell 7
General medicine Cardiovascular disease (CVD) risk (smoking,exercise, 251
alcohol),chronic illness (asthma,diabetes)
HIV and STD Condom use,needle exchange 108
Mental health Depression,scizophrenia,anxiety 15
Obstetrics,gynaecology and midwifery Prenatal care,breast feeding,infertility 31
Paediatrics Sudden infant death syndrome 6
Primary care Coughs,colds,immunisations 61
Surgery and A&E Urology,ophthalmology 11
Other Alternative medicine,marital difficulties 13
TABLE 7  Frequency of studies by health domain and design
RCTa RCTb RCTc Concurrent Historical Before/after
same sample
Cancer 13 44 16 22 8 11
Dentistry 0 5 0 2 3 0
Genetics 1 1 2 2 1 0
General medicine 22 104 36 54 8 27
HIV and STD 6 32 12 28 8 22
Mental health 3 8 1 2 0 1
Obsetrics,gynaecology and midwifery 6 8 6 4 3 4
Paediatrics 0 3 0 1 2 0
Primary care 5 30 9 8 3 6
Surgery and A&E 2 3 2 3 1 0
Other 0 2 5 3 2 1Results
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• Number of studies that referred to real of
hypothetical decision: real decisions, 512 (94%).
• Number of studies that encouraged patients to
play an active part or increase awareness of the
decision-making process: explicit decision-
making process encouraged, 26 (5%).
• Number of studies where the recipient of the
decision outcome was the participant or a 
third party: recipient same as decision 
maker, 476 (87%).
• Number of studies wither with or without time
restraint: no time restraint, 525 (96%).
Reported measures
Tables 10 and 11 describe all the measures reported
by the study authors within the text. Note that these
categories are not mutually exclusive. One study
may have reported demographic variation, assessed
anxiety and described reasons for choosing the
final behaviour.
Theoretical context
This derived variable describes the number of
studies that reported a theoretical framework and 
a decision-making process and outcome measures
(Tables 12 and 13). It attempts to provide an inform-
ed decision-making variable classification. Only five
(10%) of RCTa studies referred to a theory and
measured some aspect of ‘informed’ decision
making such as attitudes or reasons.
Reported effects
Tables 14 and 15 describe the number of studies
that reported as association, or not, between the
intervention and the health decision outcome. 
This is a crude measure based on the results
reported by the study authors and no independent
verification of the quality of the study has 
been incorporated.
Summary by study number listings
To facilitate identification of studies, the study
numbers of articles are listed by various categories in
Tables 16–20. The study number suffixes (indicating
the number of studies within an article) have been
omitted for this summary unless required to avoid
ambiguity. Study numbers in Tables 16–19 are
grouped into the following categories:
• type of intervention
• health decision
• health area
• theoretical context.
Study numbers in Table 20 are all RCT studies classi-
fied as most likely to assess informed patient deci-
sion making. That is to say, studies that have referred
to a decision-making theory and assessed a decision-
making process measure. the studies in Table 20 are
grouped according to type of intervention.
Synthesising findings
Two techniques were used in an attempt to
synthesise the review findings. First, the integration
of research findings from the five good studies that
fulfilled the specific criteria. Second, the appli-
cation of chi-square analysis to the crude measure
of reported effect with the following variables:
TABLE 8  Frequency of studies by theory reported
Type of theory Examples n
No theory reported 341
Decision-making theory Prospect theory,framing bias,health belief model (HBM),stages  101
change,theory planned behaviour
Health promotion theory Social learning theory (SLT),skill-based theory 63
Other theories Attribution,stress-coping model,illness representation 42
TABLE 9  Frequency studies by theory reported and study design
RCTa RCTb RCTc Concurrent Historical Before/after
same sample
No theory reported 36 116 41 67 29 52
Decision-making theory 7 48 20 19 2 5
Health promotion theory 2 26 7 23 1 4
Other theories 6 18 9 5 2 2Health Technology Assessment 1999; Vol. 3: No.1
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TABLE 10  Frequency of studies by measures reported
Measures Examples n
Demographics Sex,age,level of education,marital status,religion 515
Personal history Medical and family history,physiological assessment 386
Decision making Attitudes,reasons,preferences,perception of risk,social norms 169
Self-efficacy Perception of efficacy and self-efficacy 75
Knowledge Knowledge 181
Satisfaction Perceived satisfaction and usefulness  60
Affect Depression,anxiety,worry,relief 69
Trait Type A,locus control,cognitive closure 20
Other Social support,coping,health professional measures 111
TABLE 11  Frequencies of studies by measures reported and study design
RCTa RCTb RCTc Concurrent Historical Before/after
same sample
Demographics 51 198 76 106 28 56
Personal history 43 159 52 78 17 37
Decision making 11 63 27 35 9 24
Self-efficacy 6 32 11 19 0 7
Knowledge 12 57 27 49 9 27
Satisfaction 9 24 12 5 18 4
Affect 7 39 10 5 0 6
Trait 2 7 3 6 0 2
Other 9 45 16 29 5 7
TABLE 12  Frequency of studies by theoretical context
n
Theory and decision-making measures 96 
Theory only 110 
Decision-making measures only 73 
No theory or decision-making measure 268 
TABLE 13  Frequency of studies by theoretical context and study design
RCTa RCTb RCTc Concurrent Historical Before/after
same sample
Theory and decision-making measures 5 47 16 21 1 6
Theory only 10 45 20 26 4 5
Decision-making measures only 6 16 11 14 8 18
No theory or decision-making measures 30 100 30 53 21 34Results
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design; intervention; health domain; health
decision; and, theoretical context.
Five good studies
The following five studies used an RCT with low risk
of bias, reported ‘informed’ decision-making
variables and referred to a theory.
• 197 - 1 Plaskon PP, Fadden MJ. Cancer screening
utilisation: is there a role for social work in
cancer prevention? Social Work in Health Care
1995;21(4):59–70.
• 310 - 1 Quaid K, Faden R, Vining E, Freeman J.
Informed consent for a prescription drug:
impact of disclosed information on patient
understanding and medical outcomes. Patient
Education and Counseling 1990;15:249–59.
• 325 - 1 Schultz S. Educational and behavioural
strategies related to knowledge of and partic-
ipation in an exercise program after cardiac
positron emission tomography. Patient Education
and Counseling 1993;22:47–57.
• 542 - 1 Simel DL, Feussner JR. A randomised
controlled trial comparing quantitative informed
consent formats. Journal of Clinical Epidemiology
1991;44(8):771–7.
• 799 - 1 DiClemente RJ, Wingwood GM. 
A randomised controlled trial of an HIV 
sexual risk-reduction intervention for 
young African-American women. JAMA
1995;274(16):1271–6.
A formal integrative review of these five studies
would not be useful as each study evaluates a
different decision, refers to a different theory 
and considers different interventions. Some
participants were well and others physically ill, 
and some samples were selected systematically 
and others by convenience (Table 21).
Nevertheless, it appears that information and
education are not the most effective ways of facili-
tating informed decision making. One study found
that changing the amount of information about risks
and side-effects of a drug did not affect patients’
adherence to the treatment (Quaid et al). In another,
varying the quantitative information used to intro-
duce a new medication made no difference to the
decision to participate in a research trial in 55% of
out-patients (Simel and Feussner), though it did
influence the choice of the 45% who cited this
information in their decision. Although an education
intervention was found to increase exercise amongst
patients at risk of heart disease over a 12-week period,
this included behavioural planning (Schultz). When
other behavioural strategies of goal setting, self-
monitoring, positive reinforcement and telephone
follow-up were added, frequency of exercise was sig-
nificantly increased after 6 weeks. The importance of
situational factors was demonstrated in the decision
of general practice patients to use a kit for colorectal
cancer screening. All patients were given educational
information, but screening increased from 0% to
51% when patients were given a free kit rather than
told to go to the general practice office or to one of
three pharmacies to buy a kit (Plaskon and Fadden).
The role of cognitive and social, as well as behavi-
oural, factors in influencing decision making is evi-
dent in an intervention aimed at reducing HIV sexual
risk amongst African–American women (DiClemente
and Wingwood). Although an educational inter-
vention did not bring about change, a social skills
intervention, based on social cognitive theory and
theory of gender and power, increased condom use.
Although these studies are of disparate populations
making disparate decisions, they show the import-
ance of the context and social influences on
individual’s decision making.
TABLE 14  Frequency of studies reporting finding an effect or not
n
Effect reported 294
No effect reported 173
Mixed effects reported 80
TABLE 15  Frequency of studies by reported finding an effect or not and design
RCTa RCTb RCTc Concurrent Historical Before/after
same sample
Effect reported 29 100 38 61  20  46
No effect reported 15 79 31 33  7 8
Mixed effects reported 7 29 8 20  7 9Health Technology Assessment 1999; Vol. 3: No.1
17
TABLE 16  Study numbers (without suffix unless necessary) by type of intervention
Type of intervention  No.of  Study numbers
and study design studies
Additional information – written 258
RTCa 30 39,50,64,67,85,101,118,120,122,196,197,200,216,275,299,301,316,
325,333,350,387,393,483,509,542,648,724,741,778,793
RCTb 87 19,22,28,48,63,104,110,114,135,140,143,150,157,158,158,167,176,183,207,
210,211,213,216,232,233,234,241,259,265,268,269,277,279,285,288,295,
302,327,332,337,357,372,376,414,420,434,454,465,469,482,490,491,506,
511,520,525,530,533,541,572,587,600,616,632,632,635,639,644,652,667,
668,671,675,679,683,690,693,700,705,706,728,732,747,757,783,794,796
RCTc 46 58,72,83,98,115,154,169,170,181,242,248,254,287,296,303,320,324,
329,343,349,354,360,363,375,381,407,442,459,471,472,473,484,507,
508,528,601,640,646,649,712,717,743,752,754,790,792
Concurrent 53 3,44,125,136,146,171,177,180,203,205,205,206,215,237,243,245,246,251,
253,261,273,280,283,312,315,367,370,373,386,391,394,404,418,440,446,
448,453,463,464,504,515,516,579,628,631,663,665,709,726,740,780,791,813
Before/after different samples 16 26,97,149,192,193,294,340,383,462,495,514,575,619,658,670,765
Before/after same sample 26 35,42,111,126,133,162,163,218,244,262,266,270,348,384,449,450,
467,480,522,526,544,573,676,770,809,815
Additional information – audiotape 10
RCTa 2 117,581
RCTb 4 264,371,465,488
RCTc 3 154,472,754
Concurrent 1 663
Additional information – video-tape 74
RCTa 3 23,585,741
RCTb 27 28,55.1,55.2,155,207,241,289,341,376,424,438,454,458,491,502,533,616,
635,639,644,705,728,742,758,776,789,794
RCTc 15 37,181,254,287,293,310,329,354,484,528,640,646,696,720,762
Concurrent 13 184,205,205,240,246,261,311,313,464,579,628,631,791
Before/after different samples 3 26,294,658
Before/after same sample 13 35,49,79,123,364,450,467,526,594,610,651,655,746
Additional information – 
computer based 7
RCTb 5 327,396,488,493,667
Concurrent 1 40
Before/after same sample 1 795
Manipulated information – 
illustration or graphic 14
RCTa 2 50,117
RCTb 5 19,150,305,357,371
RCTc 4 324,459,473,649
Concurrent 2 177,448
Before/after same sample 1 723
Manipulated information – 
framing or quantity 84
RCTa 14 39,67,101,117,118,275,301,393,542,724,755,778,793,799
RCTb 47 19,55,86,105,137,158,167,176,183,211,226,288,295,305,321,327,
332,341,420,426,434,438,482,490,491,494,533,587,600,634,636,644,
653,667,668,671,683,685,690,693,727,742,747,757,772,783,789
RCTc 14 115,310,377,380,381,471,473,481,507,512,684,691,752,788
Concurrent 9 136,257,280,386,453,586,748,760,822
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TABLE 16 contd  Study numbers (without suffix unless necessary) by type of intervention
Type of intervention  No.of  Study numbers 
and study design studies
Change in delivery of information 
– community or hospital 10
RCTa 1 39
RCTb 3 47,234,564
RCTc 3 485,752,790
Concurrent 3 586,748,775
Change in delivery of information 
– alter contact with health 
professional 183
RCTa 18 52,64,117,196,200,202,325,333,350,585,606,638,648,678,724,778,781,799
RCTb 70 1,4,10,22,63,102,135,139,140,147,157,165,174,207,211,212,241,249,259,
263,268,269,276,277,285,289,291,304,328,336,341,353,365,369,403,439,
447,458,465,479,491,494,503,511,525,527,530,533,553,554,576,616,622,
629,632,632,635,636,639,659,693,702,707,728,742,766,776,783,807,814
RCTc 23 58,80,98,169,170,181,320,329,354,375,407,411,442,470,472,528,
601.2,640,695,720,754,763,792
Concurrent 36 71,82,89,95,136,171,177,194,205.1,205.2,206,237,246,251,253,256,260,
273,284,312,313,367.2,373,416,453,456,464,504,529,555,570,579,628,
726,740,791
Before/after different samples 8 26,239,340,462,575,619,623,674
Before/after same sample 28 35,38,49,84,111,123,162,218,244,262,270,367,449,480,521,544,621,650,
651,654,723,729,746,770,798,809,815,821
Change in delivery of information 
– letter 83
RCTa 10 39,41,52,101,216,275,299,316,378,648
RCTb 39 110,143,158.1,158.2,167,213,216,259,265,269,285,352.1,352.2,352.3,372,
395,414,420,426,439,447,469,543,566,572,589,620,630,634,652,653,668,
683,727,728,747,757,783,784
RCTc 19 56,115,154,172,248,296,320,349,363,381,412,484,507,512,640,712,717,
752,790
Concurrent 14 61,146,237,253,257,394,404,446,516,546,631,740,760,813
Before/after different samples 1 100
Change in delivery of information 
– telephone 47
RCTa 7 52,196,202,299,325,638,714
RCTb 23 63,139,143,168,233,265,288,304,352.2,353,369,403,408,414,420,482,
572,576,600,622,668,702,783
RCTc 9 287,380,475,481,512,640,711,754,788
Concurrent 3 257,394,446
Before/after different samples 4 26,239,514,619
Before/after same sample 1 218
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TABLE 16 contd  Study numbers (without suffix unless necessary) by type of intervention
Type of intervention  No.of  Study numbers 
and study design studies
Provision of feedback or skills 
acquisition 208
RCTa 14 64,107,120,275,316,325,387,393,585,648,714,755,781,799
RCTb 81 4,10,20,22,104,110,114,135,140,145,147,157,165,174,207,210,212,
216,217,220,223,226,233,241,247,263,264,268,269,277,291,295,307,
327,328,341,371,396,414,424,439,454,458,478,479,491,492,502,503,
511,525,527,530,533,541,553,562,576,616,630,632,632,635,636,644,
660,667,668,679,685,690,700,705,707,742,758,766,772,776,783,814
RCTc 33 72,80,98,115,154,287,293,320,329,354,360,375,377,381,405,407,442,
472,475,481,601,640,646,649,684,696,708,720,749,754,788,792,817
Concurrent 47 3,17,18,89,125,136,177,184,222,240,246,251,253,273,283,284,311,
313,315,335,345,367,370,373,385,386,394,404,416,440,448,453,486,
504,515,555,628,631,663,726,731,740,759,760,791,813,823
Before/after different samples 5 26,149,619,623,765
Before/after same sample 28 35,42,46,49,84,99,123,132,133,159,162,270,355,361,364,384,449,
450,480,521,522,526,594,621,654,676,688,729
Patient prompt – use of decision aid 5
RCTb 2 396,493
RCTc 1 472
Before/after same sample 2 42,594
Patient prompt – use of memory 
or information aid 45
RCTa 4 85,333,378,387
RCTb 13 157,269,372,420,447,469,482,506,576,700,707,783,794
RCTc 14 115,154,172,254,303,343,360,381,481,601,640,691,712,763
Concurrent 9 44,243,246,253,315,394,448,631,760
Before/after different samples 2 340,421
Before/after same sample 3 162,449,544
Patient prompt – shared health 
professional/patient decision making 5
RCTa 1 678
RCTb 4 27,279,337,564
Group delivery of information 163
RCTa 11 50,107,117,120,200,483,585,648,724,778,799
RCTb 46 1,4,22,96,143,145,147,174,207,211,212,223,241,255.2,263,264,269,
277,285,328,341,414,424,438,478,479,489,491,492,494,530,533,553,
564,616,632,632,635,636,659,660,705,736,766,807,814
RCTc 21 58,72,80,98,254,303,320,354,375,405,407,442,485,640,649,684,696,
720,743,749,792
Concurrent 46 3,18,44,45,95,125,136,146,180,184,203,222,238,240,253,258,261,
273,280,283,284,335,370,373,385,416,440,448,453,456,463,515,555,
570,579,608,628,665,686,709,731,740,759,760,780,825
Before/after different samples 11 97,149,192,340,383,461,514,662,670,680,765
Before/after same sample 28 38,42,49,79,99,123,132,133,159,262,270,348,355,361,364,467,521,
522,526,573,621,650,651,654,657,723,746,809
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TABLE 16 contd  Study numbers (without suffix unless necessary) by type of intervention
Type of intervention  No.of  Study numbers 
and study design studies
Change in health service provision 83
RCTa 9 39,41,52,64,197,425,509,714,741
RCTb 21 47,48,135,143,213,234,269,285,289,352.3,372,376,439,454,554,566,683,
732,736,768,769
RCTc 10 56,254,287,293,296,412,470,484,646,752
Concurrent 22 3,75,136,146,177,180,203,237,243,256,312,397,448,452,455,464,516,529,
618,686,726,822
Before/after different samples 8 340,383,421,462,575,737,765,767.1
Before/after same sample 13 38,163,218,244,342,355,537,655,729,770,795,798,809
Manipulation of the environment 23
RCTa 2 216,229
RCTb 1 220
RCTc 2 56,442
Concurrent 10 18,75,180,206,215,235,251,284,390,464
Before/after different samples 6 142,149,423,462,550,563
Before/after same sample 2 270,537
Group delivery – use of media 70
RCTb 6 22,135,143,217,285,705
RCTc 2 58,792
Concurrent 38 3,18,44,45,146,171,180,184,203,205.1,205.2,206,215,222,237,238,243,246,
251,258,280,311,312,323,335,367.2,391,448,463,464,608,631,665,686,709,
726,740,780
Before/after different samples 14 97,149,192,340,383,461,462,514,619,658,662,670,680,765
Before/after same sample 10 38,42,49,162,218,367,522,657,746,809
Other – health professional 
prompts for action 14
RCTa 1 724
RCTb 1 395
Concurrent 5 205,404,455,791,822
Before/after different samples 4 34,192,401,413
Before/after same sample 3 466,522,809
Other – patient incentives 32
RCTa 2 64,200
RCTb 12 22,102,135,156,165,216,269,352,424,644,652,814
RCTc 2 106,115
Concurrent 7 18,44,184,280,283,367,515
Before/after different samples 3 149,462,765
Before/after same sample 6 162,179,262,367,450,688Health Technology Assessment 1999; Vol. 3: No.1
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TABLE 17  Study numbers (without suffix unless necessary) by health decision
Health decision  No.of  Study numbers 
and study design studies
Decision to use a service 
e.g.attend an appointment,
use a call-out service 51
RCTa 8 196,202,333,425,606,638,678,714
RCTb 20 10,20,27,28,167,302,337,369,372,376,426,439,494,511,520,554,706,733,
769,796
RCTc 9 83,106,172,248,320,470,481,717,788
Concurrent 7 75,82,323,331,394,504,748
Before/after different samples 4 97,294,563,737
Before/after same sample 3 42,537,676
Decision to make a lifestyle 
change (health promotion)
e.g.stop smoking,exercise 357
RCTa 28 23,50,64,85,101,107,118,120,196,200,216,229,299,316,325,333,350,378,393,
581,585,648,724,741,755,781,793,799
RCTb 128 1,4,22,24,27,32,47,55,55,63,86,102,104,110,135,139,140,143,145,147,156,
157,158,158,165,174,183,207,210,211,212,213,216,217,220,223,226,233,234,
241,247,249,255,259,263,264,265,268,269,276,277,279,288,289,291,295,305,
307,308,321,327,328,336,341,356,365,371,372,376,395,396,398,402,403,408,
414,424,426,454,457,458,465,478,489,490,491,492,503,511,525,533,541,553,
562,564,572,574,576,600.616,620,632,632,633,635,636,639,644,659,660,
668,679,685,690,705,707,732,733,736,742,758,766,768,772,776,783,
807,814
RCTc 47 72,80,98,115,154,170,181,242,254,287,293,296,310,320,324,329,360,363,375,
405,407,442,459,471,472,473,475,484,485,512,528,601,601,640,646,649,684,
696,708,720,749,752,754,762,777,792,817
Concurrent 81 3,17,18,40,71,89,95,125,136,146,161,171,177,180,184,194,206,209,215,222,
235,237,238,240,245,246,251,253,255,256,257,258,260,261,273,280,283,284,
311,312,313,345,367,370,373,385,386,390,391,392,409,416,440,453,455,456,
463,464,515,529,555,570,579,618,628,631,663,665,709,726,731,740,759,773,
775,779,780,791,813,822,823
Before/after different samples 21 26,97,100,142,149,239,340,421,423,461,462,514,550,619,623,647,658,662,
680,765,767
Before/after same sample 52 35,38,49,79,84,91,123,126,132,133,159,162,163,179,198,218,244,262,266,
270,342,348,355,364,367,384,450,466,467,480,521,522,526,544,545,573,610,
621,650,651,654,655,657,676,688,723,729,746,770,798,815,821
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TABLE 17 contd  Study numbers (without suffix unless necessary) by health decision
Health decision  No.of  Study numbers 
and study design studies
Decision to attend for testing 
(health promotion)
e.g.breast/colorectal screening 114
RCTa 14 39,41,52,85,101,108,117,122,197,275,316,333,509,778
RCTb 39 48,86,114,232,285,288,289,305,307,352,352,352,353,372,395,420,438,439,
482,491,543,566,587,589,620,630,634,652,653,675,683,690,713,727,728,747,
757,784,789
RCTc 18 37,56,154,248,296,354,377,380,381,412,484,507,508,695,712,743,752,790
Concurrent 22 44,45,61,171,203,205,205,243,246,257,394,397,404,418,446,448,516,546,608,
686,760,813
Before/after different samples 10 34,192,193,294,383,401,421,575,670,737
Before/after same sample 11 46,99,126,133,348,384,466,746,795,809,815
Decision to adhere to treatment 
regimen e.g.drugs,surgery,
behaviour therapy 107
RCTa 12 53,202,216.2,229,299,301,333,378,427,483,714,781
RCTb 46 6.1,6.2,6.3,51,57,63,88,96,104,105,137,139,150,167,168,176,234,291,304,327,
328,332,357,369,395,402,414,434,447,469,479,488,502,527,530,564,572,612,
622,633,671,693,698,702,768,794
RCTc 14 98,169,170,181,303,349,363,380,411,471,512,691,711,763
Concurrent 18 18,71,82,95,124,146,313,315,323,331,335,452,455,486,586,618,775,825
Before/after different samples 6 193,239,413,563,674,767
Before/after same sample 11 42,74,342,361,449,466,522,544,594,655,676
Decision to take an active part 
in consultation or participate 
in research 20
RCTa 3 67,387,542
RCTb 11 155,216,434,488,493,506,600,629,667,700,816
RCTc 3 343,472,601
Before/after different samples 1 495
Before/after same sample 2 111,594
Other decisions e.g.donate an 
organ,pay for treatment 6
RCTb 3 19,176,408
RCTc 1 58
Concurrent 2 190,430Health Technology Assessment 1999; Vol. 3: No.1
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TABLE 18 Study numbers (without suffix unless necessary) by health domain
Health domain  No.of  Study numbers 
and study design studies
Cancer 114
RCTa 13 23,39,41,52,85,101,108,117,122,197,275,316,509
RCTb 44 48,86,114,140,207,232,263,269,285,288,307,352.1,352.2,352.3,353,395,420,
434,438,458,482,488,491,527,533,541,543,566,587,630,653,667,675,683,690,
700,705,713,727,728,757,784,789,816
RCTc 16 37,154,248,296,310,354,377,380,412,484,507,508,691,695,712,752
Concurrent 22 44,61,136,171,180,203,205.1,205.2,237,243,246,385,386,397,404,418,446,448,
546,608,686,760
Before/after different samples 8 34,100,192,383,401,421,575,765
Before/after same sample 11 46,99,126,133,198,266,466,746,795,809,815
Dentistry 10
RCTb 5 371,457,562,576,758
Concurrent non-randomised 2 529,618
Before/after different samples 3 97,563,737
Genetics 7
RCTa 1 778
RCTb 1 20
RCTc 2 743,790
Concurrent 2 430,516
Before/after different samples 1 294
General medicine 251
RCTa 22 50,53,64,67,118,120,196,200,216.2,229,301,325,350,483,542,581,648,714,
724,755,781,793
RCTb 104 1,10,20,27,28,32,47,55.1,55.2,57,63,88,102,104,105,110,137,139,140,143,
145,147,155,157,158.1,158.2,168,174,183,207,210,211,213,216,217,220,223,
226,233,241,247,249,255.2,259,263,264,265,268,269,276,277,279,291,295,
304,305,308,321,327,328,332,336,341,356,365,372,376,395,396,398,402,414,
426,439,447,469,489,490,502,503,527,530,541,564,574,600,612,620,622,629,
644,652,659,668,671,679,693,702,707,769,772,783,807,814
RCTc 36 56,72,80,115,169,170,242,254,287,303,310,320,329,343,360,375,381,405,411,
442,459,471,472,473,475,481,485,601.1,601.2,640,708,711,752,754,763,792
Concurrent 54 45,82,89,184,194,206,209,215,222,235,237,238,245,251,253,255,256,257,258,
260,261,273,280,283,284,311,312,313,315,323,345,367,370,390,394,409,416,
418,440,452,453,456,464,504,586,631,709,726,731,740,759,779,813,823
Before/after different samples 8 340,423,461,462,495,514,550,658
Before/after same sample 27 42,74,79,84,111,133,162,179,218,244,262,270,348,355,367,384,449,466,521,
522,544,594,621,657,676,798,821
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TABLE 18 contd Study numbers (without suffix unless necessary) by health domain
Health domain  No.of  Study numbers 
and study design studies
HIV and STD 108
RCTa 6 107,202,393,585,741,799
RCTb 32 4,22,24,156,165,212,223,226,247,277,289,341,424,454,465,478,492,525,600,
632,632,635,636,639,660,685,732,733,736,742,766,776
RCTc 12 181,360,407,528,646,649,684,696,720,749,762,817
Concurrent 28 17,18,71,125,161,177,240,251,311,373,391,392,453,455,463,486,515,555,579,
628,663,665,748,759,780,791,822,823
Before/after different samples 8 142,423,550,619,647,662,670,680
Before/after same sample 22 35,38,49,91,123,159,364,450,467,480,526,537,545,610,650,651,654,655,688,
723,729,770
Mental health 15
RCTa 3 67,427,606
RCTb 8 28,96,479,493,494,511,554,794
RCTc 1 717
Concurrent 2 124,825
Before/after same sample 1 361
Obstetrics and gynaecology,
and midwifery 31
RCTa 6 196,200,425,678,724,778
RCTb 8 135,137,403,616,634,698,733,768
RCTc 6 83,106,115,293,329,788
Concurrent 4 3,71,190,486
Before/after different samples 3 26,514,623
Before/after same sample 4 132,163,621,650
Paediatrics 6
RCTb 3 167,520,706
Concurrent 1 335
Before/after different samples 2 193,239
Primary care 61
RCTa 5 299,333,378,387,638
RCTb 30 6.1,6.2,6.3,19,27,32,47,51,167,174,234,302,337,357,369,395,408,414,426,506,
520,553,572,589,620,633,706,747,769,796
RCTc 9 98,172,363,470,512,601,601,752,777
Concurrent 8 95,146,190,257,331,418,775,813
Before/after different samples 3 193,413,767
Before/after same sample 6 62,342,348,466,537,573
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TABLE 18 contd Study numbers (without suffix unless necessary) by health domain
Health domain  No.of  Study numbers 
and study design studies
Surgery/A&E 11
RCTa 2 581,714
RCTb 3 150,490,622
RCTc 2 80,777
Concurrent 3 40,75,394
Before/after different samples 1 674
Other area of health care 13
RCTb 2 176,288
RCTc 5 58,170,293,324,349
Concurrent 3 194,570,773
Before/after different samples 2 149,461
Before/after same sample 1 84
TABLE 19  Study numbers (without suffix unless necessary) by reported theory and measure of informed decision making
Theory,measures No.of  Study  numbers 
and study design studies
Theory and measure reported 96
RCTa 5 197,301,325,542,799
RCTb 47 24,86,114,140,145,176,210,211,217,220,232,255.2,276,277,288,321,371,376,
420,424,426,434,438,454,458,478,492,502,525,616,620,622,632.1,632.2,635,
659,660,667,668,690,700,742,758,766,768,776,784
RCTc 16 72,115,242,354,360,380,472,507,640,691,696,717,749,762,792,817
Concurrent 21 89,180,238,240,253,255,313,345,370,373,391,416,453,515,516,608,663,709,
759,760,822
Before/after different samples 1 26
Before/after same samples 6 46,126,198,364,526,594
Theory only 110
RCTa 10 101,107,117,120,275,333,387,427,483,585
RCTb 45 1,4,19,20,27,104,157,158.1,158.2,165,167,207,223,226,233,241,247,264,269,
291,295,305,307,332,357,403,457,469,490,493,503,506,541,576,600,633,636,
644,685,707,757,789,794,814,816
RCTc 20 56,58,80,98,169,181,248,254,287,324,329,375,405,442,484,508,528,601.1,
601.2,646
Concurrent 26 17,18,95,136,184,190,209,237,251,261,311,367,386,404,440,446,456,463,464,
486,618,628,631,726,780,823
Before/after different samples 4 462,647,658,765
Before/after same sample 5 179,262,367,450,654
Measure only 73
RCTa 6 39,316,350,509,581,678
RCTb 16 102,105,135,147,183,212,249,302,336,341,489,494,520,562,698,783
RCTc 11 154,310,343,381,459,473,649,684,712,720,743
Concurrent 14 3,44,45,177,243,256,385,430,504,570,665,686,773,825
Before/after different samples 8 193,239,383,413,423,514,619,662
Before/after same sample 18 35,49,79,111,132,159,163,218,244,342,467,480,573,610,621,650,655,688Results
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TABLE 20  Study numbers (without suffix unless necessary) by intervention from informed decision-making RCTs
Intervention No.of Study  numbers 
and study design studies
Additional information 45 72,114,115,140,176,197,210,211,232,242,277,288,301,325,354,360,371,376,
420,424,434,438,454,458,472,502,507,525,542,616,632.1,632.2,635,640,667,
668,690,696,700,717,742,758,762,776,792
Additional written information 35 72,114,115,140,176,197,210,211,232,242,277,288,301,325,354,360,376,420,
434,454,472,507,525,542,616,632.1,632.2,635,640,667,668,690,700,717,792,
Manipulation of information 20 86,115,176,211,288,301,321,380,420,426,434,438,507,542,667,668,690,691,
742,799
Provision of feedback/ 40 72,114,115,140,145,210,217,220,277,325,354,360,371,424,454,458,472,478,
skills acquisition 492,502,525,616,632.1,632.2,635,640,660,667,668,690,696,700,742,749,758,
766,776,792,799,817
Use of patient prompts 7 115,360,420,472,640,691,700
Group delivery of information 22 72,145,211,255.2,277,354,424,438,478,492,616,632.1,632.2,635,640,659,660,
696,749,766,792,799
Manipulation of the environment 1 220
Incentives 2 115,424
TABLE 21  Results information for five RCTa studies assessing informed decision making
Health decision and  Impact of intervention  Process measures  Impact intervention on 
intervention on health decision (other measures) process and other measures
197 Utilisation screening kit: 0% uptake VI only Perception of risk of  Not used in analysis
1 – verbal information (VI) 51% uptake VI + kit having colorectal 
2 – VI + free kit provided cancer (none)
301 Adherence to medication: No group differences  Perceived seriousness  Enhanced WI associated greater 
1 – routine written  to adherence drug  risks and side-effects perceived seriousness risks 
information (WI)  (anxiety,knowledge) (no effect anxiety,greater 
2 – enhanced risk (WI) enhanced WI) knowledge 
325 Uptake exercise: No group differences on  Perception of health Not used in analysis
1 – VI + screening results exercise uptake and  (knowledge) (no group differential effect 
2 – VI + screening results  maintenance.Both groups  knowledge,increase over time)
+ encouraged to self- increased over time
monitor by writing 
down goals,diary 
of exercise
542 Consent to participate  Participation greater in  Type of information used  ‘Twice as fast’ used more 
in research: ‘twice as fast’ group for decision,reasons  ‘quantitative’ information,
1 – WI framed as a drug  participation (none) not analysed by group
working ‘twice as fast’
2 – WI framed as a drug 
working ‘half as fast’
799 Changes risky sex: Social skills group only  Perception of partner  Social skills group associated 
1 – delayed intervention associated greater safer  norms (knowledge, changes in perception of partner 
2 – VI about HIV prevention  sex practices perceived self-efficacy)  norms 
(culturally) framed  (no group differences knowledge,
(one session) Note:differential  social skills greater perceived 
3 – VI + social skills  attrition rates self-efficacy)
(five sessions)Health Technology Assessment 1999; Vol. 3: No.1
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Non-parametric analyses
Non parametric chi-square analyses were carried
out between the crude reported effect variable 
and intervention used, health domain, and 
health decision.
Intervention
Because many studies involved more than 
one manipulation within the intervention, 
such as written information and delivery of
information, individual analyses were carried 
out for each intervention. All eight chi-square
analyses assessing the association between 
the type of intervention employed and the
likelihood of reporting an effect size for the 
health behaviour described are reported in 
Table 22. As several analyses were carried 
out, the results ought to be interpreted 
with caution.
Health domain
Table 23 describes the chi-square analysis for health
domain by reported health behaviour effect. It
assesses the association between the health domain
of the decision and the likelihood of reporting an
effect for the health behaviour described.
Type of health decision
Table 24 describes the chi-square analysis for 
the type of health decision by reported health
behaviour effect. It assesses the association 
between the type of decision context with the
likelihood of reporting an effect for the health
behaviour described.
TABLE 22  Eight chi-square analyses for type of intervention by reported health behaviour effect
Effect  No effect  Mixed effect  Chi-square value Significance
(n = 294) (n = 173) (n = 80) (d.f.= 2)
Additional information  157 93 51 2.89 p = 0.236
Manipulation of information 42 31 11 1.30 p = 0.524
Change in delivery of information 161 75 37 6.17 p = 0.046
Provision of feedback 99 70 39 6.70 p = 0.035
Use of patient prompts 33 17 5 1.74 p = 0.420
Use of group-delivery information 92 61 35 4.42 p = 0.110
Manipulation of environment 11 5 7 5.00 p = 0.082
Other 52 23 14 1.65 p = 0.439
d.f.= degrees of freedom
TABLE 23  Chi-square analysis for health domain by reported health behaviour effect
Effect  No effect  Mixed effect  Chi-square value Significance
(d.f.= 10)
General medicine 87 68 34 18.7 p = 0.044
Cancer 70 31 8
HIV 55 27 21
Primary care 28 19 8
Obstetrics 15 9 5
Other 19 19 4
TABLE 24  Chi-square analysis for type of health decision by reported health behaviour effect
Effect  No effect  Mixed effect  Chi-square value Significance
(d.f.= 8)
Lifestyle change 129 93 53 24.1 p = 0.002
Attendance testing 66 28 9
Adherence to treatment 58 27 7
Utilisation of service 23 17 11
Other 18 8 0Results
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The trajectory of knowledge
The number of included studies by year of
publication is shown in Figures 1–4. The total 
is shown in Figure 1, trials broken down by quality of
randomisation in Figure 2, non-randomised studies
in Figure 3 and studies using a decision theory or
recording an informed decision measure are 
shown in Figure 4.
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FIGURE 3  Number of studies using a decision theory or
recording an informed decision measure (n n,decision theory 
only; l l,informed decision measure only; s s,theory and informed
decision measure)
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FIGURE 2  Number of studies by quality of randomisation 
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FIGURE 4  Number of observation studies by year (n n,
concurrent; l l,before/after same sample; s s,before/after 
different samples)Health Technology Assessment 1999; Vol. 3: No.1
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T
his bibliography summarises 547 controlled
studies evaluating the effect of a range of
interventions on real patient decision making. The
strengths are the systematic method of compilation,
the quality classifications using the hierarchy of
evidence and by theory, the categorisation of all
measures recorded, and the classification by 
health domain and by type of intervention. We
have identified under-researched areas for future
empirical work and well-studied areas to which
quantitative systematic reviews can be applied. 
The following discussion is divided into four parts:
an evaluation of our methods; an overview of the
findings; suggested uses of the review; and
recommendations for further research.
Evaluating the methods
Systematic identification
The advantage of integrating research by the
systematic application of set criteria to all eligible
articles is reduced bias. Other types of review tend
to be guided by specific research agendas and may
preferentially include studies supporting this.
Recommendations drawn from this type of
systematic review will be based on a fairer
representation of the literature. The main
disadvantage of a rigid methodology is the
systematic exclusion of information from studies
that do not fulfil the inclusion criteria. 
Three areas of related research were excluded for
this reason: studies of patient’s preferences for
health care; studies assessing changes in knowledge
without recording behaviour; and comparative
studies describing predictors of behaviour. Studies
measuring preferences were excluded because these
are only weakly associated with the final treatment
choice or health decision. Nevertheless, as the
patient is not committed to the final choice, they
provide an excellent opportunity to evaluate more
theoretically driven interventions.
29–31 Many such
studies exist and their integration should be a
priority for a future systematic review. Likewise,
studies describing only knowledge change were
excluded because knowledge alone is not a direct
measure of informed patient decision making. Com-
parative studies describing predictors of behaviour
such as the reasons why individual’s attend or do not
attend for screening, were omitted because there is
no evaluation of an intervention. Reviews in all three
of these areas would probably increase understand-
ing of how individuals make decisions, and which
measures best assess informed decision making but
would not evaluate intervention to facilitate
informed patient decision making. 
Although, this review systematically applied the 
pre-defined criteria to a large number of studies 
(n = 17,860), not all the available evidence was
evaluated. Resource constraints resulted in 
three electronic databases being searched for
publications from only 5 years, and three journals
handsearched for papers from a 10-year period.
The complete electronic databases and reference
sections from included articles or ‘grey literature’
were not searched. This deficit will have reduced
the number of studies in the review. However, it 
was clear from the handsearching that patient
rather than expert or professional decision 
making is a more recent area of interest.
Overview of results
Describing the area researched
Although the search strategy effectively generated 
a high proportion of studies with an RCT design
(Table 1), less than 10% of studies were classified 
as having a low risk of bias. Although some studies
in which the randomisation procedures were not
adequately explained may also have had a low risk
of bias, this is disappointing. The number of such
studies is rising only slowly and as a proportion of
all studies, rising not at all (Figure 2). 
The majority of interventions involved providing
patients with more information (55%) and/or
changing the delivery of information (50%). Few
evaluated the manipulation of information (17%)
or the effectiveness of patient prompts or decision
aids (10%). This is disappointing as it is manip-
ulation of information and the application of
decision aids rather than additional information
that are more likely to be associated with changes
in informed patient decision making.
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The majority of decisions were concerned with
health promotion. For example, decisions
Chapter 4
DiscussionDiscussion
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regarding healthy eating or attendance for
screening. There were few comparative studies
evaluating decision making within the area of
adherence to treatment, genetics, or active
participation within the consultation. The least-
researched areas of health appear to be genetics,
obstetrics, surgery, dentistry and mental health.
This is surprising as both prenatal and genetic
testing particularly emphasise the importance of
autonomy and informed patient decision making
within their aims. Although there is an established
literature evaluating the impact and uptake of such
testing
33 few studies have used experimental
designs to evaluate facilitation of informed patient
decision making. The lack of studies in mental
health is also particularly striking and should 
be remedied. 
Over 90% of studies recorded some demographic
details of participants. By identifying consistent
variations within populations, interventions can be
appropriately targeted. However, unless researchers
investigate why these variations occur it is unlikely
that interventions will be sufficiently informed. 
The results of Table 10 suggest that few studies are
able to explain any between-participant variations.
Less than a third assess decision-making process
measures or knowledge and less than an eighth
assess affect so that few conclusions can be drawn
about either the impact or interaction between
emotion and decision making. Finally, only 4%
assess any trait variations that may account for
individual differences for preferences for amount
of information or styles in utilising the information. 
Only 18% of studies referred to both a theory to
inform their study and assessed measures associated
with the decision-making process. This figure is, if
anything, over-generous. Any theory referred to
within the study was recorded whether or not it was
adequately operationalised. Additionally, less than
15% of studies were concerned with other factors
that have been associated with the decision-making
process such as time pressure and proxy decision
making. As so few studies actually employed a
theory that may explain variations in patient
decision-making behaviour, it is not unreasonable
to conclude that few experimental studies have
actually evaluated informed patient decision
making. The absolute rate of studies using a theory
and recording a measure of informed decision
making is rising only slowly in proportion to the
overall rise in studies generally (Figure 3).
Only five studies were identified that were theory
driven, assessed measures associated with informed
decision-making, and used a randomised trial
design with a low risk of bias. This suggests that
future NHS research effort in this area should
concentrate on better quality primary research
rather than on secondary reviews of existing
evidence. As the rate of production of such good
quality studies is low (Figures 2 and 3), the Health
Technology Assessment programme need not
repeat this systematic review for at least 5 years.
Synthesising the review data
Can decision making be facilitated?
The ideal evidence to answer this question could be
provided by the five studies that assessed informed
patient decision making using an RCT design with
low risk of bias (Table 21). However, of these only
three assessed the association between the inter-
vention and decision making process measures.
Although research exists evaluating the application
of decision-making techniques to professionals’
decision making and explaining patient decision
making, it is clear that interventions aimed at
facilitating patient informed decision making 
are under-researched.
Do people who have more information make
better decisions? 
It is impossible to give a single answer to this
apparently simple question because it implies 
that some decisions may be better than others 
and suggests that there is an external way of vali-
dating whether the decision made was correct. 
The criteria by which a decision is evaluated
depends on the underlying theory. In the absence
of theory it is not obvious for example whether 
an intervention that increases knowledge, alters
behaviour, but also causes anxiety, is resulting 
in a more informed decision. 
In this review, we assess whether additional
information was associated with the health
behaviour, but note that few studies operationalised
a theory or aimed to manipulate factors associated
with the decision process and outcome. Note also
that because there was little consistency in the
presentation of findings between studies, only a
crude measure of intervention effect was created for
this latter analysis. This indicated whether the study
reported a change (effect), no change (no effect) or
a mixture of change and no change (mixed effect)
in the health behaviours. Consequently, the findings
from this analysis are tentative.
Interventions, then, usually included two or more
factors that may be associated with decision-making
measures. Subsequent analysis could not compare
the effectiveness of different interventions with
health decision, as this classification did not haveHealth Technology Assessment 1999; Vol. 3: No.1
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mutually exclusive categories. Independent 
chi-square analysis had to be carried out for 
each intervention and the likelihood of reporting
an effect (Table 22). The reporting of an effect did
not mean that the decision was any more or less
informed. The results of the analysis for inter-
ventions using additional information are 
located on row 1 (Table 22).
Half of the 301 studies evaluating additional
information reported an effect of information on
the decision behaviour. However, studies were no
more likely to report an effect than report no or
mixed effects. So, additional information may or
may not be associated with decision behaviour. A
more detailed breakdown of the additional inform-
ation studies would be needed before conclusions
could be drawn. For example, what information
medium was used? Was the intervention comparing
information with no information or information
with another type of intervention? What was the
quality of the information? All the study numbers
of informed decision making studies using RCT
designs (good quality) are listed (Table 20) to
provide the basis for any reader attempting a
quantitative review in these areas. For example, 
45 studies were recorded under the additional
information intervention. Of these 21 (47%)
reported an effect on the decision behaviour, 
17 (38%) no effect, and 7 (16%) mixed effects.
Does the way in which we present information
change the effectiveness of the decision?
There were a number of interventions that may 
be referred to when answering this question: addi-
tional intervention; manipulation information;
delivery information; group delivery information;
and, patient prompts. Those studies that altered the
delivery of information were more likely to report an
effect. Twenty good quality trials manipulated the
delivery of the information (Table 20), 11 (55%)
reported an effect on decision behaviour. Studies
that provided feedback and social skills training
were more likely to report mixed effects on
behaviour. If the 40 good-quality trials using
feedback (Table 20) were more closely categorised,
some reliable differences between effective and
ineffective feedback interventions may be illustrated.
Does the effectiveness of information on
decision making vary by medical setting?
The analysis suggests there is an association
between the health domain in which the research is
carried out and the likelihood of reporting of an
effect (Table 23). Studies evaluating cancer related
decisions were more likely to report an effect on
behaviour. Such a finding may mean that inter-
ventions within the cancer domain are more
refined so impacting on the behaviour or that 
there is something about cancer that interacts 
with the decision. It is probably not justified to
extrapolate findings from studies in cancer to 
other health areas, and researchers need to be
aware that the setting may affect the informed
decision making process.
Does the context of the decision affect 
decision making?
The analysis suggests an association between the
type of health decision and the likelihood of
studies reporting an effect (Table 24). There is an
effect from the type of health decision (Table 23)
with studies concerned with lifestyle and utilisation
of services being less likely to report a treatment
effect than others. Similarly studies that showed
little or no effect of interventions on lifestyle or
service utilisation decisions should not be extra-
polated to other types of decisions where more
effects may be seen.
Suggested applications of 
the review
Identification of under-researched areas
Certain health areas and types of decisions have
been more extensively researched than others and
the studies in Table 20 provide the basis for a num-
ber of systematic reviews. Bekker has embarked 
on two: a review of the effect of manipulation of
information, and a review of the effect of the effect
of provision of feedback and skills acquisition.
Clinical genetics and prenatal diagnosis are other
obvious under-researched areas. Work in these
areas should be a priority, not only because patient
decision making is widely recognised to be import-
ant here, but also because the strong scientific 
base provides an excellent test bed for improving
our understanding of real patient decision 
making generally.
Design of the ideal study
All studies in this area would benefit from reference
to one of the decision-making theories, which were
described in the chapter 1, at the design stage. A
study evaluating how people make decisions ought
to include a measure of the individual’s decision-
making process such as a description of the
information used to make the decision. Knowledge
measures alone are not sufficient. Explanatory
studies will find a cross-sectional design the most
useful, and a process tracing technique applied to
the transcript of a consultation will usually provide
the best understanding of how decisions were made.Discussion
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Studies evaluating decision facilitation may use
observational methods to formulate the research
question, but must eventually use the best-quality
experimental design, the RCT. Typically, the com-
parison should be against routine care, as there are
no well-evaluated and clearly effective interventions
in this area. The following is a description of an
unpublished study carried out by Bekker. It is an
example of an ideal study to evaluate the facilitation
of informed decision making.
Question: Does decision analysis increase informed
decision making by women – choosing to
have a diagnostic test in pregnancy after
a screen positive?
Theory: Decision analysis is a decision aid derived
from expected utility theory. Expected
utility theory, the theory of planned
behaviour, and reasoned-based models 
of decision making informed the
evaluation measures.
Design: RCT with a low risk of bias – numbered,
sealed, opaque envelopes were opened
for allocation to either a routine
information consultation or a decision-
analysis consultation.
Measures: The consultation was audio-tape
recorded, transcribed and coded. A
questionnaire was completed after the
decision was made and 4 weeks later. 
The following variables were assessed:
– informed decision making: study speci-
fic coding frame and computer pro-
gramme applied to transcripts assessing
thinking words and information utilised
– reasoning: questionnaire included
measures of beliefs, attitudes,
perception of risk, and knowledge
– affect: anxiety and decisional conflict
assessed by questionnaires, use of
emotion-laden words assessed by 
the computer programme analysis 
of transcripts
– clinical: consultation length recorded
and perceived usefulness of information
– behaviour: decision to be or not 
be tested
– other: demographic variations,
reproductive history and individual
differences in information processing
assessed by questionnaires.
In summary the ideal study should randomise 
using a method with a low risk of bias, be designed
with reference to decision-making theory, and
include measures of the decision-making process
and outcome.
Recommendations for research
• Future primary research should not simply 
rely on behavioural or psychometric outcomes
but should work under a theory of decision
making, and record decision process measures
that permit evaluation of whether the decision
was informed. If evaluating experimental inter-
ventions, they must use RCT methods with a 
low risk of bias.
• A booklet describing the main decision-
making theories, and an inventory of suitable
questionnaires and interview-based outcome
measures could be developed to help 
clinical health researchers design 
appropriate studies.
• Complementary systematic reviews of the
following topics would be valuable:
– trials evaluating the effect of interventions 
on patient preferences. At least 50 such
studies were excluded from the present
bibliography because no behaviour change
was recorded.
– observational studies furthering the
understanding of real patient decision
making. Three process-tracing methodo-
logies will predominate: tape-recorded
consultations; verbal protocols of thinking
aloud techniques; and information 
boards or computer programmes to
document the information referred 
to by patients.
– assessing the effect of additional information,
manipulation of information, provision of
feedback, and group delivery of information
on subsequent informed patient 
decision making.
• Primary research is required in the following
health areas:
–  genetics and prenatal diagnosis. This area 
is a good place to begin because the nature 
of the information base, with relatively 
simple clearly-defined options with known
risks corresponds closely to the terms that
decision theories use.
–  areas where decisions are often made 
by proxy such as paediatrics and 
mental health.
• Primary research is required to evaluate the
following types of interventions:
– Decision aids, such as graphical, 
pictorial, computer and Internet-
based devices.
– Information manipulation, such as decision
analysis, patient prompts and provision of
feedback, and scenario-based approaches to
informing choice of treatments.Health Technology Assessment 1999; Vol. 3: No.1
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Appendix 2
The principle of the search strategy
Decision-making terms
Career choice
Decision making
Communication
Cybernetics
Advertising
Decision support techniques
Thinking
Creativeness
Patient terms
Psychological models
Psychological theory
Probability
Risk
Patient acceptance health care
Patient participation
Knowledge, attitudes, practice
Truth disclosure
Treatment refusal
Fees, charges, willingness to pay
Consumer satisfaction
Consumer participation
Health education
Professional–patient relations
Public opinion
Sick role
Counselling
Genetic counselling
Applied psychology
Comparative-study terms
Comparative study
Cross-sectional study
Data collection
Statistics
Evaluation studies
Feasibility studies
Cohort studies
Random allocation
Clinical trials
Control trials
Research study design
Pilot projects
Intervention studies
Measures
OR
PLUSHealth Technology Assessment 1999; Vol. 3: No.1
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career choice/
exp decision making/
2 not 1
exp communication/
exp cybernetics/
exp advertising/
exp animal communication/
5 or 6 or 7
4 not 8
exp decision support techniques/
“neural networks (computer)”/
10 not 11
informed consent/
exp thinking/
exp autism/
creativeness/
exp esthetics/
15 or 16 or 17
14 not 18
models, psychological/
exp probability/
exp risk/
risk-taking/
exp psychological theory/
exp patient acceptance of health care/
exp patient participation/
exp knowledge, attitudes, practice/
exp truth disclosure/
exp treatment refusal/
(patient adj3 decision).ti,ab.
fee$ charg$.ti,ab.
willing$ to pay.ti,ab.
or/3,9,12-13,19-32
exp consumer participation/
exp consumer satisfaction/
exp health education/
health status/
exp professional-patient relations/
exp patient acceptance of health care/
exp public opinion/
sick role/
genetic counseling/
exp counseling/
psychology, applied/
(referral and consultation).ti,ab,sh.
exp attitude to health/
(patient adj3 decision).ti,ab.
or/34-47
comparative study/
cross-sectional studies/
exp data collection/
exp statistics/
exp evaluation studies/
exp feasibility studies/
exp cohort studies/
exp random allocation/
exp clinical trials/
exp research/
exp “study design (non mesh)”/
exp pilot projects/
exp intervention studies/
(clinical adj2 trial).ti,ab.
(control$ adj2 trial$).ti,ab.
measure$.ti,ab.
or/49-64
33 and 48 and 65
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Appendix 4
Data extraction coding forms
Page 1, Table 1 — Article identification details
Field Details
Article review number ...................
number studies ...................
project number ...................
number of duplicate ...................
Authors .........................................................................................................................................................
Title .........................................................................................................................................................
Journal details .........................................................................................................................................................
Included/excluded  included             excluded
(reasons exclude) .........................................................................................................................................................
Database MEDLINE PsycLIT BIDS handsearch 
Date downloaded ______ /______
Date sent to reviewer ______ /______
Date returned reviewer ______ /______
Initials  reviewer MA HB JC JH JM MM SM AP MR JT 
Page 2, Table 1 – Describing health decision and quality study
Summary health decision (free text)
Location research: Participants: The nature of the decision is: 
unknown UK North  America  unknown adult well  A)  real intended hypothetical 
S. Africa  Australia/NZ  pregnant  physically impaired  B) implicit  explicit 
other  (write .................................... elderly (> 65)  mentally impaired  C) affects – participant  other 
..........................................................) child (< 17)  non-English speaking  D) made at – time intervention  later 
Domain of health care: Defining type of health decision: Authors awareness theory:
Write type of illness or health domain  Write type of health decision (e.g.  Decision making theory:
research located (e.g. cervical/breast  screening, diagnostic testing, medication/ 0 = no theory referred to 
cancer, asthma, health promotion,  drug therapy, surgical treatment,  Write in the name of theory referred to in 
cardiovascular risk factors, HIV/condom  behavioural therapy, willingness to pay,  the introduction or methods section ... 
use, smoking cessation, drug use,  research, cessation, etc.)
tuberculoses, malaria, etc.)
..................................................................... ..................................................................... ........................................................................
..................................................................... ..................................................................... ........................................................................
Quality of study: Quality of study continued... Quality of study continued...
Design of study: Level of intervention: Sample size:
randomised (RCT)   a  b  c  patient level  other level  not rec.  total number available _____ not rec. 
non-randomised concurrent  Sample invited to participate: total number invited _____ not rec. 
before/after different sample  total ‘population’ available  number participated _____ not rec. 
before/after same sample  stratified/systematic sample  number excluded _____ not rec. 
Other (e.g. matched case-controlled)  volunteer/non-systematic sample  number in final analysis _____ not rec. 
..................................................................... not adequately described 
Quality of study continued... Quality of study continued... Reference to be accessed ...
Causes for concern: Development intervention materials:
no/not obvious causes for concern  piloted intervention: no  yes  in part 
yes (please write any concerns)  piloted measures: no  yes  in part 
..................................................................... readability score: no  yes  in part 
.....................................................................Appendix 4
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Page 3, Table 1 – Description of intervention groups
Nature of intervention: explicit information  change in service  other 
Comparative group Description of intervention (write ...) Code Number in group (n)
Group 1 ...................................................................... [        ]  [        ]
...................................................................... [        ]  [        ]
Group 2 ...................................................................... [        ]  [        ]
...................................................................... [        ]  [        ]
Group 3 ...................................................................... [        ]  [        ]
...................................................................... [        ]  [        ]
Group 4 ...................................................................... [        ]  [        ]
...................................................................... [        ]  [        ]
Group 5 ...................................................................... [        ]  [        ]
...................................................................... [        ]  [        ]
Page 3, Table 2 – Variables described within article
Variable Code Descriptives Main effect analysis Interaction analysis
Write variables described within the study 
(e.g. age, gender, attitudes, social support)
Alongside each variable, tick whether the 
analysis of the variable was descriptive, main 
effect or interaction.
Page 4, Table 1 – Description health decision outcome
Description (write...) Continuous/categorical Validated, piloted, study specific Description validated measure (write): 
val pil study 
val pil  study 
Page 4, Table 2 – Results evaluating the association of the intervention and decision outcome
Variable Categorical Group 1 Group 2  Group 3  Group 4 Group 5
level/group not available or not available or not available or not available or not available or
e.g. adhere 1 ‘n’ or ‘n’ or ‘n’ or ‘n’ or ‘n’ or
not adhere 2 mean (sd) n mean (sd) n mean (sd) n mean (sd) n mean (sd) n
sd = standard deviation
Page 4, Table 3 –Text box summarising the results of the intervention
Write summary results of intervention on decision outcome and author’s main outcome measures.Health Technology Assessment 1999; Vol. 3: No.1
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Appendix 7
Decision details by study design
(grouped by health area)
TABLE 25  Description of the decision,the interventions,and the measures recorded in studies:RCTa
Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
23 - 1 Adherence to self-care  None Cancer Control – routine care for radiation  Age,sex,level of education,marital 
behaviour in adults  therapy patients status,ethnicity,knowledge,usefulness 
undergoing radiotherapy Group 1 – routine plus video  of information
39 - 1 Uptake of cervical cancer  None Cancer Control – no additional information Age,level of education,social class,
screening in adult well  Group 1 – general practitioner (GP)  marital status,actual risk status,medical 
women reminder letter history,health behaviours-general 
Group 2 – letter headed by clinic knowledge,perception of risk,intention 
Group 3 – additional information leaflet posted 
41 - 1 Uptake of mammography  None Cancer Control – letter not signed by GP Age,social class,health behaviours-
in adult well women Group 1 – letter signed by GP posted to  general
women ‘refusers’
52 - 1 Uptake of mammography  None Cancer Control – no additional information Age,social class,marital status,actual 
in well adult women Group 1 – physician reminder telephone calls risk status,health insurance
Group 2 – medical assistant telephone call
Group 3 – reminder letter
85 - 1 Adherence to breast self- None Cancer Group 1 – information only Age,level of education,ethnicity,health 
examination (BSE) in adult, Group 2 – information BSE and prompt on  behaviours-general,self-efficacy
well women contraceptive pill packet
108 - 1 Uptake of faecal occult  None Cancer Control – usual screening pad:manipulation  Age,sex,health insurance
blood (FOB) screening in  of stools
well adults Group 1 – experimental testing stools:pad 
dangled in toilet after bowel movement
122 - 1 Colorectal screening in  None Cancer Group 1 – haemoccult kit:manipulation  Age,sex
well adults stools and information on diet
Group 2 – early detector pad:used like toilet 
paper.Information about diet
Group 3 – coloscreen:tissue paper placed in 
toilet after use.Information on diet
316 - 1 Uptake of colorectal  None Cancer Control – letter:availability of FOB testing  Age,sex,level of education,marital 
screening in well adults  at work status,ethnicity,actual risk status,family 
(workplace) Group 1 – risk appraisal form assessing  history,health behaviours-general,
personal risk plus letter invite colorectal  knowledge,attitudes,perception of risk,
screening at work intention 
509 - 1 Uptake of mammography  None Cancer Group 1 – one-to-one counselling,leaflet plus  Age,level of education,social class,
in well adult women free mammography voucher marital status,actual risk status,family 
Group 2 – same information as Group 1, history,medical history,health 
no voucher behaviours-general,health insurance,
living arrangements,knowledge,reasons,
health professional measures,efficacy
101 - 1 Uptake of mammography  Framing  Cancer Control – routine letter invitation Age,family history,health behaviours-
in well women informa- Group 1 – letter plus section on worrisome facts  general
tion about breast cancer (anxiety condition)
Group 2 – letter plus encouraging (coping) things 
about breast cancer
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TABLE 25 contd  Description of the decision,the interventions,and the measures recorded in studies:RCTa
Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
117 - 1 Uptake of colorectal  Health  Cancer Control – routine slide plus tape presentation Age,sex,level of education,social class,
screening in elderly  promotion  Group 1 – elderly information giver gave talk  marital status,ethnicity
well adults before slide show (close identity participants)
Group 2 – adapted slide show,more accessible,
more procedural information about screening
Group 3 – elderly educator and modified 
slide show
197 - 1 Uptake of colorectal  Social  Cancer Group 1 – verbal plus written information  Sex,level of education,ethnicity,health 
cancer screening in  cognition  about colorectal cancer and screening behaviours-general,perception of risk
well adults model Group 2 – Group 1 plus free screening kit
275 - 1 Uptake of mammography  Social  Cancer Control – routine letter invitation Age,family history,medical history,
in well adult women cognition  Group 1 – letter plus more explanation risk  reproductive history,health behaviours-
model breast cancer general
Group 2 – risk invitation plus self-evaluation 
risk questionnaire
Group 3 – risk invitation,risk questionnaire 
plus personalised risk letter
53 - 1 Adherence to medication  None Medicine  Control – routine medical care Age,sex,level of education,social class,
in adults with hypertension Group 1 – telephone link,regular care plus  marital status,actual risk status
weekly calls using computerised voice and 
touch tone answers for feedback
50 - 1 Adherence to health  None Medicine Group 1 – illustrated leaflet about cardio- Age,sex,level of education,social class,
lifestyle,cessation of  vascular disease (CVD) risk-reducing factors actual risk status,physiological/ 
unhealthy lifestyle in  Group 2 – group counselling (1–2 hours),goal  psychological assessment
well adults achievement,weight loss programmes
64 - 1 Cessation of smoking, None Medicine Control – routine CVD risk examination  Age,sex,social class,marital status,
alcohol and uptake of  plus leaflet ethnicity,actual risk status,health 
exercise in medicine  Group 1 – paid GPs,routine examination plus  behaviours-general,health insurance
well adults additional counselling,follow-up visit plus 
patient reimbursement
118 - 1 Cessation of smoking in  None Medicine Control – routine smoking risk information  Age,level of education,marital status,
well adults with asthmatic  plus quit smoking in home advice ethnicity,actual risk status
children Group 1 – child’s physician gave information 
on passive smoking plus leaflet plus ways 
reducing child exposure smoke
216 - 2 Adherence to cessation  None Medicine Group 1 – invitation letter,leaflet on smoking  Age,sex,level of education,actual risk 
of smoking/fatty food  and weight programmes,cost US$5 flat fee status,physiological/psychological 
programme in well adults Group 1 – letter invitation,leaflet and  assessment
refundable deposit US$60 
229 - 1 Cessation of smoking in  None Medicine Group 1 – verbal information on smoking and  Age,sex,level of education,social class,
well adults nicotine gum plus free gum actual risk status
Group 2 – verbal information on smoking and 
gum plus gum cost US$6
Group 3 – information on smoking and gum 
plus gum cost US$20
350 - 1 Cessation of smoking in  None Medicine Group 1 – two appointments to discuss  Age,sex,level of education,marital 
well patients quitting and progress,offered gum plus leaflet status,actual risk status,health 
Group 2 – same Group 1 plus offered  behaviours-general,usefulness 
additional visit information,intention,social 
reinforcement/norms,motivation
483 - 1 Adherence to medication  None Medicine  Control – pharmacists informed study but  Age,sex,level of education,social class,
in elderly adults training deferred  marital status,actual risk status,
Group 1 – pharmacists trained in workshops  attitudes,usefulness of information
in identifying problems with adherence plus 
leaflets for patients
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Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
648 - 1 Cessation of smoking in  None Medicine Group 1 – minimal counselling:leaflet plus  Age,sex,level of education,ethnicity,
well adults (worksite) told to wear nicotine patch (22 mg or  actual risk status,medical history,
44 mg strength) physiological/psychological assessment,
Group 2 – individual counselling:leaflet plus 
motivational message by physician plus quit 
letter
Group 3 – group counselling:leaflet plus attend 
clinic for counselling and skill acquisition
793 - 1 Cessation of in well adults None Medicine Group 1 – nicotine patch plus usual leaflet Age,sex,actual risk status,perception 
Group 2 – nicotine patch plus additional  of well-being 
information
Group 3 – placebo patch plus leaflet
Group 4 – placebo patch plus additional 
information
781 - 1 Adherence to self- None Medicine Control – routine clinic care Age,sex,actual risk status,health 
management in adult  Group 1 – verbal information self- behaviours-general,physiological/ 
with asthma management,asthma,therapies,feedback  psychological assessment
on inhaler use
755 - 1 Changes to CVD risk  None Medicine Control 1 – another company delayed  Age,sex,social class,actual risk 
factors in well adults intervention  status,health behaviours-general,
Control 2 – delayed intervention within  physiological/psychological assessment
company
Group 1 – health information
Group 2 – health information plus 
cholesterol score feedback
Group 3 – health information plus 
cholesterol risk figure
Group 4 – health information plus cholesterol 
level plus risk score
67 - 1 Intention to have cardio- None Medicine Control – no additional information Age,sex,level of education,social class,
pulmonary resuscitation  Group 1 – leaflet CPR,framed in terms  marital status,religion,ethnicity,living 
(CPR) in well adults of senility arrangements knowledge
Group 2 – leaflet CPR,framed in terms of 
Alzheimers disease
196 - 1 Cessation of smoking, None Medicine, Control – routine leaflet Age,marital status,ethnicity,
adherence to diet,use of  obstetrics  Group 1 – leaflet plus weekly phone call  reproductive history anxiety – state/ 
services in well,pregnant  and  from interviewer trait,depression,other affect,social 
women gynaecology support/stress
(midwifery)
714 - 1 Utilisation of care in  None Medicine, Control – assessment only Age,sex,level of education,social class,
parents of children recently  surgery  Group 1 – health professional follow-up phone  marital status,ethnicity,actual risk 
attended emergency (A&E) call to parents to answer any questions status,health insurance,perceived 
satisfaction
200 - 1 Adherence to exercise, None Medicine, Control – no additional information Age,level of education,social class,
cessation of poor diet in  obstetrics  Group 1 – group programmes by dietician: marital status,ethnicity,reproductive 
adult well premenopausal  and  meal plans,exercise information,goal  history,health behaviours-general,
women gynaecology setting,newsletter physiological/psychological  assessment,
(midwifery) health professional measures,worry,
attitudes,social support/communication,
usefulness of information,coping
724 - 1 Cessation of smoking in  None Medicine, Control – assessment only Age,level of education,ethnicity,
pregnant women obstetrics  Group 1 – routine information plus explanation  reproductive history
and  on leaflet use plus follow-up session plus note 
gynaecology  prompt plus buddy
(midwifery)
581 - 1 Cessation of smoking in  None Medicine, Control – blank tape played during surgery Age,sex,actual risk status,medical 
adults undergoing minor  surgery Group 1 – suggestion to give up smoking tape  history,motivation,awareness of 
surgery played during surgery intervention
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Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
542 - 1 Participation in clinical trial  Framing  Medicine Group 1 – treatment A twice as effective Age,level of education,social class,
in ambulatory adult patients information Group 2 – treatment A half as effective ethnicity,medical history reasons 
120 - 1 Cessation of alcohol in  Health  Medicine Control – control group  Sex,knowledge,attitudes,efficacy
school children promotion  Group 1 – modified ‘alcohol misuse prevention 
study’ information:more role-play against social 
pressure,interactive sessions with feedback
301 - 1 Compliance with medication  Communi- Medicine Group 1 – information medication using  Age,sex,level of education,marital 
in well and epileptic adults cation standard ‘medical practice’ form status,actual risk status,anxiety – state,
Group 2 – modified information written for lay  knowledge,perception of risk
person plus risk and side-effect information
325 - 1 Uptake of exercise in  Shared  Medicine Group 1 – leaflet and verbal information on  Age,sex,level of education,social class,
adults with CVD consult- exercise,checking pulse marital status,actual risk status,health 
ation Group 2 – Group 1 plus behavioural strategies: behaviours-general,physiological/
goal setting,reinforcement (phone) and diary psychological assessment,knowledge,
social reinforcement/norms
202 - 1 Uptake of appointment  None STDs (HIV) Control – no additional contact Age,sex,social class,ethnicity,actual 
in adult substance users Group 1 – telephone call emphasising  risk status,medical history,perceived 
importance of attendance satisfaction
393 - 1 Cessation of/adherence to  None STDs (HIV) Control – individual risk assessment HIV,leaflet  Age,sex,ethnicity,actual risk status,
risky/safe sex in adolescents  and counselling on condom use/HIV prevention medical history,health behaviours-
with STD Group 1 – routine information plus physician  general
asking about knowledge and skills to modify 
behaviour
741 - 1 Cessation of risky sex/ None STDs (HIV) Control – counselling only on HIV risk  Age,sex,level of education,social class,
uptake of safe sex in adults  factors plus blood test for STD marital status,ethnicity,actual risk 
with STD Group 1 – HIV counselling plus STD blood  status,medical history,worry,
plus HIV test perception of well-being,knowledge
107 - 1 Use of condoms/safer sex  Social  STDs (HIV) Control – no additional information Age,sex,social class,actual risk status,
in school children cognition  Group 1 – verbal information:sexual  health behaviours-general,knowledge,
model development,STD,contraception,skill attitudes,self-efficacy
acquisition in groups and communication skills
585 - 1 Adherence to safe sex in  Social  STDs (HIV) Group 1 – video information:HIV risks and  Age,sex,actual risk status,knowledge
well adolescents cognition  behaviour and discussion groups
model, Group 2 – information structured by protection- 
health  motivation theory,skill acquisition
promotion
799 - 1 Changes HIV risky  Social  STDs (HIV) Control – delayed information Age,level of education,social class,
behaviour in well  cognition  Group 1 – social skills acquisition,culturally  actual risk status,reproductive history,
adult women model appropriate information on HIV health behaviours-general,living 
Group 2 – HIV information only arrangements knowledge,perception of 
control,self-efficacy,social 
reinforcement/norms
299 - 1 Uptake of immunisation in  None Primary care Control – routine Age,sex,actual risk status,
well adults Group 1 – physician reminder – printed on  reproductive history
‘bill’ after consultation
Group 2 – telephone call made by nurse
Group 3 - letter signed by physician
378 - 1 Uptake of immunisation  None Primary care Control – routine care Age,sex,social class
in well adults Group 1 – reminder postcard to visit physician
638 - 1 Utilisation of services in  None Primary care Control – usual care Age,marital status,actual risk status,
adult male patients primary  Group 1 – re-appointment times made and  medical history,health behaviours-
care telephone contact made at three time points  general,perception of well-being,
by physician perceived satisfaction
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Study  Summary decision  Theory Health  Comparison groups Variables referred to
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387 - 1 Increased participation in  Shared  Primary care Control – health eating leaflet,note examples  Age,sex,social class,health professional 
consultation in adult general  consult- high fat foods measures perception of control,perceived 
practice patients ation Group 1 – leaflet encouraging patients to be more  satisfaction,self-efficacy,usefulness of
active in consultation,note concerns for doctor, information
ask questions diagnosis and treatment (piloted)
333 - 1 Adherence to immunogens  Health  Primary care Control – assessment only Age,sex,level of education,social class,
in elderly well adults promotion Group 1 – verbal information about medication, marital status,actual risk status,medical 
appointments,illness history,health behaviours-general,
physiological/psychological assessment,
depression
425 - 1 Uptake of prenatal services None Obstetrics Control – usual 13 visits with health professional Age,level of education,social class,marital
in pregnant well women and Group 1 – reduced to seven visits with health status,ethnicity,reproductive history,
gynaecology professional health behaviours-general,physiological/
(midwifery) psychological assessment,health 
professional measures,worry,attitudes,
social support communication,usefulness 
of information,coping
778 - 1 Uptake of prenatal screening  None Obstetrics  Control – routine care  Age,social class,ethnicity,reproductive 
in well pregnant women and  Group 1 – additional individual session plus  history,anxiety – state,depression,
gynaecology  leaflet and verbal information serum screening, worry
(midwifery), ultrasound,carrier testing for cystic 
genetics fibrosis (CF)
Group 2 – women attended group sessions 
plus leaflets
678 - 1 Uptake of antenatal care in  None Obstetrics  Control – usual antenatal care:attend clinics  Age,social class,marital status,
well pregnant women and  by different professionals reproductive history,physiological/ 
gynaecology  Group 1 – team-care:known team of midwives  psychological assessment,autonomy in 
(midwifery) provided continuity care throughout pregnancy decision making,perception of informed 
consent,perceived satisfaction,
usefulness of information
606 - 1 Uptake of appointments in  None Mental  Control – usual care:patients contact clinic Age,sex,level of education,social class,
adults who attempted suicide health Group 1 – nurse visit to patients not attending  marital status,actual risk status,medical 
follow-up appointment history,anxiety – state,depression
427 - 1 Adherence to medication  Health  Mental  Control – supportive (listening) counselling Age,sex,ethnicity,actual risk status,
in psychotic adults promotion health Group 1 – counselling guided by ‘compliance’  medical history,attitudes,disability 
therapy:beliefs,coping,attitudes to drug use scaleAppendix 7
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TABLE 26  Description of the decision,the interventions,and the measures recorded in studies:RCTb
Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
352 - 1 Uptake of mammography  None Cancer Control – routine reminder postcard Age
in well women Group 1 – routine reminder postcard plus 
voucher on attendance (US$2)
352 - 2 Uptake of mammography  None Cancer Control – routine reminder postcard Age
in well women Group 1 – telephone reminder 
352 - 3 Uptake of mammography  None Cancer Control – clinic-based reminder letter Age
in well adults Group 1 – signed letter physician reminder
353 - 1 Uptake of mammography  None Cancer Control – no additional contact Age,level of education,social class,
in well women Group 1 – volunteers ‘taught’ about purpose  marital status,ethnicity,health 
mammography and to contact five acquaintances  behaviours-general
to encourage their attendance
420 - 1 Uptake of colorectal  None Cancer Control:letter invitation,FOB test plus leaflet plus  Age,sex,reasons
screening in well adults reminder letter:half receive gain frame,half loss 
frame information
Group 1 – routine care plus reminder phone call:
gain/loss framed information
Group 2 – routine plus information leaflet 
(readability score) about efficacy screening plus 
phone reminder:gain/loss framing
Group 3 – routine plus additional leaflet plus 
reminder phone with additional information on 
use:gain/loss frame information
482 - 1 Uptake of colorectal  None Cancer Control – routine care:letter invitation plus  Age,sex
screening in well adults testing kit
Group 1 – routine care plus reminder phone call
Group 2 – routine care plus leaflet plus reminder call
Group 3 – routine care plus leaflet plus ‘how to use 
test’ call plus reminder call
653 - 1 Uptake of mammography  None Cancer Control – routine letter invitation Age,marital status,ethnicity,
in well adult women Group 1 – letter invitation plus information on  living arrangements
taking part study for ‘additional scientific 
investigation’
675 - 1 Uptake of colorectal  None Cancer Group 1 – perform test over 3 days without diet  Age,sex
screening in well adults restriction
Group 2 – perform test over 6 days without diet 
restriction
Group 3 – perform test over 3 days with diet 
restriction
Group 4 – perform test over 6 days with diet 
restriction
683 - 1 Uptake of colorectal cancer  None Cancer Group 1 – signed GP letter plus diet restrictions  Age,sex,marital status
screening in well adults plus FOB test
Group 2 – signed GP letter plus faecal kit
Group 3 – signed letter,leaflet plus FOB testing kit
Group 4 – signed letter plus instructions to phone 
for free kit
Group 5 – letter signed by ‘professor’ and FOB 
testing kit
491 - 1 Uptake of BSE in well  None Cancer Control – group session on BSE,video plus leaflet  Age,level of education,marital status,
women (work) plus practice movement ethnicity,health behaviours-general,
Group 1 – control plus feedback on BSE on model physiological/psychological assessment
Group 2 – control plus Group 2 plus individual 
session plus intensive feedback
533 - 1 Uptake of BSE in  None Cancer Control – verbal,video and leaflet information 
well women on BSE and ‘over-clothing’ technique
Group 1 – control plus individual supervision on 
model with lumps
Group 2 – Group 1 plus individual counselling
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566 - 1 Returning colorectal  None Cancer Control – hemoccult cards by post,no stamped  Age,sex,marital status,ethnicity,
screening cards in  addressed envelope health insurance
well adults Group 1 – hemoccult cards sent with stamped 
addressed envelopes
705 - 1 Adherence to safe-sun  None Cancer Control – questionnaire only Age,sex,actual risk status,
behaviours in well  Group 1 – read through leaflet knowledge,attitudes
adolescents Group 2 – read leaflet plus video
Group 3 – read leaflet plus designed poster
Group 4 – leaflet plus discussion one week later
728 - 1 Uptake of cervical smear  None Cancer Control – usual care Age,social class,marital status,
in well women Group 1 – leaflet plus fact sheet by post  religion,ethnicity,actual risk status,
(available in several Asian languages) usefulness of information
Group 2 – personal visit plus fact sheet plus video
Group 3 – personal visit plus fact sheet plus leaflet
630 - 1 Uptake of breast screening  None Cancer Group 1 – home visits by nurse,ascertained  Age,perception of control,self-esteem
well women non-attendees reasons non-attendance and information on 
screening
Group 2 – home visit nurse,ascertained 
reasons non-attendance
Group 3 – signed reminder letter GP
285 - 1 Uptake of colorectal cancer  None Cancer Group 1 – letter to all households plus leaflet  Age,sex
screening in well adults information colorectal cancer screening,media 
campaign plus refund for buying test
Group 2 – Group 1 plus given free test at surgery
Group 3 – Group 1 plus test sent by post to 
non-attendees
727 - 1 Uptake of mammography  None Cancer Group 1 – free screening plus media information  Age
in well women plus open invitation letter to non attendees
Group 2 – Group 1 plus fixed appointment letter
543 - 1 Uptake of cervical smear  None Cancer Control – routine breast screening appointment Age,ethnicity,health behaviours-
in well women Group 1 – timed cervical screening appointment  general
as well as breast screening
587 - 1 Uptake of in prostate  None Cancer Group 1 – verbal information availability screening Age,level of education,social class,
screening in well male  Group 2 – description of procedure screening ethnicity,family history,health 
adults insurance
713 - 1 Uptake of cervical smears  None Cancer Control – routine care Age,level of education,marital status,
in well women with screen- Group 1 – information leaflet worry,knowledge
positive smears
48 - 1 Uptake of cervical screening  None Cancer Control – comparison women in hospital ward Age,level of education,marital status,
in well women Group 1 – offered smear in hospital ethnicity,reproductive history,health 
Group 2 – offered leaflet when discharged professional measures
488 - 1 Uptake of hypothetical  None Cancer Group 1 – audio-tape plus verbal information  Age,sex,level of education,knowledge,
medication trial in adults  cancer,trial and treatment provided perceived satisfaction,usefulness of
with cancer Group 2 – computer screen touch control, information
programme same information as Group 1
86 - 1 Uptake of breast and  Health  Cancer Control – information about community living Age,level of education,social class,
cervical screening in well  promotion  Group 1 – information about the importance  marital status,ethnicity,attitudes,health 
adult women of screening,BSE,nutrition and attending  behaviours-general,service utilisation 
health centres of,health insurance,knowledge,
reasons,self-efficacy
114 - 1 Uptake of mammography  Social  Cancer Control – no additional information Age,level of education,ethnicity,
in adult well women cognition  Group 1 – belief intervention:‘stages of change/ health behaviours-general,knowledge,
model HBM’ assessment,tailored belief intervention  attitudes,perception of risk,reasons,
plus leaflet plus professional contact operationalised model,motivation
Group 2 – information only:facts,timing and 
procedure mammography
Group 3 – Group 1 plus 2:facts on procedure 
plus targeted beliefs
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232 - 1 Uptake of mammography  Social  Cancer Control – leaflet by post:breast cancer plus thank  Age,education,social class,marital 
in well women cognition  you for questionnaire completion status,ethnicity,health behaviours,
model Group 1 – extra leaflet:importance screening, insurance,knowledge,attitudes,
procedure and attendance encouragement plus  perception of risk,reasons,intent,
thank you note efficacy
438 - 1 Uptake of mammography  Framing  Cancer Group 1 – video:positive frame mammography  Age,level of education,social class,
in well adult women  information screening (saves lives) marital status,religion,ethnicity,family 
(workplace) Group 2 – video:negative frame mammography  history,health behaviours-general,
screening (not attend is life threatening) knowledge,attitudes,perception of risk,
self-efficacy,intention ,efficacy,other affect
784 - 1 Uptake of mammography  Social  Cancer Control – women not interviewed until after  Age,level of education,social class,
in well women cognition  screening marital status,religion,ethnicity,family 
model Group 1 – women interviewed before screening history,medical history,health behaviours-
Group 2 – postal questionnaire sent before  general,physiological/psychological 
screening assessment,living arrangements,repro-
ductive history,perception of well-being,
attitudes,perception of risk,perception 
of susceptibility,intention,efficacy
700 - 1 Participation in  Shared  Cancer Group 1 – informed cancer services are available Age,sex,actual risk status,medical 
consultation in adults  consult- Group 2 – information encouraged writing  history,living arrangements,anxiety 
with cancer ation questions down before consultation – state,knowledge,preference consult-
ation style,perceived satisfaction,
disability scale,coping
789 - 1 Uptake of mammography  Attri-  Cancer Group 1 – neutral information video about  Age,level of education,social class,
in well women bution  breast screening marital status,religion,ethnicity,actual 
theory Group 2 – video plus internal responsibility frame  risk status,family history,medical history,
to get mammography perception of well-being,relief/
Group 3 – video plus external (physician)  reassurance,regret/responsibility,know-
responsibility frame to order mammography ledge,attitudes,usefulness of information
207 - 1 Cessation of smoking/ Social  Cancer, Control – questionnaire only Age,sex,knowledge,attitudes
adherence to diet in  learning  medicine Group 1 – verbal information:tobacco prevention 
well children theory plus culturally appropriate peer volunteer in school
Group 2 – information to improve diet
Group 3 – information aimed at diet and smoking
288 - 1 Uptake of radon testing  Social  Cancer, Group 1 – telephoned adults plus leaflet plus  Age,sex,level of education,
in well adults cognition  other advised to test home reproductive history,health behaviours-
model Group 2 – telephoned adults plus leaflet plus  general,perception of risk,perception 
encourage house testing plus told high risk area  of susceptibility,reasons
and house likely to have radon
690 - 1 Uptake of BSE Social  Cancer Control – data collection only Age,level of education,ethnicity,
cognition  Group 1 – belief targeted verbal plus leaflets  attitudes,perception of risk,
model (HBM):breast cancer and BSE  perception of susceptibility,reasons,
Group 2 – routine information plus skills on BSE operationalised model,motivation
Group 3 – Groups 1 plus 2 
458 - 1 Cessation of skin cancer  Social  Cancer Control – assessment only Age,sex,level of education,actual 
risks in well adolescents cognition  Group 1 – videotape risks skin cancer,self- risk status,health behaviours-general,
model assessment form,feedback and ways change  knowledge,attitudes,perception of 
behaviour susceptibility,intention,social 
reinforcement/norms
307 - 1 Uptake of BSE in older  Social  Cancer Control – basic one-to-one BSE instruction Age,level of education,marital status,
well women cognition  Group 1 – peer BSE ‘buddy’ selected  attitudes,self-efficacy
model Group 2 – women brought partner of choice 
for BSE buddy
140 - 1 Cessation of smoking  Social  Cancer, Control – routine care Age,sex,level of education,marital 
in adults with cancer cognition  medicine Group 1 – leaflet plus quit smoking sessions plus  status,actual risk status,medical 
model trained health professional history,physiological/psychological 
assessment,knowledge,attitudes,
operationalised model
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757 - 1 Uptake of mammography  Framing  Cancer Control – no assessment Age,level of education,ethnicity,actual 
in well women information Control 2 – assessment only risk status,medical history
Group 1 – leaflet mammography negatively 
framed plus invitation letter
Group 2 – leaflet positively framed plus letter 
434 - 1 Uptake of trial cancer  Framing  Cancer Group 1 – scenario:surgical removal intestine  Age,sex,level of education,actual risk 
treatment in adults  information followed by chemotherapy,neutrally framed status,medical history,attitudes,
with cancer Group 2 – scenario:surgery followed by  autonomy in decision making
chemotherapy positively framed
Group 3 – scenario:surgery followed by 
chemotherapy negatively framed
816 - 1 Participation in clinical  Shared  Cancer Control – routine informed consent procedures Age,sex,level of education,marital 
trials in adults with  consult- Group 1 – control plus follow-up phone calls by  status,actual risk status,medical 
cancer ation  research nurses (information giving) history,anxiety – state,perceived 
satisfaction,memory,awareness 
intervention
667 - 1 Participation in decision  Shared  Cancer Group 1 – leaflet breast cancer treatments and  Age,level of education,ethnicity,actual 
making in women with  consult- others experience risk status,knowledge,autonomy in 
breast cancer ation Group 2 – computer interaction,pictures and text decision making
671 - 1 Cancellation surgery in  None Medicine  Group 1 – information:procedure,side-effects  Age,sex,level of education,actual risk 
adults with CVD and complications status,medical history,anxiety – state,
Group 2 – more information risks and  disability scale,usefulness of information
complications
1 - 1 Uptake of exercise in well  None Medicine Control – usual care:GP suggests changes weight, Age,sex
adults with risk factors  exercise,and smoking
for CVD Group 1 – control plus attendance at local group 
session led by a health professional
10 - 1 Use of health care by  None Medicine  Control – internist recommends specialist to  Age,level of education,social class,
medicine male patients patients when attend primary care marital status,ethnicity,actual risk 
Group 1 – evaluation patient’s needs,develop  status,depression,perception of 
personalised care plan,nurse coordinated  well-being,disability scale,social 
care from clinic. support/communication
28 - 1 Use of health services  None Medicine, Control – usual care Age,sex,level of education,social class,
in adult patients with  mental  Group 1 – propath programme:provide in-depth  marital status,ethnicity,actual risk 
Parkinson’s disease health advice on coping with Parkinson’s disease,use  status,perception of well-being,other 
leaflet and video. affect,perceived satisfaction,disability 
scale
63 - 1 Uptake of exercise in  None Medicine Control – routine care Age,sex,level of education,social class,
adult back pain patients Group 1 – control plus leaflet information on  marital status,ethnicity,actual risk 
back pain and coping techniques status,health behaviours-general,
Group 2 – Group 1 information delivered by nurse  depression,perception of well-being,
plus telephone call for additional information knowledge,perceived satisfaction
47 - 1 Uptake of immunisations  None Medicine, Group 1 – health screening by local hospital Age,sex,level of education,social class,
and CVD risk factor  primary  Group 2 – health screening by physician marital status,medical history,health 
reduction in well adults care insurance,living arrangements
55 - 1 Cessation of smoking in  None Medicine Control – routine information giving video Age,sex,level of education,social class,
adult well children Group 1 – culturally sensitive video knowledge,usefulness of information
55 - 2 Cessation of smoking in  None Medicine Control – discussion group about smoking Age,sex,level of education,social 
adult well children Group 1 – showing previously developed videos class,ethnicity,self-efficacy,usefulness 
of information
57 - 1 Adherence to medication  None Medicine  Group 1 – medication once per day Age,sex,physiological/psychological 
in adults with hypertension Group 2 – medication twice a day assessment
88 - 1 Adherence to medication  None Medicine  Control – medication only Age,medical history,knowledge
in adult medicine physically  Group 1 – medication plus information about 
ill sample side-effects,name,adherence to regimen
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102 - 1 Cessation of smoking in  None Medicine Control – smoking status assessed Age,sex,level of education,social class,
well adults Group 1 – US$10 incentive plus win ‘ex-smoker  actual risk status,intention 
of the month’ money
105 - 1 Adherence to medication  None Medicine  Control – usual medication regimen Age,sex,ethnicity,actual risk status,
in medicine adults Group 1 – same packaging but twice daily  perception of well-being,perception of 
pill taking  risk,disability scale
Group 2 – modified information and twice 
daily dosing
110 - 1 Cessation of smoking/ None Medicine Control – informed that a programme running  Age,sex,level of education,actual risk 
adherence to healthy  and health claims monitored status,health behaviours-general,
lifestyle in medicine  Group 1 – underwent risk appraisal,personalised  physiological/psychological assessment,
well population risk feedback,letters,leaflets stress
Group 2 – underwent risk appraisal only 
147 - 1 Cessation of fatty diet  None Medicine Control – recorded and weighed food Age,sex,actual risk status,attitudes,
in well adults Group 1 – group counselling by nutritionist, reasons
feedback on fat intake,asked to make changes
155 - 1 Consent to participate  None Medicine  Group 1 – patient consent to observation only Age,sex,level of education,other 
in well adults Group 2 – consent to observation plus videotape affect,perceived satisfaction
183 - 1 Cessation of alcohol use  None Medicine Control – newsletters of ‘dummy’ interests Age,level of education,social class,
in well adult women Group 1 – newsletter included articles on alcohol  marital status,ethnicity,actual risk 
use and abuse status,knowledge,attitudes,reasons
216 - 1 Adherence to cessation of  None Medicine Group 1 – letter invitation,leaflet smoking and  Age,sex,level of education,actual risk 
smoking and poor diet in  weight loss programme,incentive (US$) option  status,physiological/psychological 
well adults and/or flat fee payment to programme assessment
Group 2 – invitation letter,programme leaflets 
sent if returned further information card
217 - 1 Cessation of smoking in  None Medicine Control – no intervention Sex,level of education,ethnicity,actual 
well adolescents Group 1 – group sessions:smoking,skills to resist  risk status,knowledge,self-efficacy,
smoking,feedback intention,coping
Group 2 – media intervention
Group 3 – health information plus Group 1
Group 4 – Group 1 plus Group 2 plus Group 3
249 - 1 Cessation of smoking  None Medicine Control – routine physician advice Age,sex,level of education,social class,
in well adults Group 1 – routine plus two-part counselling  actual risk status,medical history,
with trained ‘smoking’ counsellor health behaviours-general,perception of 
well-being,self-efficacy,intention,
motivation,stress
259 - 1 Cessation of alcohol use  None Medicine Control – no additional contact Age,sex,level of education,social class,
in well adult women Group 1 – leaflet information about alcohol level  actual risk status,health behaviours-
screen positive,cessation of,follow-up letter general,physiological/psychological 
Group 2 – reasons screen positive,asked about  assessment
drinking habits,monthly consultations
279 - 1 Cessation of smoking/ None Medicine Control – screening only Actual risk status,physiological/ 
adherence to healthy  Group 1 – verbal and leaflet information on diet, psychological assessment
lifestyle in well children exercise regimens and smoking ;obese children 
additional counselling
356 - 1 Cessation of salt in  None Medicine Control – no intervention Age,level of education,marital status
diet – adults with  Group 1 – nurses trained information on:addition 
hypertension salt,diet and hypertension,take blood pressure 
574 - 1 Cessation of smoking  None Medicine Group 1 – immediate cessation of counselling Age,sex,actual risk status,depression,
in well adults Group 2 – tailored cessation of plus placebo gum perception of well-being,other affect
Group 3 – tapered quitting plus active gum
652 - 1 Attendance of follow-up  None Medicine  Control – routine testing plus leaflet Age,sex,level of education,social class,
cholesterol screening  Group 1 – letter plus notification receive US$17  marital status,actual risk status,medical 
appointment in well adults  food coupon on attendance history,health behaviours-general
(mobile unit in car-park) Group 2 – reminder letter to attend
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679 - 1 Uptake of exercise in  None Medicine Control – routine health instruction and  Age,sex,social class,ethnicity,health 
well children assessment behaviours-general,physiological/ 
Group 1 – trained teacher,leaflets on:diet, psychological assessment,living 
smoking and exercise plus extra  arrangements,knowledge
exercise classes
489 - 1 Uptake of cessation of  None Medicine  Control – content unclear Age,sex,level of education,marital 
lifestyle change in adults  Group 1 – patient-designed intervention to reduce  status,actual risk status,family history,
with hyperlipidaemia CVD risk factors delivered by health professionals medical history,health behaviours-
Group 2 – professional-designed programme  general,perception of risk,reasons,self-
carried out by same health professionals,no  efficacy,operationalised model
further information given
772 - 1 Cessation of drinking in  None Medicine Control – waiting list control Age,sex,level of education,marital 
adult problem drinkers Group 1 – directive style consultation:drinking  status,actual risk status,family history,
defined as a problem,advice total giving up attitudes
Group 2 – patient-centred:reflective listening,
not labelled alcoholics,not confront problem
807 - 1 Adherence to self- None Medicine Control – training programme only
management in adults  Group 1 – training programme plus 
with medicine support groups
447 - 1 Adherence to medication  None Medicine  Control – health education package Age,sex,social class,marital status,
in adults with hypertension Group 1 – letter before appointment,follow-up  medical history,health behaviours-
on non-attendance plus card with clinic details general,physiological/psychological 
assessment
783 - 1 Cessation of smoking in  None Medicine Control – enhanced usual care:leaflet and access  Age,sex,level of education,marital 
well adults self-help materials status,ethnicity,actual risk status,
Group 1 – leaflet plus self-quitting guidelines: medical history,health behaviours-
coping techniques plus manual plus no smoking  general,attitudes,reasons,self-efficacy,
prompts plus feedback cards to return intention 
Group 2 – Group 1 plus letter encouraging 
adoption smoker buddy
Group 3 – Group 2 plus additional telephone 
contact with counsellor
336 - 1 Cessation of/adherence to  None Medicine Control – assessment only Age,sex,ethnicity,physiological/ 
lifestyle CVD factors in well  Group 1 – assessment plus screening psychological assessment,knowledge,
adolescents Group 2 – know your body information:lifestyle  attitudes,social reinforcement/norms
behaviours and changes in diet,exercise,smoking
Group 3 – assessment plus screening plus 
Group 2
530 - 1 Compliance with  None Medicine Control – assessment only Age,sex,level of education,marital 
medication in adults  Group 1 – four asthma management sessions: status,ethnicity,physiological/ 
with asthma lectures,leaflet and feedback skills psychological assessment knowledge
564 - 1 Cessation of drinking in  None Medicine Group 1 – hospitalisation plus attendance  Age,sex,social class,ethnicity,actual 
adults with drinking habit  AA on release risk status,health behaviours-general,
(workplace) Group 2 – attended AA only law infringements
Group 3 – offered choice of AA,hospitalisation,
alternative counselling or no treatment
702 - 1 Adherence to medication  None Medicine  Control – routine care Age,actual risk status
in medicine patients Group 1 – teaching session plus pill review
Group 2 – Group 1 plus follow-up phone call
213 - 1 Cessation of smoking  None Medicine Control – delayed intervention group Age,sex,actual risk status
in elderly adults Group 1 – physician trained on quitting 
plus leaflet 
for older adults (readability) plus letter
327 - 1 Adherence to self-care in  None Medicine Control – routine verbal plus leaflet information: Sex,level of education,social class,
adults with asthma house mites and asthma marital status,actual risk status
Group 1 – control plus computer programme 
feedback given on responses (piloted)
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328 - 1 Adherence to self-care  None Medicine Control – delayed intervention  Age,sex,actual risk status,medical 
in adults with medicine Group 1 – verbal information by health pro- history,physiological/psychological 
fessional:diet,exercise,self-monitoring,adherence assessment,self-efficacy
to medication plus skills plus group meetings
612 - 1 Adherence to minor  None Medicine Group 1 – oral ‘snore-guard’ used when sleeping Age,sex,actual risk status,
surgical therapy in adults  Group 2 – use nasal continuous positive airway  physiological/psychological assessment 
with sleep apnoea pressure treatment perception of well-being,attitudes,
perceived satisfaction
629 - 1 Uptake of advance  None Medicine  Control – routine care Age,sex,ethnicity,actual risk status,
directives in elderly adults  Group 1 – counsellor information on health  health insurance,physiological/psycho
with acute illness proxy,noted in charts  logical assessment,perception of well-being
268 - 1 Cessation of CVD risk  None Medicine Control – screened but not informed at risk Actual risk status,health behaviours-
factors in men at increased  Group 1 – physician letter about family risk by  general,physiological/psychological 
risk CVD and families lifestyle plus physician/ dietician counselling plus  assessment
newsletter prompt
395 - 1 Uptake of screening/ None Medicine, Control – routine care Age,sex,ethnicity,health behaviours-
immunisation in well  cancer, Group 1 – computer/note prompt for physician general,health insurance
adults primary  Group 2 – computer/note prompt plus patient 
care reminder letter 
Group 3 – patient reminder letter
396 - 1 Self-management/diet in  None Medicine Control – delayed information Age,sex,social class,actual risk 
adults with medicine Group 1 – use of computer and diet package  status,medical history,physiological/ 
to check diet psychological assessment knowledge,
perceived satisfaction
398 - 1 Diet/exercise adherence to  None Medicine Group 1 – behaviour therapy plus low calorie  Age,sex,level of education,actual risk 
in adults with medicine diet (1200 kcal per day) status,medical history,physiological/ 
Group 2 – behaviour therapy plus very low  psychological assessment depression
calorie diet (500 kcal on alternate days)
402 - 1 Adherence to treatment in  None Medicine Group 1 – all patients offered same behavioural 
adult alcoholics programme
Group 2 – patients randomised to either 
psychiatric or behavioural therapy
439 - 1 Uptake of CVD screening/ None Medicine  Control – routine Age,sex,level of education,social class,
utilisation of service in well  Group 1 – staff training,counselling about  marital status,actual risk status,health 
elderly adults CVD risks and prevention,Medicaid voucher, insurance,health behaviours-general,
free screening living arrangements anxiety – state,
depression,perception of well-being
527 - 1 Adherence to medication  None Medicine, Control – yearly assessment plus inhaler Age,sex,level of education,ethnicity,
in adults with chronic  cancer Group 1 – intensive smoking cessation of,health  actual risk status,medical history
obstructive pulmonary  professional contact and feedback every 4 months 
disease plus inhaler with medication or placebo 
168 - 1 Adherence to medication  None Medicine  Control – routine drug allocation Age,ethnicity,actual risk status,medical 
in adults with hyper- Group 1 – drug allocation plus five phone calls history,physiological/psychological 
cholesterolaemia assessment
265 - 1 Cessation of CVD risks in  None Medicine Control – re-assessed at one year only  Age,sex,actual risk status,knowledge,
children with family history  (and matched) health behaviours-general,physiological/ 
CVD Group 1 – home visits,letter and phone calls: psychological assessment
information shopping,cooking,signing diet contracts
Group 2 – Group 1 but delayed start intervention
365 - 1 Dietary change in well men None Medicine Control – assessment only Age,level of education,social class,
Group 1 – information from nutritionist –  actual risk status,family history,medical 
dietary changes history,health behaviours-general
372 - 1 Utilisation of services/  None Medicine Control – usual care Age,sex,level of education,social class,
lifestyle change in adults  Group 1 – patient level:personalised risk letter, marital status,ethnicity,actual risk 
screened positive for  reminder for doctor,fridge magnet status,family history,physiological/
cholesterol Group 2 – doctor received patient pack:letter  psychological assessment,health 
for patient,result screening test insurance
Group 3 – Group 1 plus Group 2
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263 - 1 Changes in diet in well  None Medicine, Control – assessment only Age,level of education,social class,
women at risk for breast  cancer Group 1 – group sessions – weekly sessions  actual risk status,family history,
cancer with nutritionist physiological/psychological assessment
693 - 1 Adherence to medication  None Medicine  Group 1 – leaflet Age,sex,level of education,
in elderly patients Group 2 – leaflet plus researcher explaining  physiological/psychological assessment,
information knowledge
Group 3 – Group 2 plus medication prompt plus 
additional home visits
Group 4 – Group 3 plus additional information 
about medication
137 - 1 Adherence to medication  None Medicine, Group 1 – information about safety antibiotics  Age,sex
in breast-feeding women  obstetrics  while breast feeding
requiring antibiotics and  Group 2 – Group 1 plus information about 
gynaecology  diarrhoea in babies as side-effect
(midwifery) 
139 - 1 Adherence to self- None Medicine Control – routine care Age,sex,ethnicity,actual risk status,
management in elderly  Group 1 – monthly phone calls reminding clinic  physiological/psychological assessment 
adults with medicine appointments,encouragement healthy lifestyle and  perceived satisfaction
drug adherence
143 - 1 Cessation of smoking in  None Medicine Group 1 – television-based information and leaflet Age,sex,level of education,social class,
well adults Group 2 – Group 1 plus monthly newsletters plus  ethnicity,actual risk status,self-efficacy,
support line numbers awareness intervention
668 - 1 Cessation of smoking Social  Medicine Group 1 – routine smoking leaflet by post Age,sex,social class,marital status,
cognition  Group 2 – ‘appropriate’ leaflet to stages of change  ethnicity,actual risk status,reasons 
model of smoker
Group 3 – ‘appropriate’ leaflet plus report of 
progress
Group 4 – ‘appropriate’ leaflet plus feedback 
progress plus phone call
332 - 1 Uptake of living will in  Framing  Medicine Group 1 – positively framed information:PVS, Age,sex,level of education,religion,
well elderly adults inform-  stroke,dementia and living wills (vignettes  living arrangements
ation readability)
(prospect  Group 2 – Group 1 information,negatively framed
theory) Group 3 – Group 1 information,in style of medical 
guidelines
20 - 1 Use of services in adults  Health  Medicine, Control – disease education information Age,sex,level of education,social class,
with sickle cell  promotion sickle cell Group 2 – disease information plus training  marital status,actual risk status,
in cognitive coping skills for pain disability scale,coping
27 - 1 Adherence to self-care  Shared  Medicine, Control – patients only contacted for assessment Age,sex,level of education,ethnicity,
behaviour in adult patients  consult- primary  Group 1 – symptom monitoring (placebo):asked  actual risk status,other affect,disability 
with arthritis ation care about symptoms,no mention arthritis  scale,social support/communication
Group 3 – counselling group:skills talking with 
doctor plus clarifying information about disease 
and medication plus reality therapy focusing on 
behaviour change
104 - 1 Self-maintenance in adults  Health  Medicine Control – routine clinic care Age,sex,social class,marital status,
with medicine promotion  Group 1 – compliance:focus on medication  actual risk status,physiological/ 
behaviours psychological assessment
Group 2 – behavioural:focus on behavioural 
strategies to change behaviour
Group 3 – Group 2 plus instruction:focus on 
behaviour strategies plus write contract
220 - 1 Adherence to exercise  Social  Medicine Control – school-based health education only Age,sex,ethnicity,actual risk status,
and healthy diet in  cognition  Group 1 – Child and Adolescent Trial for  knowledge,attitudes,self-efficacy,social 
well children model Cardiovascular Health (CATCH) programme: support/communication,intention,
specific CVD risk factor information plus feedback  social reinforcement/norms
over 3 years plus no smoking policy plus alter food 
available in school
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233 - 1 Adherence to exercise  Health  Medicine Control – assessment only:no feedback  Age,sex,level of education,social class,
and healthy diet in  promotion  or information marital status,ethnicity,actual risk 
well adults Group 1 – assessment plus face-to-face  status,medical history,physiological/ 
information plus feedback on adherence to  psychological assessment
exercise and diet plus phone call
241 - 1 Adherence to exercise  Social  Medicine Control – leaflet plus video plus lectures:exercise, Age,sex,actual risk status,health 
in well adults learning  diet,smoking,use gym behaviours-general,physiological/ 
theory Group 1 – tailored self-efficacy theory information: psychological assessment,self-efficacy
log exercise achieved plus feedback from instructor 
plus social modelling plus further explanation 
exercises plus buddy groups
276 - 1 Cessation of smoking  Health  Medicine Control – no additional information Sex,actual risk status,knowledge,
in well adolescents promotion  Group 1 – information given by older students  attitudes,social reinforcement/norms
plus skills to resist smoking plus no smoking 
contract 
295 - 1 Adherence to diet in  Health  Medicine Control – no additional information Age,sex,level of education,actual risk 
adults with hypertension promotion  Group 1 – task-centred instruction (Glaser):less  status,physiological/psychological 
emphasis on knowledge disease more on ways of  assessment,knowledge
coping/functioning
Group 2 – task centred plus goal setting plus 
self-monitoring (use contract)
305 - 1 Adherence to screening/ Lay model  Medicine Control – routine information hypertension: Age,sex,ethnicity,actual risk status,
healthy lifestyle in adults  illness definition,link with disease,importance health  health behaviours-general,physiological/ 
with hypertension  checks,reduction lifestyle behaviours psychological assessment,knowledge,
(workplace) Group 1 – action plan message:control plus leaflet  attitudes,self-efficacy,coping
plus illustrations on reducing risk factors
Group 2 – wellness thinking:routine plus information 
on experience of hypertension (no symptoms) plus 
emphasis on health,feeling good,visual information 
on enjoying exercise
321 - 1 Adherence to exercise  Social  Medicine Group 1 – exercise instruction plus verbal  Age,physiological/psychological 
in well women learning  reinforcement assessment,anxiety – state/trait,
theory Group 2 – exercise instruction plus verbal  depression,perception of control,
reinforcement plus positive cognitive statements motivation,personality type
157 - 1 Cessation of smoking in  Health  Medicine Control – data collection only Age,level of education,ethnicity,
well women with children promotion  Group 1 – social learning theory verbal plus leaflet  actual risk status,medical history,
(effects passive smoking) (piloted):skills to maintain smoke-free environment  reproductive history,health 
plus memory prompt plus feedback plus nurse  behaviours-general
home visits
376 - 1 Attendance at smoking  Social  Medicine Control – physician advise to quit plus health  Age,sex,ethnicity,actual risk status,
cessation programme in  cognition  counsellor session perception of well-being,self-efficacy,
well adults model Group 1 – control plus quitting leaflets operationalised model,motivation
Group 2 – control plus video cessation of group 
from former quitter plus told sessions free plus 
additional leaflets
Group 3 – control plus video plus choice of 
self-quitting leaflets or group counselling
469 - 1 Medication compliance in  Health  Medicine  Control 1 – new patients:no additional  Age,sex,actual risk status
adults with hypertension promotion information 
Group 1 – new patients:medication plus leaflet:
importance adhering and lifestyle change plus 
monthly newsletter
Control 2 – existing patients:no additional 
information
Group 2 – existing patients plus Group 1 
information
502 - 1 Self-management in  Framing  Medicine Control – small group instructions:lecture plus  Age,sex,actual risk status,knowledge,
children with medicine information video plus feedback reasons
Group 1 – video plus lecture framed using 
anchored instructions and context patient’s life
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503 - 1 Uptake of/adherence  Social  Medicine Control – no details  Age,sex,level of education,social class,
to lifestyle in adults  cognition  Group 1 – nurse counselling:modifying eating/ marital status,ethnicity,actual risk 
with medicine model exercise plus monitor calorie intake plus social  status,health behaviours-general,
support plus identify barriers physiological/psychological assessment,
perception of well-being,knowledge,
social support/communication
707 - 1 Cessation of/adherence  Social  Medicine  Control – usual care verbal information:smoking, Age,sex,level of education,social 
to lifestyle behaviours in  learning  nutrition and exercise class,ethnicity,actual risk status,
adults following infarction theory Group 1 – self-efficacy based information: physiological/psychological assessment
feedback,skill acquisition,additional contact. HCP.
158 - 1 Cessation of smoking in  Social  Medicine Control – generic health letter Age,sex,actual risk status
well adults cognition  Group 1 – personalised,theoretically driven leaflet 
model, plus signed letter
attrib.
theory
158 - 2 Cessation of smoking in  Social  Medicine Control – questionnaires only Age,sex,level of education,actual 
well adults cognition  Group 1 – tailored letter and personal details risk status
model,
attrib.
theory
210 - 1 Uptake of/cessation of  Social  Medicine Group 1 – standard healthy eating leaflets Age,sex,level of education,actual 
healthy diet in well adults  learning  Group 2 – information tailored to results  risk status,attitudes,physiological/ 
(workplace) theory preliminary questionnaire psychological assessment,usefulness 
of information,intention 
211 - 1 Cessation of smoking in  Social  Medicine Group 1 – ‘fair’ to provide health feedback  Age,sex,level of education,actual 
well adults (church based) cognition  self-help leaflet  risk status,operationalised model
model Group 2 – fair,sermons,additional volunteers,
audio-tapes,script-guided information
644 - 1 Cessation of smoking/  Social  Medicine Group 1 – risk assessment and feedback Age,sex,level of education,social 
CVD risk factor reduction  cognition  Group 2 – Group 1 plus leaflet and video  class,marital status,physiological/ 
in well adults (workplace) model information:risk factors psychological assessment
Group 3 – Group 2 plus behavioural counselling:
target setting based on stages change model
Group 4 – Group 3 plus financial incentives
269 - 1 Adherence to diet in  Health  Medicine, Control – routine letter to double fibre rate Age,sex
elderly well adults promotion cancer Group 1 – leaflet plus free fibre supplement plus 
group counselling plus newsletters plus recipe 
competitions
Group 2 – letter plus fibre supplement free 
for 3 months
291 - 1 Adherence to self- Social  Medicine Control – routine medical care Age,sex,ethnicity,worry
management in parents  learning  Group 1 – family counselling:self-management,
of children with asthma theory feedback and skill acquisition
541 - 1 Adherence to/cessation  Social  Medicine, Control – routine nutritional information Age,actual risk status,medical history,
of healthy diet in women  learning  cancer Group 1 – fat content information common foods  health behaviours-general,physiological/ 
with breast cancer theory plus food diary plus counselled to reduce fat intake psychological assessment
255 - 2 Cessation of smoking  Health  Medicine Control  Age,sex,actual risk status,social 
in well adolescents promotion  Group 1 – Minnesota smoking prevention  reinforcement/norms
campaign (social influences model)
Group 2 – shorter version Group 1
Group 3 – smoke free generation programme
145 - 1 Cessation of smoking in  Social  Medicine Control – assessment smoking behaviour only Age,sex,actual risk status,other affect,
well adolescents cognition  Group 1 – group lessons:smoking,skill acquisition, perception of risk,social reinforcement/ 
model, changing social norms over 3 years norms,stress,personality type
health 
promotion 
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264 - 1 Cessation of/adherence  Social  Medicine Control – exercise intervention programme Age,sex,level of education,actual risk 
to diet and exercise in  learning  Group 1 – information about healthy diet and food  status,health behaviours-general,
well adults theory preparing skills physiological/psychological assessment
Group 2 – information about healthy diet
Group 3 – information weight management 
and exercise
659 - 1 Change in diet in  Expected  Medicine Control – assessment only Age,education,social class,risk status,
well men utility  Group 1 – women attended small group  medical history,health behaviours,
theory sessions weekly perception of well-being,knowledge,
attitudes,social reinforcement/norms
622 - 1 Adherence to treatment  Social  Medicine, Control – routine care Age,sex,level of education,marital 
in adults with acute and  cognition  surgery  Group 1 – routine care plus phone call  status,ethnicity,actual risk status,
chronic illness model (A&E)  information based on HBM medical history,knowledge,perception 
Group 2 – routine care plus HBM clinic  of risk,perception of susceptibility,
intervention reasons,operationalised model
Group 3 – routine plus HBM clinic 
intervention plus phone call
814 - 1 Uptake of exercise in  Social  Medicine Control – exercise classes only Age,physiological/psychological 
well adult women learning  Group 1 – information based on relapse  assessment
theory prevention plus exercise class
Group 2 – Group 1 plus incentive 
490 - 1 Uptake of rehabilitation  Stress –  Medicine, Control – routine ‘pre surgery’ information Age,sex,anxiety – state,perceived 
exercise in adults with  coping  surgery Group 1 – routine ‘pre-surgery’ information plus  satisfaction,waiting time/consultation,
hip replacements model further information on hip replacement usefulness of information,stress
22 - 1 Uptake of condoms  None STDs (HIV) Control – no health information Age,sex,level of education,anxiety – 
in well adults Group 1 – house campaigns plus community plus  state,knowledge
calendars/T-shirts plus posters plus leaflets:HIV,
condom use and prevention information
732 - 1 Cessation of risky risk  None STDs (HIV) Control – comparison,delayed intervention  Sex,actual risk status,medical history
in well adults community
Group 1 – STD information plus leaflets plus 
medication plus free condoms
736 - 1 Cessation of risky HIV  None STDs (HIV) Control – waiting list control Age,sex,level of education,social class,
behaviours/uptake of safer  Group 1 – group education session on HIV marital status,actual risk status,medical 
practices in adult drug users Group 2 – group counselling session plus  history,health behaviours-general
opportunity to be tested
341 - 1 Cessation of drug use in  None STDs (HIV) Control – interview plus waiting list Age,sex,level of education,marital 
adult substance users Group 1 – information HIV (video,feedback) plus  status,ethnicity,actual risk status,
waiting list for test counselling health behaviours-general,knowledge,
Group 2 – HIV information plus counselling about  attitudes,perception of risk
having test plus test
156 - 1 Cessation of drug use in  None STDs (HIV) Control – reward for ‘drug free’ behaviour  Age,sex,marital status,ethnicity,actual 
adult drug users delayed 3 months risk status,physiological/psychological 
Group 1 – high reward:4 stars for a prize for  assessment
drug free behaviour
Group 2 – low reward:8 stars for a prize for 
drug free behaviour
212 - 1 Cessation of drug use  None STDs (HIV) Control – school curriculum:might be similar to  Sex,ethnicity,actual risk status,health 
in well adolescents intervention group behaviours-general,attitudes,social 
Group 1 – Drug Abuse Resistance Education  reinforcement/norms
(DARE) project:skill acquisition,drug use 
lesson-based information
639 - 1 Cessation of/adherence  None STDs (HIV) Group 1 – leaflets and opportunity to ask questions  Age,level of education,ethnicity,
to HIV behaviours in  Group 2 – video-tape information  reproductive history,worry,knowledge,
well mothers Group 3 – nurse educator attitudes
289 - 1 Adherence to safe sex/ None STDs (HIV) Control – assessment plus free condoms  Age,sex,social class,actual risk status
uptake of HIV testing in  Group 1 – anticipatory guidance:lecture plus 
well young adults video:efficacy condoms,individual counselling 
plus free condoms
Group 2 – Group 1 plus individual counselling by 
peer plus free condoms
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465 - 1 Cessation of/adherence  None STDs (HIV) Group 1 – peer educator information,video,leaflet Age,ethnicity,knowledge,attitudes
to risky/safe sex in  Group 2 – health professional trained to provide 
well women brief information
733 - 1 Cessation of drug use/ None STDs (HIV), Control – no additional visits Age,level of education,marital status,
attendance post-natal care  obstetrics  Group 1 – health professional visited client for  actual risk status,medical history,
in women drug-abusers and  18 months:support plus information plus  health behaviours-general,other affect,
gynaecology  problem solving attitudes,reproductive history,stress
(midwifery)
4 - 1 Cessation of cocaine/  Social  STDs (HIV) Control – 90-min counselling session twice  Sex,level of education,social class,
adherence to therapy  cognition  a week ethnicity,actual risk status,family 
sessions in adult  model, Group 1 – 120-min session,five times a week history,health behaviours-general,
cocaine users health  personality 
promotion 
24 - 1 Intention to use condoms  Health  STDs (HIV) Control – given non-alcoholic drink Age,level of education,marital status,
in adult well males promotion Group 1 – given alcoholic drink ethnicity,health behaviours,knowledge,
attitudes,perception of susceptibility,
reasons,efficacy
223 - 1 Cessation of drug use in  Health  STDs (HIV), Control – verbal information:prevalence drug use, Age,level of education,social class,
female adolescent users promotion medicine teenage development and sexual behaviour marital status,ethnicity,actual risk 
Group 1 – group plus individual sessions tailored  status,reproductive history
to drug use,skills acquisition,problem solving
226 - 1 Cessation of drug use in  Health  STDs (HIV), Control – information:health and social  Sex,social class,ethnicity,actual 
well adolescents promotion medicine consequences drug use risk status
Group 1 – information:consequences drugs plus 
resistance skills
Group 2 – information aimed at beliefs:drug use,
norms within school
Group 3 – resistance skills plus targeted 
information
247 - 1 Cessation of drug use in  Health  STDs (HIV), Group 1 – social skills:resist drug taking Sex,ethnicity,actual risk status,
well adolescents promotion medicine Group 2 – affect management:focus decision  health behaviours-general
making skills plus stress management
Group 3 – social skills plus affect management
277 - 1 Cessation of drug use in  Health  STDs (HIV), Control – no additional information Sex,level of education,ethnicity,actual 
well adolescents promotion medicine Group 1 – health belief model information by  risk status,knowledge,attitudes,
teachers:smoking,marijuana and alcohol use, perception of risk,self-efficacy,
resistance skills intention,social reinforcement/norms
Group 2 – Group 1 information plus peer 
volunteer
424 - 1 Cessation of/adherence to  Social  STDs (HIV) Control – delayed programme Sex,ethnicity,actual risk status,
risky/safe sex in children  cognition  Group 1 – video plus classroom information:HIV  knowledge,attitudes,health 
(school) model and skill acquisition plus competitions plus  behaviours-general,reasons,intention,
feedback plus training teacher social reinforcement/norms
Group 2 – Group 1 plus parents encouraged to 
attend and help child with homework 
478 - 1 Cessation of/adherence  Social  STDs (HIV) Control – routine curriculum Sex,education,religion,ethnicity,family 
to risky/safe sex in well  learning  Group 1 – information based on social learning  history,knowledge,attitudes,self-
adolescents (school) theory theory:contraception plus role-play plus skill  efficacy,social support/communication,
acquisition intention,social reinforcement/norms
600 - 1 Participation in research/  Social  STDs (HIV), Group 1 – letter plus leaflet plus questionnaire 
cessation of substance  cognition  medicine completion plus option to take part in 
abuse in well adolescents model counselling (TRS)
Group 2 – Group 1 information plus no choice 
about counselling
685 - 1 Uptake of condoms in  Social  STDs (HIV) Control – family planning professional information: Age,actual risk status,reproductive 
well female adolescents  cognition  condom use plus demonstration history,knowledge,attitudes,self-
model Group 1 – control plus encouraged client to  efficacy
handle condom
Group 2 – Group 1 plus feedback plus elicitation 
clients condom use self-efficacy
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742 - 1 Cessation of/uptake of  Social  STDs (HIV) Control – no additional information Age,level of education,social class,
safer sex in pregnant  learning  Group 1 – general health promotion video plus  ethnicity,actual risk status,reproductive 
women theory role play plus peer volunteer history,health behaviours-general,
Group 2 – Group 1 delivery information but  knowledge,perception of risk,social 
specifically about AIDS support/communication,intention 
492 - 1 Cessation of/adherence  Social  STDs (HIV) Control – delayed intervention Age,sex,ethnicity,health behaviours-
to risky sex in well  cognition  Group 1 – information:HIV and condoms plus  general,knowledge,attitudes,
adolescents model, overcoming barriers plus skill acquisition perception of risk,self-efficacy,
social intention 
learning 
theory
766 - 1 Cessation of/adherence  Health  STDs (HIV) Group 1 – Group discussion information:HIV  Age,sex,actual risk status,health 
to risky/safe sex in well  promotion, and AIDS behaviours-general,knowledge,
adolescents social  Group 2 – information plus skills acquisition: attitudes,reasons,self-efficacy,social 
learning  decision making and communication plus support  support/communication,efficacy
theory and exposure to peers with HIV
776 - 1 Change of sex behaviour  Social  STDs (HIV) Control – ‘placebo’ information:nutrition, Actual risk status,health behaviours-
in ‘high risk’ women cognition  child and family care general,knowledge,perception of risk,
model Group 1 – HIV-AIDS information plus skill  social support/communication
acquisition plus support
165 - 1 Cessation of risky drug  Social  STDs (HIV) Control – no group sessions  Age,sex,level of education,social 
use in drug users learning  Group 1 – Group session information AIDS  class,ethnicity,actual risk status,health 
theory Group 2 – Group 1 plus additional sessions on  insurance,living arrangements,law 
skill acquisition infringements
632 - 1 Cessation of/adherence  Social  STDs (HIV) Group 1 – leaflets Age,sex,level of education,social class,
to HIV risk behaviours  cognition  Group 2 – leaflets plus group discussion  marital status,ethnicity,actual risk 
in adult drug users model, information:HIV and prevention,skill  status,anxiety – state,knowledge,atti-
social  acquisition plus homework tudes,perception of susceptibility,self-
learning efficacy,social  support/communication,
theory sexual orientation,efficacy
632 - 2 Cessation of/adherence  Social  STDs (HIV) Group 1 – leaflets Age,sex,level of education,social class,
to for drug using adults  cognition  Group 2 – group discussion plus leaflet  marital status,ethnicity,actual risk 
model, information (social learning theory):HIV  status,anxiety – state,knowledge,
social  risks and prevention plus homework attitudes,perception of susceptibility,
learning self-efficacy,social  support/
theory communication,alienation
635 - 1 Cessation of risky sex/ Social  STDs (HIV) Group 1 – group information session viewing  Age,education,physiological/ 
drug use in black,male  cognition  video plus leaflets psychological assessment,anxiety – 
adult drug users model, Group 2 – psychologist led group session  state,knowledge,perception of 
social  plus leaflet plus skill acquisition plus feedback susceptibility,self-efficacy,social 
learning support/communication,efficacy
theory
636 - 1 Cessation of risky sex/ Social  STDs (HIV) Group 1 – HIV information in first week Age,sex,education,ethnicity,actual 
drugs in adult drug users cognition  Group 2 – HIV information in second week risk status,living arrangements,
model Group 3 – enhanced theory-based group  law infringements
information plus additional counselling
525 - 1 Cessation of risky drug  Social  STDs (HIV) Control – assessment of risk Age,sex,education,social class,
use in adult substance  cognition  Group 1 – stages change assessment to tailor  marital status,actual risk status,health 
users model, cognitive-behaviour intervention behaviours-general,living arrangements,
health reasons,operationalised  model
promotion
660 - 1 Change in HIV risk  Social  STDs (HIV) Control – assessment only Age,sex,level of education,ethnicity,
factors amongst well  cognition  Group 1 – group information guided by theory  knowledge,attitudes,self-efficacy,social 
adolescents model, plus skill acquisition reinforcement/norms
social 
learning 
theory
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454 - 1 Changes in HIV risks  Stress –  STDs (HIV) Control – information:culturally sensitive HIV  Age,level of education,social class,
in well women coping  prevention plus free condoms plus free test plus  marital status,ethnicity,actual risk 
model free bleach status,anxiety – trait,depression,
Group 1 – control plus more information specific  worry,knowledge,attitudes,perception 
to the woman’s problems plus skill acquisition  of risk,reproductive history,
plus leaflet stress,coping
706 - 1 Utilisation of primary care  None Primary  Control – no information or questionnaire Age,level of education,marital status,
in mothers of children with  care, Group 1 – questionnaire plus leaflet (readability  reproductive history
childhood illnesses paediatrics plus piloting)
6 - 1 Adherence to medicine  None Primary  Control – ‘official’ drug Age,sex
in physically ill children care Group 1 – generic or alternative to official drug
6 - 2 Adherence to medication  None Primary  Control – official drug Age,sex
in physically ill children care Group 1 – generic product,not official
6 - 3 Adherence to medication  None Primary  Control – official drug Age,sex
in physically ill children care Group 1 – generic,‘non-official’ group
32 - 1 Compliance with healthier  None Primary  Group 1 – regular food/time:usual food depends  Age,level of education,actual risk 
diet in adult obese women care, on weeks of treatment status,medical history,attitudes,
medicine Group 2 – regular food/weight:usual food  perception of control,disability scale,
depending on reaching target weight social support/communication
Group 3 – stimulus/time:new diet depends on 
weeks of treatment
Group 4 – stimulus/weight:new diet depends on 
reaching target weight
51 - 1 Adherence to medication  None Primary  Group 1 – medication given a syrup and cup to  Age,sex,level of education,actual risk 
in children with pneumonia care take medication status,living arrangements
Group 2 – medication in the form of a syrup and 
a spoon
Group 3 – medication in tablet form
Group 4 – medication given as a powdered sachet
174 - 1 Uptake of exercise and diet  None Primary  Control – cancer screening plus information plus  Age,level of education,social class,
in obese women care, option to attend delayed intervention marital status,ethnicity,physiological/ 
medicine Group 1 – group plus one-to-one counselling: psychological assessment,knowledge,
weight issues plus ways to change diet/ increase  self-efficacy
exercise plus feedback plus problem solving plus 
buddy support system
302 - 1 Utilisation of service in  None Primary  Control – kept diary children’s illnesses Age,level of education,social class,
well adult parents care Group 1 – diary children’s illness plus leaflet on  family history,reproductive history,
management common illness (piloted) reasons
589 - 1 Uptake of health screening  None Primary  Group 1 – signed letter invitation with fixed  Health behaviours-general,
in well adults care appointment physiological/psychological assessment,
Group 2 – prompt on GPs notes to encourage  worry,attitudes,usefulness of information
screening
572 - 1 Uptake of immunisation  None Primary  Control – non-attendees sent reminder letter
well children care Group 1 – letter plus leaflet plus phone call
747 - 1 Uptake of osteoporosis  None Primary  Group 1 – fixed time letter plus leaflet Social class
screening in well women care Group 2 – fixed appointment but needed to 
confirm plus leaflet
Group 3 – letter requiring women to make 
appointment plus leaflet
769 - 1 Use of primary care  None Primary  Group 1 – patient in A&E seen by GP Perceived satisfaction
service in patients  care, Group 2 – A&E patient seen by senior house 
attending A&E medicine officer
Group 3 – A&E patient seen by registrar
520 - 1 Utilisation of doctor in  None Primary  Control – usual care Age,level of education,social class,
parents of ill children care, Group 1 – leaflet on common childhood illnesses  medical history,living arrangements,
paediatrics and symptoms worry,perception of well-being,percep-
tion risk,perception of susceptibility,
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234 - 1 Uptake of influenza vaccine None Primary  Control – newsletter on vaccine plus results of  Age,sex,level of education,marital status,
in elderly well patients care health status medical history,health insurance
Group 1 – newsletter on vaccine plus free 
immunisation at hospital
Group 2 – newsletter on vaccine plus free
immunisation by primary care physician
337 - 1 Utilisation of physician in  None Primary  Control – assessment only Age,sex,actual risk status,
adults with coughs care Group 1 – leaflet:causes coughs,self-care  health insurance
remedies,when contact physician plus explained 
by nurse/physician
796 - 1 Utilisation of primary care  None Primary  Control – no additional information after  Age,sex,actual risk status,
in adults with coughs care contact GP health insurance
Group 1 – doctor explained leaflet in consultation
414 - 1 Adherence to therapy/ None Primary  Group 1 – exercise classes plus leaflet weight loss  Age,sex,health behaviours-general,
diet in obese adults care, plus group discussion diet plus minimum support: physiological/psychological assessment,
medicine weekly letter and feedback weight loss  depression
Group 2 – Group 1 plus 2 plus booster sessions:
feedback and skill acquisition plus phone contact
553 - 1 Adherence to exercise in  None Primary  Control – usual treatment:relaxation Age,sex,ethnicity,actual risk status,
adults with arthritis care Group 1 – aerobic walking:exercise to increase  physiological/psychological assessment,
heart rate  anxiety – state,depression,perception 
Group 2 – water aerobics:same as Group 1 but  of well-being,disability scale,social 
in water support/communication
408 - 1 Uptake of immunisation  None Primary  Control – routine information Age,sex,ethnicity,actual risk status
in well children care Group 1 – telephone reminder recorded message
19 - 1 Uptake of hypothetical  Framing  Primary  Group 1 – survival data of therapies presented as  Age,sex,level of education,
treatments in male  inform- care point estimates medical history
geriatric patients ation Group 2 – survival data presented in the form of 
a curve
167 - 1 Adherence to well-child  Social  Primary  Control – no additional information Age,level of education,social class
clinic in well parents cognition  care, Group 1 – letter reminder informed by HBM
model paediatrics Group 2 – postcard reminder prompt
357 - 1 Adherence to medication  Health  Primary  Control – routine care:verbal information plus  Age,ethnicity,reproductive history
in women with children  promotion care explanation syringe use in Spanish
acute otitis media Group 1 – written leaflet (readability score) plus 
leaflet with pictures plus verbal information
426 - 1 Uptake of health screening  Social  Primary  Control – letter invite to make an appointment Attitudes,perception of risk,
in well adults cognition  care, Group 1 – letter invite with fixed appointment  perception of susceptibility,reasons,
model medicine intention,efficacy
506 - 1 Participation in  Communi- Primary  Control – placebo leaflet:description clinics  Age,sex,level of education,social class,
consultation in  cation care available  health insurance,perceived satisfaction,
physically ill patients Group 1 – leaflet encouraging question  awareness intervention
asking (readability)
633 - 1 Uptake of flu vaccine  Social  Primary  Control – nurse visit plus information on safety Age,sex,actual risk status,perception 
in well elderly cognition  care Group 1 – nurse visit plus vaccine information  of well-being 
model
369 - 1 Adherence to  Stress –  Primary  Control – routine care Age,sex,level of education,social 
medication in adults  coping  care Group 1 – monthly phone call class,ethnicity,perception of well-being,
with osteoarthritis model Group 2 – information within clinic perceived satisfaction,disability scale,
Group 3 – information in clinic plus phone call social support/communication
620 - 1 Uptake of health check  Social  Primary  Group 1 – invitation letter Age,worry,attitudes,perception of 
in well adult males cognition  care, Group 2 – invitation within surgery control,perception of susceptibility,
model medicine reasons,operationalised model,
intention,efficacy
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135 - 1 Decision to breast feeding  None Obstetrics  Control – usual care groups:breast feeding vs. Knowledge,attitudes,social 
in pregnant well women and  formula feeding plus leaflets on breast pump plus  support/communication,intention 
gynaecology  T-shirts plus posters
(midwifery) Group 1 – feedback groups:fears,misperceptions 
and positioning advice plus breast pump and wipes 
plus free football ticket for husband plus peer 
counsellor
698 - 1 Adherence to hormone  None Obstetrics  Control – no HRT Age,medical history,reproductive 
replacement therapy (HRT)  and  Group 1 – HRT that induces cyclical withdrawal  history,physiological/psychological 
in well women gynaecology  menorrhoea assessment,perception of well-being,
(midwifery) Group 2 – HRT induces complete amenorrhoea reasons
634 - 1 Uptake of osteoporosis  None Obstetrics  Group 1 – open letter:contact clinic to  Social class
screening in well women and  make appointment
gynaecology  Group 2 – letter with fixed appointment time
(midwifery)
768 - 1 Maintenance of breast  Expected  Obstetrics  Group 1 – commercial pack containing  Age,level of education,social class,
feeding in well women utility  and  formula only marital status,religion,ethnicity,actual 
theory gynaecology  Group 2 – pack contained breast pump,pads  risk status,attitudes,intention 
(midwifery) and cream (no formula)
616 - 1 Uptake of breast feeding  Health  Obstetrics  Control – leaflets only Age,level of education,social class,
in well women promotion and  Group 1 – culturally sensitive video-tape plus  marital status,ethnicity,health 
gynaecology  three group discussions behaviours-general,knowledge,atti-
(midwifery) tudes,reproductive history,intention 
403 - 1 Uptake of breast feeding  Health  Obstetrics  Control – routine information Age,level of education,social class,
in well women promotion and  Group 1 – women phoned by nurses medical history,reproductive history,
gynaecology  Group 2 – women visited by nurse attitudes,stress
(midwifery)
562 - 1 Adherence to teeth  None Dentistry Control – no additional information Knowledge,reasons
hygiene in well children Group 1 – school lecture to parents and children,
small group discussion and feedback skills 
for children
Group 2 – lecture information only
576 - 1 Adherence to oral hygiene  Health  Dentistry Control – routine dental care
in well adults promotion  Control 2 – routine plus patient phone in results 
of ‘plaque test’
Group 1 – additional consultation plus feedback 
from health professional
Group 2 – Group 1 plus checklist of tasks
758 - 1 Uptake of oral hygiene in  Social  Dentistry Control – routine dental hygiene instructions Age,sex,social class,actual risk status,
adults with gingivitis cognition  Group 1 – video-tape information plus feedback  physiological/psychological assessment,
model session with hygienist self-efficacy,attitudes,perception of risk,
intention,social reinforcement/norms,
motivation
371 - 1 Adherence to dental care  Social  Dentistry Control – information about teeth Knowledge,intention 
in well adolescents cognition  Group 1 – verbal information:teeth,prevention,
model health and social factors
457 - 1 Adherence to dental  Social  Dentistry Control – toothbrush only Attitudes,perceived satisfaction
hygiene in well adults learning  Group 1 – electric toothbrush and gel toothpaste
theory Group 2 – shower-based oral hygiene system:
toothbrush,paste and mouth rinse
304 - 1 Adherence to medication  None Infectious  Control – no additional information
in children screened  disease Group 1 – telephone call every 3 months to 
positive for tuberculosis  encourage drug adherence
(TB) bacteria Group 2 – nurse visited child’s home every 
3 months
Group 3 – child saw doctor every 3 months
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308 - 1 Adherence to anti-malaria  None Infectious  Control – assessment only Age,actual risk status,knowledge
procedures in well children disease Group 1 – small group teaching about malaria
96 - 1 Adherence to medication  None Mental  Group 1 – counselling about schizophrenia with  Age,sex,level of education,social class,
in adult psychotic patients health family:one family per clinician marital status,ethnicity,medical history,
Group 2 – counselling about schizophrenia: utilisation of services
six families per counsellor
479 - 1 Adherence to medication  None Mental  Control – routine medication  Age,sex,actual risk status,medical 
in adults with schizophrenia health Group 1 – medication plus family counselling: history,physiological/psychological 
group meetings plus visit by health professional  assessment,attitudes,disability scale
plus supervision
511 - 1 Adherence to exercise/ None Mental  Control – delayed onset trial Age,actual risk status,medical history,
health care/utilisation of  health Group 1 – signed physician letter plus leaflet: health behaviours-general,self-efficacy,
in adults with Parkinson’s  exercise,diets and side-effects plus bi-monthly  stress
disease feedback by physician
494 - 1 Utilisation of services  None Mental  Control – non-active counselling:carers told  Age,sex,level of education,social class,
in adult carers of patients  health where to obtain information religion,ethnicity,actual risk status,
with Alzheimer’s disease  Group 1 – counselling on getting support plus  depression,perception of well-being,
obtained information plus counselling with  perception of risk,disability scale,social 
carer plus family plus directive means to  support/communication
encourage attendance
554 - 1 Utilisation of services in  None Mental  Control – usual services of Medicaid beneficiaries  Age,sex,level of education,social class,
adults with mental health  health Group 1 – Medicaid beneficiaries enrolled in  marital status,ethnicity,actual risk 
disabilities pre-paid services and advice on selecting  status,living arrangements anxiety – 
services state,depression,perception of well-being,
social support/communication
794 - 1 Adherence to medication  Health  Mental  Control – routine care Age,sex,level of education,social class,
in adults with depression promotion health Group 1 – trained physicians plus patient watched  marital status,actual risk status,anxiety 
video plus question form for participation in  – state,depression,other affect,
consultation perceived satisfaction
493 - 1 Decision confidence/skill  Expected  Mental  Control – assessment only  Age,sex,depression,other affect,
in carers of people with  utility  health Group 1 – trained to use computer decision  perception of control,usefulness of 
Alzheimer’s disease theory programme:information,decision tree,elicitation  information,alienation
utilities and best outcome plus computer 
installation
176 - 1 Choice of hypothetical  Framing  Other Group 1 – choice of two medications for  Age,sex,level of education,actual risk 
medication in adult  (prospect  hypothetical disease framed risk figures using  status,medical history,reasons 
well patients theory) either relative or absolute figures.
150 - 1 Adherence to wound care  None Surgery  Control – leaflet on wound care (readability  Age,sex,level of education,ethnicity,
in adults with emergency  (A&E)  formula applied) waiting time/consultation,perceived 
lacerations Group 1 – leaflet plus cartoon illustration satisfactionHealth Technology Assessment 1999; Vol. 3: No.1
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37 - 1 Uptake of cervical cancer  None Cancer Control – no additional information Age,ethnicity,health insurance
screening in adult  Group 1 – video information (culturally sensitive) 
well women displayed in waiting area before physician 
appointments
154 - 1 Uptake of mammography  None Cancer Control – letter invitation plus questionnaire Age,level of education,marital status,
in well women with family  Group 1 – written plus audio-tape information: actual risk status,family history,health 
history breast cancer screening,breast cancer plus feedback BSE  behaviours-general,attitudes,
plus decision making kit (reasons for having  perception of risk,efficacy
mammography:information aid not decision aid)
296 - 1 Adherence to colorectal  None Cancer Control – no additional information Age,sex,actual risk status,health 
screening in well adults Group 1 – physician trained plus verbal information  professional measures
plus screening leaflet plus free kit
Group 2 – Group 1 plus reminder letter
377 - 1 Uptake of cervical  None Cancer Group 1 – immediate offer smear by physician, Age,marital status,actual risk status,
screening in well  if refused made appointment to re-attend medical history,attitudes
women Group 2 – physician offered smear immediately plus 
discussion about refusal plus encouragement to have 
test immediately
412 - 1 Uptake of colorectal  None Cancer Control – return hemoccult cards in person Age,sex,ethnicity,health behaviours-
screening in well adults Group 1 – return in addressed envelope general,health insurance
Group 2 – return in stamped addressed envelope
695 - 1 Uptake of mammography  None Cancer Control – routine invitations only Age,ethnicity,knowledge
in well Asian women Group 1 – volunteer attend women’s home plus 
verbal information breast cancer
712 - 1 Uptake of mammography  None Cancer Group 1 – reminder card and appointment date Age,reasons,usefulness of information
in well women Group 2 – Group 1 plus additional reminder letter
Group 3 – reminder letter 
Group 4 – verbal recommendation to attend 
for follow-up
310 - 1 Cessation of smoking in  None Cancer, Control – placebo video:seat-belt use Age,sex,social class,perception of 
well adults (workplace) medicine Group 1 – video:man with lung cancer explains risks risk,intention 
Group 2 – Group 1 video plus increase self-efficacy 
message
Group 3 – Group 1 video with ‘gruesome’ scene 
taken out
Group 4 – information about smoker who had both 
legs amputated from smoking
752 - 1 Colorectal cancer  None Cancer, Group 1 – hemoccult test posted Age,sex
screening/health checks  medicine, Group 2 – Group 1 plus letter invite health check
in well adults primary  Group 3 – invite health check plus explanation 
care hemoccult test
Group 4 – invite health check
691 - 1 Choice irradiation  Shared  Cancer Control – routine consultation Age,level of education,marital status,
therapy in women  consult- Group 1 – clinician given checklist prompt actual risk status,knowledge,attitudes 
with breast cancer ation Group 2 – consultation plus checklist plus women  autonomy in decision making,
used a decision board  preference consultation style,reasons,
usefulness of information
248 - 1 Attendance for follow-up  Social  Cancer Control – routine letter invitation Age,level of education,social class,
appointment in adult  cognition  Group 1 – letter plus leaflet explaining cervical  marital status,ethnicity,medical 
women with screen- model smear results history,reproductive history,health 
positive cervical smear behaviours-general
354 - 1 Uptake of mammography  Social  Cancer Control – letter about survey plus incentive to  Age,level of education,marital status,
in well women cognition  return questionnaire ethnicity,actual risk status,family 
model, Group 1 – letter plus video plus group discussions  history,health behaviours-general 
health  plus leaflets (piloted and informed by health belief  knowledge,attitudes,perception of 
promotion  model) plus times mammography risk,reasons
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380 - 1 Adherence to colposcopy  Communi- Cancer Control – routine phone call to reschedule  Age,level of education,marital status,
in women with screen- cation appointment ethnicity,reasons
positive smears Group 1 – counselling confronting barriers 
to attendance
484 - 1 Uptake of cervical smears  Social  Cancer Group 1 – signed letter plus brief explanation  Age,level of education,marital status,
in well women cognition  smear plus leaflet ethnicity,actual risk status,health 
model Group 2 – free bus tickets mailed plus letter insurance
Group 3 – video in waiting room on cervical 
screening 
507 - 1 Uptake of mammography  Social  Cancer Control – routine leaflet plus letter Age,level of education,marital status,
in well adult women cognition  Group 1 – tailored leaflet (social cognition model): attitudes,perceived satisfaction,
model positive framing previous screening experiences self-efficacy,intention,social 
Group 2 – Group 1 plus opinion of GP and peer  reinforcement/norms
member in glossier leaflet
508 - 1 Uptake of cervical  Expected  Cancer Control – routine consultation Age,level of education,marital status,
screening in adult women  utility  Group 1 – piloted leaflets explaining about  ethnicity,actual risk status,reproductive 
with dysplasia/atypia theory dysplasia/atypia history,health behaviours-general,
health insurance
303 - 1 Adherence to medication  None Medicine  Control – general health information given by  Age,sex,marital status,actual risk 
in elderly patients nurse in groups status,knowledge,self-efficacy
Group 1 – control plus leaflet plus personalised 
prompt of current medication
320 - 1 Cessation of/adherence  None Medicine Control – routine clinic visit Age,sex,actual risk status,health 
to healthy lifestyle and  Group 1 – letter invitation for patient plus relatives  behaviours-general,physiological/ 
attendance clinic in  plus written and verbal information.hypertension, psychological assessment
adults with hypertension medication,diet plus feedback
381 - 1 Attendance referral  None Medicine  Control – leaflet plus screening plus feedback on  Age,sex,actual risk status,family 
appointment in adults  raised cholesterol level history,medical history,health 
with raised cholesterol  Group 1 – screening leaflet plus feedback screen  behaviours-general,reasons,intention 
(workplace) positive plus letter of cholesterol figure plus leaflet 
explaining link between cholesterol and CVD
471 - 1 Cessation of alcohol  None Medicine Group 1 – self-help leaflet:steps to sensible drinking  Age,sex,level of education,social class,
use in well adults plus routine therapy session marital status,actual risk status,
Group 2 – brief summary information in leaflet  physiological/psychological assessment
during routine therapy sessions
Group 3 – additional counselling as required
473 - 1 Cessation of smoking  None Medicine Control – no additional information Age,sex,level of education,social class,
in well adults Group 1 – quit for good illustrated leaflets:reasons  marital status,actual risk status,
for quitting,minimising weight increase,people to  perception of risk,self-efficacy,usefulness 
contact,coping skills of information,intention,social 
Group 2 – quit and win illustrated leaflets:identify  reinforcement/norms,awareness 
problems,structured quitting intervention,coping
475 - 1 Uptake of self-care in  None Medicine Control – no additional information Age,sex,level of education,social class,
elderly adults with  Group 1 – patients contacted by phone for 4 weeks  marital status,ethnicity,actual risk 
medicine after discharge,additional information given as  status,health behaviours-general,
needed physiological/psychological assessment,
knowledge
485 - 1 Cessation of alcohol use  None Medicine Group 1 – inpatient rehabilitation Age,sex,level of education,social class,
in well adults Group 2 – advised attend alcoholics anonymous marital status,ethnicity,actual risk 
Group 3 – advice from counsellors plus offered  status,health behaviours-general,
either AA or hospital depression,perceived satisfaction,stress
763 - 1 Adherence to medication  None Medicine  Control – routine care:medication administered  Age,sex,marital status,actual risk 
in elderly discharged  by nurses status,waiting time/consultation,
hospital patients Group 1 – pharmacist discussed medication patients  knowledge
plus nurse supervised patient self-medication plus 
memory prompt
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459 - 1 Cessation of smoking in  None Medicine Group 1 – leaflet for young mothers on  Age,level of education,ethnicity,
women with children quitting (readability) actual risk status,reasons,usefulness 
Group 2 – general giving up smoking leaflet of information
Group 3 – illustrated and coloured leaflets
754 - 1 Changes diet in children  None Medicine Control – screened negative controls Age,sex,ethnicity,knowledge
with high cholesterol Control 2 – screened positive control group
Group 1 – leaflet information (social cognitive 
theory):diet and cholesterol plus audio-taped 
feedback
Group 2 – counselling with dietician plus 
specific dietary instructions plus leaflets plus 
phone contact
708 - 1 Changes CVD risk factors  None Medicine Control – health information plus cholesterol test  Age,sex,social class
in well adults (no feedback)
Group 1 – health information plus reading plus 
feedback of cholesterol
711 - 1 Adherence to treatment  None Medicine Group 1 – routine care Age,sex,social class,marital status
in adult substance users Group 2 – introduction of a follow-up telephone 
call for patients
170 - 1 Accident prevention  None Medicine, Control – no additional information Level of education,social class
in well parents other Group 1 – counselling by nurse plus leaflets:
cessation of smoking,effects passive smoking and 
prevention home injuries
343 - 1 Uptake of advance  None Medicine Control – notes used for analysis Age,sex,social class,marital status,
directives in geriatric  Group 1 – information advance directives,copies  ethnicity,actual risk status,medical 
patients forms,reminder card to discuss with physician history,health insurance perception of 
well-being,attitudes,reasons 
56 - 1 Attendance for CVD  Social  Medicine Group 1 – invitation to attend free screening for  Age,social class,marital status,
risk screening in adult  cognition  CVD risk factors actual risk status,health behaviours,
well males model Group 2 – invitation to attend for screening but  physiological/psychological assessment
charged US$40
472 - 1 Involvement in  Shared  Medicine Control – routine consultation  Age,sex,level of education,social class,
consultation in adults  consult- Group 1 – health professional consultation plus  actual risk status,medical history,
with diabetes ation decision tree plus active role in treatment  physiological/psychological assessment,
information plus skill acquisition plus audio and  depression,worry,need cognition,
leaflet home package plus prompt for next  autonomy in decision making,
consultations preference consultation style,perceived 
satisfaction,alienation
72 - 1 Cessation of smoking  Social  Medicine Control – screening session only Age,sex,level of education,marital 
well adults via school- cognition  Group 1 – screening plus leaflet plus group  status,ethnicity,actual risk status,health 
based programme model counselling plus feedback behaviours-general,health insurance,
knowledge,operationalised model
242 - 1 Cessation of smoking  Social  Medicine Control – usual care  Age,actual risk status,medical history,
in well male adults cognition  Group 1 – self-help leaflet tailored to stages  operationalised model,usefulness 
model of change on smoking information
254 - 1 Cessation of smoking  Social  Medicine Control – ‘stop smoking’ statement plus leaflet Age,sex,level of education,social class,
in well adults cognition  Group 1 – self-quit advice statement plus decision  ethnicity,actual risk status,physiological/ 
model to quit video plus quitting aids plus calendar prompt  psychological assessment,perception of 
plus leaflet well-being
Group 2 – group recruitment:advice statement 
plus attendance group video plus offer free group 
plus leaflet 
Group 3 – Group 1 plus 2
375 - 1 Adherence to exercise  Social  Medicine Control – routine group information on medication, Age,sex,actual risk status,knowledge,
in adults with CVD learning  diet and exercise disability scale
theory Group 1 – additional control information by health 
professional plus an exercise contract
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792 - 1 Cessation of smoking  Social  Medicine Control – usual lesson Age,level of education,social class,
in adolescents cognition  Group 1 – media plus school-based information  ethnicity,health behaviours-general,
model based on social cognition models attitudes,reasons,social reinforcement/ 
norms
640 - 1 Cessation of smoking  Social  Medicine Control – no additional information Age,sex,ethnicity,actual risk status,
in well adolescents learning  Group 1 – peer volunteer group information: social reinforcement/norms
theory tobacco use plus T-shirts plus skill acquisition plus 
video plus feedback plus competitions plus letter 
plus phone booster messages
287 - 1 Cessation of smoking  Social  Medicine Control – assessment only Age,sex,level of education,actual risk 
in adult hospital patients cognition  Group 1 – stage of change assessed and targeted  status,medical history
model video plus verbal plus leaflet information plus free 
gum plus telephone contact
169 - 1 Adherence to medication  Communi- Medicine  Control – routine verbal plus leaflet information Age,sex,level of education,actual risk 
in elderly patients cation Group 1 – leaflet plus contact pharmacist to  status,medical history,living arrange-
discuss medication ments,knowledge,disability scale
405 - 1 Cessation of smoking  Health  Medicine Control – assessment only Sex,knowledge,attitudes
in well adolescents promotion  Group 1 – peer volunteer group information on 
cessation of smoking plus skill acquisition
442 - 1 Changes in CVD risk  Social  Medicine Control – delayed intervention Sex,social class,ethnicity,health 
factors in well adults  cognition  Group 1 – assessed stage of change plus target  behaviours-general
(work) model information:CVD risks plus skill acquisition plus 
changes workplace
360 - 1 Cessation of alcohol, Health  Medicine, Control – waiting list control  Age,sex,level of education,ethnicity,
smoking and drug use  promotion  STDs (HIV) Group 1 – weekly lessons:alcohol,tobacco and  actual risk status,knowledge,attitudes,
in well children marijuana plus skill refusal acquisition plus key-ring  self-efficacy,social reinforcement/norms
prompts plus stickers 
115 - 1 Adherence to healthy  Social  Medicine, Group 1 – self-assessment ‘quiz’ plus leaflet plus  Age,social class,marital status,
diet in pregnant women cognition  obstetrics  shopping list pad plus stickers reproductive history,health behaviours-
model and  Group 2 – letter from GP plus leaflet with recipes  general,knowledge,attitudes,reasons,
gynaecology  and stickers intention,social reinforcement/norms
(midwifery)
329 - 1 Cessation of smoking  Social  Medicine, Control – routine no smoking information  Age,level of education,marital 
in pregnant women cognition  obstetrics  by physician status,ethnicity
model and  Group 1 – health professional explained no 
gynaecology  smoking leaflet plus feedback
(midwifery) Group 2 – video informed by HBM (piloted) plus 
leaflet plus opportunity for feedback
80 - 1 Adherence to healthy  Health  Medicine, Control – routine care and assessments Age,sex,level of education,social 
lifestyles,cessation of  promotion  surgery Group 1 – routine plus behavioural education  class,marital status,physiological/ 
unhealthy lifestyle in  programme:goal setting,feedback,additional  psychological assessment,anxiety – 
coronary artery by-pass  contact,group exercise sessions state,depression,perception of 
graft patients  well-being
649 - 1 Uptake of safer sex in  None STDs (HIV) Control – questionnaires only Age,sex,actual risk status,knowledge,
well adults Group 1 – comic of ‘real-life’ stories plus leaflet  attitudes,intention 
plus group discussions plus feedback plus skill 
acquisition
684 - 1 Uptake of safe sex in  None STDs (HIV) Group 1 – information about HIV Age,level of education,marital status,
adult drug abusers Group 2 – enhanced information:emphasis on  ethnicity,actual risk status,health 
skill acquisition behaviours-general,living arrangements,
attitudes,perception of susceptibility,self-
efficacy,social support/communication,
social reinforcement/norms
720 - 1 Cessation of HIV risk in  None STDs (HIV) Control – video and group routine information  Age,sex,level of education,social class,
adult substance users about HIV marital status,ethnicity,actual risk 
Group 1 – control plus additional sessions plus  status,reproductive history,health 
feedback plus skills behaviours-general,social support/ 
communication,social reinforcement/ 
norms,living arrangements
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407 - 1 Cessation of risky HIV  None STDs (HIV) Control – usual counselling Age,sex,level of education,actual 
behaviours in adult  Group 1 – HIV skill information:use condoms, risk status
substance users bleaching and risk reduction
181 - 1 Adherence to oral  Communi- STDs (HIV) Control – routine contraception information Age,marital status,actual risk status,
contraception in female  cation Group 1 – additional nurse information:examine  attitudes,efficacy
adolescents barriers to adherence,ways of coping
762 - 1 Cessation of/adherence  Social  STDs (HIV) Control – usual public health video (white males  Age,level of education,social class,
to sexual and drug  cognition  in video) marital status,actual risk status,health 
behaviour in adult  model, Group 1 – video:black women gave information behaviours-general,anxiety – state,
well women framing  Group 2 – video:black women with more culturally  knowledge,attitudes,perception of risk,
information specific message (piloted) usefulness of information
528 - 1 Cessation of risky HIV  Social  STDs (HIV) Group 1 – verbal plus leaflet plus video information  Age,sex,level of education,social class,
behaviours in adult  cognition  (HBM):HIV test,condom and safe drug use ethnicity,actual risk status,health 
drug users model Group 2 – Group 1 plus additional follow-up visits  behaviours-general,living arrangements
plus specialist information
646 - 1 Cessation of risky HIV  Health  STDs (HIV) Control – routine video information:HIV and  Age,level of education,social class,marital 
behaviours in Latino  promotion, risk reduction status,religion,actual risk status,health 
adult female drug users stress –  Group 1 – culturally sensitive video plus peer  behaviours-general,depression,worry,
coping  volunteer plus leaflet plus discussion:coping and skill  perception of well-being,knowledge,
model acquisition plus leaflet plus free condoms and bleach attitudes,stress,coping,self-esteem
696 - 1 Uptake of condoms in  Social  STDs (HIV) Control – routine clinic information Sex,ethnicity,knowledge,attitudes,
adults with STDs cognition  Group 1 – watched video based on theory  perception of risk,self-efficacy
model reasoned action
Group 2 – video plus group discussion
817 - 1 Cessation of risky drug  Social  STDs (HIV) Group 1 – information based on HBM,TRA Sex,level of education,ethnicity,actual 
use in adult substance  cognition  Group 2 – enhanced information (relapse  risk status,health behaviours-general,
users model prevention):additional contact plus skill building knowledge,attitudes,perception of risk,
perception of susceptibility,self-efficacy
749 - 1 Adherence to/cessation  Social  STDs (HIV) Control – career planning and opportunities  Age,level of education,actual risk status,
of risky sex behaviour in  cognition  information health behaviours-general,knowledge,
well male adolescents model Group 1 – information HIV,skill acquisition,feedback attitudes,intention,personality type
777 - 1 Uptake of face washing  None Primary  Control – treatment trachoma only Age,sex,actual risk status
in children treated for  care, Group 1 – treatment trachoma plus face-washing 
trachoma surgery information
172 - 1 Attendance for  None Primary  Control – no additional invitation Satisfaction,health insurance,health 
appointment in well  care Group 1 – postcard reminder professional measures,awareness 
adults (primary care) of intervention
363 - 1 Uptake of immunisation  None Primary  Control – no additional information Age,ethnicity,reproductive history
rates in well women  care Group 1 – discussion with nurse and GP plus 
with children  leaflet (readability) plus reminder letter
470 - 1 Uptake of primary care  None Primary  Control – routine ‘new patient’ treatment
health services in well  care Group 1 – new patients interviewed by physician 
adults and nurse
512 - 1 Uptake of immunisation  None Primary  Control – no additional information Age,sex,ethnicity,actual risk status,
in well children care Group 1 – pre-recorded general reminder plus  living arrangements
recall message
Group 2 – pre-recorded specific recall plus 
reminder message 
98 - 1 Adherence to self- Health  Primary  Control – saw physiotherapist only Age,sex,actual risk status,medical 
management in adult  promotion  care Group 1 – physiotherapist plus group sessions, history,physiological/psychological 
patients with arthritis feedback,information on arthritis,coping and  assessment,anxiety – state,depression,
problem solving,relaxation knowledge,self-efficacy,disability scale
601 - 1 Request information/ Shared  Primary  Control – consent form only Age,sex
change lifestyle in  consult- care, Group 1 – prompt card asking questions/ brief 
well adults ation medicine information CVD 
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601 - 2 Request information/ Shared  Primary  Control – consent only Age,sex
change lifestyle in  consult- care, Group 1 – nurse prepared patients for consultation 
well adults ation medicine using script to discuss health behaviours
83 - 1 Utilisation of (prenatal)  None Obstetrics  Control – routine visits from health professionals  Age,medical history,reproductive 
services amongst  and  plus informed study history,physiological/psychological 
pregnant women gynaecology  Group 1 – reduced visits:consultation focused on  assessment,health insurance,
(midwifery) ‘prenatal milestones’ plus leaflets knowledge,usefulness of information
106 - 1 Attendance postpartum  None Obstetrics  Control – routine care Age,marital status,ethnicity,
appointment in  and  Group 1 – routine care plus teddy bear reproductive history,health behaviours-
adolescents gynaecology general,health  insurance,alienation
(midwifery)
788 - 1 Utilisation of postnatal  None Obstetrics  Control – routine nursery care Age,level of education,ethnicity,
care in new mothers and  Group 1 – health professional information:caring  medical history,reproductive history,
gynaecology  new-born plus feedback plus 24 hour phone access  anxiety – state,depression,knowledge,
(midwifery) plus appropriate utilisation of services social support/communication
481 - 1 Attendance for  None Infectious  Control – no reminder message Age,sex,ethnicity,attitudes
appointment in adults  disease Group 1 – pre-recorded telephone message 
with TB with appointment time plus clinic number
Group 2 – pre-recorded message plus time 
appointment plus emphasis government scheme (authority)
Group 3 – recorded message plus appointment time 
plus emphasis importance attending (importance)
Group 4 – recorded message plus appointment time 
plus both authority and importance
411 - 1 Adherence to treatment  None Infectious  Control – routine information given by clinic staff Age,sex,level of education,social 
in adults with TB disease Group 1 – additional information given by  class,marital status,religion,ethnicity,
another professional health insurance,living arrangements,
knowledge,attitudes
743 - 1 Uptake of CF carrier  None Genetics Group 1 – leaflet plus counselling plus offer of  Age,sex,social class,marital status,
screening in pregnant/  stepwise screening family history,anxiety – state,percep-
well adults Group 2 – leaflet plus counselling plus couple  tion of well-being,knowledge,attitudes,
testing only perception of risk,reproductive history,
social support/communication,intention 
790 - 1 Uptake of carrier  None Genetics Group 1 – letter in year 1 Age,sex,anxiety – state,knowledge
testing (CF) in  Group 2 – letter plus leaflet
well adults Group 3 – leaflet at clinic
Group 4 – approached researcher plus leaflet 
plus explanation plus test
Group 5 – invite at clinic plus leaflet plus 
explanation plus test appointment
Group 6 – letter year 2
293 - 1 Uptake of infant car seat  None Other, Control – routine care only Age,level of education,social 
in well mothers obstetrics  Group 1 – car seat plus information video class,ethnicity
and  Group 2 – car seat plus video plus instructions
gynaecology 
(midwifery)
349 - 1 Attendance for sexual- None Other Control – sent appointment times Age,sex,living arrangements,health 
difficulties clinic in  Group 1 – questionnaire plus information sheet  professional measures
well adults plus stamped addressed envelope plus appointment
58 - 1 Having donor card  Social  Other Control – no specific information Age,sex,social class,religion,
in well adults cognition  Group 1 – leaflet plus inclusion donor cards by post knowledge,attitudes
model Group 2 – trained health professionals to participate 
in meetings and promote donor cards plus media
Group 3 – Group 1 plus 2
324 - 1 Adherence to safety  Social  Other Control – questionnaire only Age,level of education,ethnicity,
advice in well mothers learning  Group 1 – illustrated leaflet (readability) reproductive history,knowledge,
theory attitudes,self-efficacy,social desirability
717 - 1 Utilisation of health care  Communi- Mental  Control – appointment letter only Anxiety – state,preference consultation 
in adults with mental  cation health –  Group 1 – letter plus information about services style,perceived satisfaction
health problems generalcontinuedHealth Technology Assessment 1999; Vol. 3: No.1
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44 - 1 Uptake of mammography  None Cancer Control – community comparison Age,level of education,social class,
in adult well women Group 1 – community intervention:posted  family history,health behaviours-general,
leaflets plus calendar prompts plus trained  health insurance,knowledge,perception 
health professionals of risk,awareness of intervention
61 - 1 Uptake of cervical  None Cancer Control – no additional information Age
cancer screening in  Group 1 – letter invitation sent to eligible women
well adult women
203 - 1 Uptake of mammography  None Cancer Control – comparative community Age
in adult well women Group 1 – increasing awareness in community 
(variety methods) plus health professionals 
(by letter)
Group 2 – increase community awareness plus 
women leaflet posted
243 -1 Uptake of mammography  None Cancer Control – no additional programme Age,level of education,social class,
in adult well women Group 1 – trained physicians plus leaflet plus  actual risk status,family history,health 
community groups plus memory prompts behaviours-general,health insurance,
knowledge,attitudes,reasons,social 
support/communication
246 - 1 BSE in well adult women None Cancer Control – pre- and post-test measurements only Age,level of education,social 
Control 2 – annual survey’s only class,self-efficacy,social support/ 
Group 1 – trained nurse information at women’s  communication,awareness of 
community groups plus video plus feedback plus  intervention
calendar reminder plus skill acquisition plus media
Group 2 – Group 1 plus second maintenance 
reminder programme
385 - 1 Cessation of tobacco  None Cancer Control – completed measures Age,sex,level of education,actual risk 
(not smoking) use in  Group 1 – school-based intervention plus  status,reproductive history,health 
well children acquisition skills (resisting) plus drug information behaviours-general,depression,
Group 2 – Group 1 plus parental education plus  attitudes,perceived satisfaction,
community leader ‘enforcers’ intention,social reinforcement/norms
686 - 1 Uptake of mammography  None Cancer Control – comparison community Age,level of education,social class,
in well adult women Group 1 – physician information breast cancer  ethnicity,health insurance,health 
screening plus media plus community campaigns  professional measures,knowledge,
plus cheaper mammograms attitudes,intention,awareness 
intervention
171 - 1 Uptake of general  None Cancer Control – no additional information Age,level of education,ethnicity,
cancer prevention in  Group 1 – cancer-related consultations made  knowledge,awareness of intervention
well adult women priority plus group discussions:self-examination 
and prevention plus leaflet plus newsletter
205 - 1 Uptake of mammography  None Cancer Group 1 – media promotion organised by hospitals Age,awareness of intervention
in well women Group 2 – community:elected representatives from 
business and social groups plus show videos plus 
leaflet distribution
205 - 2 Uptake of mammography  None Cancer Group 1 – community:elected organisers from  Age,awareness of intervention
screening in well women business and social groups plus show video plus 
leaflet distribution
Group 2 – family practitioner recommend 
attendance plus notes prompt plus leaflets plus 
posters in surgery
397 - 1 Uptake of cervical/breast  None Cancer Control – no additional information Age,ethnicity,actual risk status,
screening in well women Group 1 – opportunistically nurse invitation: knowledge,awareness of intervention
information plus free screening plus appointment 
for next day
546 - 1 Uptake of cervical  None Cancer Control – routine invitation by national programme Age,medical history,living 
screening in well women Group 1 – control plus letter invitation from GP arrangements
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448 - 1 Uptake of colorectal  None Cancer Control – routine slide show offer plus free  Age,sex,level of education,social class,
cancer screening in  hemoccult kit plus diet change  marital status,ethnicity,family history,
elderly well adults Group 1 – control plus elderly framed information  medical history,physiological/ 
plus memory prompts psychological assessment,perception 
Group 2 – Group 1 plus demonstration hemoccult  of well-being,disability scale
test using peanut butter
418 - 1 Uptake of screening  None Cancer, Control – north clinic:no information Age,sex,level of education
tests in well adults primary  Group 1 – south clinic:no information
care, Group 2 – north clinic:leaflet on screening and 
medicine  health preventive behaviours (readability)
386 - 1 Uptake of BSE in  Health  Cancer Control – verbal information on placebo topic Age,level of education,actual risk 
well women promotion  Group 1 – American Cancer Society (ACS) leaflet  status,family history,medical history,
and verbal information:BSE,cancer plus model  reproductive history,health behaviours-
demonstration general,knowledge,efficacy
Group 2 – ACS information plus additional 
feedback session
760 - 1 Uptake of mammography  Social  Cancer Control – assessment only Age,level of education,social class,
in well adult women cognition  Group 1 – group information (HBM):breast cancer  marital status,ethnicity,health 
model and screening behaviours-general,knowledge,
Group 2 – Group 1 information plus arguments for  attitudes,perception of risk,perception 
and against plus role model plus planning action  of susceptibility,reasons,operationalised 
plus letter model,intention 
608 - 1 Uptake of mammography  Social  Cancer Control – usual offer mammography with  Age,level of education,social class,
in well adults women cognition  mobile vans ethnicity,living arrangements,worry,
model Group 1 – routine offer plus media campaign knowledge,attitudes,perception of risk,
perception of susceptibility,awareness 
of intervention
404 - 1 Uptake of mammography  Health  Cancer Control – routine breast screening Age,level of education,social class,
in well women promotion  Group 1 – leaflets plus free screening plus faster  marital status,ethnicity,family history,
feedback reports plus reminder letters plus training  health professional measures
staff plus staff feedback
446 - 1 Uptake of mammography  Social  Cancer Control – no information Age,level of education,social class,
in well women cognition  Group 1 – information leaflet plus GP reminder  marital status,ethnicity,health insurance
model letter plus counselling by phone
136 - 1 Adherence to sun  Health  Cancer Control – assessment only Age,sex,social class,actual risk status,
protection in well  promotion  Group 1 – group information plus posters plus  knowledge,attitudes
children free sunscreen
Group 2 – Group 1 plus skill acquisition plus leaflets 
plus continued information from teachers
237 - 1 Adherence to/cessation  Social  Cancer, Control – assessment only Age,sex,level of education,social class,
of to healthy lifestyle in  cognition  medicine Group 1 – trained group leaders plus leaflet plus  marital status,actual risk,health 
well adults model verbal group information plus media plus letter  behaviour
plus activities
180 - 1 Uptake of safer sun in  Social  Cancer Control – routine information through schools and  Age,sex,knowledge,attitudes,
well adults cognition  media,information on wearing protective clothing  perception of risk,social reinforcement/ 
model and sunscreen norms,motivation,efficacy
Group 1 – more intensive programme using more 
media,message based on theory of identification/ 
attitude confronting,more shady spaces,reduction 
in sunscreen prices
45 - 1 Uptake of cholesterol  None Medicine  Control – no additional information Age,sex,ethnicity,medical history,
screening in well adults Group 1 – package intervention:media plus setting  health behaviours-general knowledge,
up network in community plus workplace plus  perception of risk
trained health professionals
82 - 1 Health care utilisation  None Medicine Control – no exposure to information Age,sex,actual risk status,medical 
in asthma patients Group 1 – teaching session on asthma:knowledge  history,physiological/psychological 
and management assessment,knowledge,quality of life
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218 - 1 Cessation of smoking  None Medicine Control – comparison community Sex,age,level of education,health 
in adult smokers Group 1 – trained volunteers plus media plus  behaviour,self-efficacy,social norm,
quit-line plus leaflet plus group sessions awareness of intervention
222 - 1 Cessation of/adherence  None Medicine Control – matched no intervention schools Age,sex,level of education,social class,
to healthy/risky lifestyle  Group 1 – teachers screened/feedback  ethnicity,marital status,medical history,
in well adolescents physiological/psychological assessment,
health behaviours,attitude
235 - 1 Cessation of smoking  None Medicine Group 1 – no restrictions on smoking Age,sex,level of education,
in well adults Group 2 – employees agree smoking contract  marital status
within workplace
Group 3 – smoking ban imposed
245 - 1 Cessation of smoking in  None Medicine Group 1 – motivational counselling:health and  Age,sex,level of education,social class,
CVD adult patients well-being,anticipation quitting problems marital status,actual risk status,health 
Group 2 – behavioural counselling:quit date set, behaviours-general,anxiety – trait,
abrupt quitting,compliance contract,self-reward  depression,social support/ 
and relaxation communication,coping
Group 3 – behavioural counselling plus nicotine 
fading:gradual quitting
256 - 1 Cessation of smoking  None Medicine Control – physician advice only Age,sex,marital status,ethnicity,actual 
in well adults Group 1 – advice plus cessation counselling by  risk status,medical history,health 
physicians (behaviour oriented model) behaviours-general,self-efficacy,social 
Group 2 – Group 1 plus prescription nicotine gum support/communication,intention 
258 - 1 Cessation of/adherence  None Medicine  Control –  Age,sex,level of education,actual risk 
to lifestyle in well adults  Group 1 – intervention 1980–1986 involved school  status,physiological/psychological 
and children plus community plus media information assessment
260 - 1 Cessation of smoking  None Medicine Control – usual smoking cessation information 
in well adult males by physicians
Group 1 – intervention by research staff:dosage 
reduction and coping ‘risky’ situations
280 - 1 Cessation of smoking  None Medicine Control – television based smoking cessation  Sex,level of education,actual risk 
in well adults programme status,awareness of intervention
Group 1 – North Karelia intervention plus control 
plus best ‘non smoker’ competition
Group 2 – control plus competition in Turku 
community
283 - 1 Cessation of smoking None Medicine Group 1 – group meetings – behavioural strategies  Age,sex,level of education,social class,
to reduce smoking,buddy system,stress  actual risk status,stress
management,relaxation,leaflet,gum
Group 2 – all information Group 1 plus competition 
for best ‘no smoker’
284 - 1 Cessation of smoking  None Medicine Control – health screen only for smokers and  Age,sex,level of education,social class,
in well adults non smokers actual risk status,medical history,
Group 1 – health screen plus programmes on  perception of well-being 
healthy lifestyle plus attend in own time programmes 
about diet,smoking,stress,etc.(buddy systems,ways 
coping smoking cessation,etc.),smoking areas plus 
no smoking signs
315 - 1 Adherence to  None Medicine  Control – medication prompt card,feedback on  Age,sex,actual risk status
medication in  taking medication (pills from a bottle)
elderly adults Group 1 – medication card,feedback on taking 
medication and pills in foil packet – dates marked 
so know if taken pill
390 - 1 Cessation of/adherence  None Medicine Control – health education plus exercise classes  Actual risk status,health behaviours-
to healthy lifestyle in  (none attendance) general,physiological/psychological 
well adults (workplace) Group 1 – workplace introduced a well publicised  assessment
fitness room 
Group 2 – counselling to high risk factor employees 
plus encouraged to take up exercise
Group 3 – counselling plus organised exercise 
sessions plus buddy system plus fitness facility
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504 - 1 Uptake of services in  None Medicine Control – waiting list control Age,sex,actual risk status,medical 
parents with asthmatic  Group 1 – trained GPs plus parent leaflet (piloted)  history,perception of risk
children plus consultation content prompt plus feedback
657 - 1 Cessation of smoking  None Medicine Control – smokers exposed to the ‘kick the habit’  Sex,level of education,social class,
in well adults TV programme ethnicity,actual risk status,medical 
Group 1 – control plus asked for self-quit leaflet history
731 - 1 Cessation of smoking  None Medicine Control – no planned intervention Age,sex,social class,family history,
in well adolescents Group 1 – family smoking education (no details) health behaviours-general,knowledge,
Group 2 – adolescent focused smoking intervention attitudes,perception of control,
Group 3 – Group 1 plus 2 reproductive history,self-esteem
740 - 1 Cessation of smoking  None Medicine Control – cholesterol screening result letter, Age,sex,actual risk status,physiological/ 
in well adults contact physician psychological assessment,knowledge
Group 1 – control plus media campaign:change 
diet,smoking cessation,exercise uptake.
Group 2 – Group 1 plus managing risk leaflet plus 
public meetings plus health professional contact
779 - 1 Cessation of smoking  None Medicine Control – comparison village (monk smoking norm) Age,sex,level of education,social class,
in well adults Group 1 – monk discourages smoking in ceremonies  actual risk status
and asks all new monks to give up smoking
206 - 1 Cessation of CVD risk  None Medicine Control – national population sample Age,sex,physiological/ psychological 
factors in well adults Group 1 – health centre/community/social groups  assessment
plus leaflets plus meetings plus poster information:
CVD change,diet,changes in canteens and shops
215 - 1 Cessation of fatty diet  None Medicine Control – comparison community
in well adults Group 1 – health screenings plus school information 
plus prompts and healthy changes in grocery stores
Group 2 – media information plus changes 
grocery stores
Group 3 – information diet change at community and 
health centre levels
409 - 1 Change diet in  None Medicine Control – routine school nutrition information Knowledge,attitudes,health 
well adolescents Group 1 – trained teachers:nutrition for life  professional measures
programme
312 - 1 Change diet in  None Medicine Control – comparison community Age,sex,social class
well adults Group 1 – community plus media plus health 
centres plus workplace plus schools information:
reduction CVD risk factors
273 - 1 Cessation of smoking  None Medicine Control – no additional information Age,sex,ethnicity,living arrangements
in well adolescents Group 1 – media and school-based information 
plus leaflets plus peer volunteers
394 - 1 Uptake of eye checks in  None Medicine, Control – interviewed only Age,sex,level of education,social class,
adults with medicine surgery Group 1 – examined eyes at home plus leaflet  marital status,ethnicity,medical history,
plus result letter plus phone call reminder health behaviours-general,physiological/ 
psychological assessment,knowledge
194 - 1 Intention to drive safely  None Medicine, Control –  Sex,level of education,knowledge,
in school children other Group 1 – information plus skills teaching about  attitudes
driving safety
89 - 1 Adherence to exercise  Social  Medicine Control – no information about control Age,sex,attitudes,health behaviours-
in adult well population cognition  Group 1 – pre-intervention group (same workplace  general,physiological/psychological 
model as post-intervention group) assessment,self-efficacy,intention,social 
Group 2 – post intervention group information: reinforcement/norms
feedback risk factors,screening,and CVD risks plus 
encouraged to attend GP
184 - 1 Cessation of smoking  Social  Medicine Group 1 – school intervention plus video plus peers  Age,sex,social class,ethnicity,actual 
in well adolescents cognition  volunteer information plus skill acquisition risk status,health behaviours-general,
model Group 2 – media intervention aimed at adolescents  knowledge,social support/communi-
plus competition cation,awareness of intervention
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253 - 1 Cessation of/adherence  Social  Medicine Control – assessment only Level of education,social class,living 
to healthy diet in well  learning  Group 1 – trained teachers plus verbal plus leaflet  arrangements,ethnicity,knowledge,
parents of school children theory  information:change salt,fibre and diet plus parent  intention,attitude,self-efficacy,social 
information plus feedback support
Group 2 – letter information plus newsletter plus 
classes plus fridge magnet prompt
Group 3 – Group 1 plus 2
345 - 1 Cessation of smoking  Social  Medicine Control – routine clinic advice on smoking  Age,sex,ethnicity,actual risk status,
in well adults cognition  cessation of health behaviours-general,health 
model Group 1 – trained physician assessed and targeted  professional measures,reasons,
information to patient’s stages change smoking  operationalised model,awareness 
cessation of intervention
416 - 1 Adherence to exercise/ Social  Medicine Control – assessments only Age,sex,level of education,actual risk 
diet in overweight adults cognition  Group 1 – self-directed change group information: status,physiological/psychological 
model exercise and diet plus skill acquisition plus feedback  assessment,health behaviours-general,
problem solving plus support anxiety – state/trait,perception of 
Group 2 – Group 1 plus individual counselling with  control,self-efficacy,social support/ 
health professional communication,motivation,awareness 
Group 3 – Group 1 plus individual counselling  of intervention,stress,coping
with peer
440 - 1 Cessation of smoking  Social  Medicine Control – no additional information Age,sex,level of education,social class,
and CVD risk factors  learning  Group 1 – social learning theory based community  ethnicity,physiological/psychological 
in well adults theory group leader information:risk factors and skill  assessment
acquisition plus support groups
209 - 1 Uptake of exercise  Social  Medicine Control – routine doctor information on hepatitis B Age,sex,social class,marital status,
in well adults cognition  Group 1 – counselling by doctor (stages of change)  ethnicity,actual risk status
model on exercise uptake
631 - 1 Adherence to/cessation  Social  Medicine Control – no media information Age,sex,level of education,
of diet in well adults learning  Group 1 – information informed by SLT:media plus  physiological/psychological 
theory leaflet plus group meetings plus letters plus school- assessment knowledge
based information plus memory aids
464 - 1 Uptake of exercise  Social  Medicine Control – assessment only Age,sex,ethnicity,actual risk status,
in well adults learning  Group 1 – Stanford five city project 6 year  physiological/psychological assessment,
theory dissemination information:verbal plus leaflets plus  knowledge,attitudes,self-efficacy
media plus posters plus leaders community groups
658 - 1 Cessation of/uptake  Social  Medicine  Control – comparison community Age,sex,level of education,social class,
of lifestyle change in  cognition  Group 1 – school-based,community-based,grocery  ethnicity,actual risk status,medical 
well adults model, shop changing,healthy restaurant menus,walking  history,health behaviours-general,
social clubs,videos,newspapers physiological/psychological  assessment,
learning  awareness of intervention
theory
726 - 1 Cessation of smoking/  Social  Medicine Control – assessment only Age,sex,actual risk status,medical 
adherence to exercise  learning  Group 1 – group leaders plus institutions trained  history,physiological/ psychological 
in well adults theory about CVD risk and prevention plus introduction  assessment,knowledge,attitudes,
screening plus media plus school plus health  awareness of intervention
centres plus communities
255 - 1 Cessation of smoking  Health  Medicine Control – comparison community Age,sex,social reinforcement/norms
in well adolescents promotion  Group 1 – trained teachers school-based intervention
313 - 1 Adherence to self- Social  Medicine Control – assessment only Age,sex,actual risk status,anxiety – 
management in adults  cognition  Group 1 – health professional provided information  state,knowledge,attitudes,perception 
with medicine model on self-care of risk,perception of control,
Group 2 – peer provided information about self-care operationalised model,intention,
social reinforcement/norms
367 - 2 Cessation of smoking  Social  Medicine Group 1 – quit and win programme Age,sex,level of education,marital 
in well adults learning  Group 2 – attendees of heart check programme status,actual risk status
theory
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370 - 1 Cessation of alcohol use  Social  Medicine Control – school-based assessment information only Actual risk status,knowledge,
in well adolescents learning  Group 1 – group lessons:alcohol use plus skill  perception of control,social 
theory acquisition plus booster session reinforcement/norms
238 - 1 Cessation of smoking  Social  Medicine Control – comparison community
in well adolescent learning  Group 1 – leaflet plus verbal information:risks 
theory smoking and skill acquisition plus trained teachers 
plus ban smoking
261 - 1 Change CVD risk factors  Social  Medicine Control – assessment only Actual risk status,physiological/ 
in well adolescents learning  Group 1 – video plus group information (social  psychological assessment knowledge
theory learning theory) plus posters plus feedback
456 - 1 Change CVD risks in  Social  Medicine Control – assessment only Age,sex,level of education,marital 
well elderly adults learning  Group 1 – peer-led group information sessions  status,medical history,knowledge,
theory on diet,exercises and stressors self-efficacy
709 - 1 Change CVD risk  Social  Medicine Control – assessment only Age,sex,level of education,marital 
behaviours in well adults learning  Group 1 – community leaders diffuse information  status,self-efficacy,social reinforcement/ 
theory plus media plus exercise classes norms,awareness of intervention
311 - 1 Cessation of substance  Health  Medicine, Control – no additional information Sex,ethnicity
use in well adolescents promotion  STDs (HIV) Group 1 – information framed by social influences 
behaviour plus skill acquisition plus media
Group 2 – information framed to control affect 
plus stress management plus decision making
125 - 1 Cessation of drug use, None STDs (HIV) Control – waiting list control Age,social class,ethnicity,actual risk 
adherence to safe sex in  Group 1 – Group format health information HIV  status,health behaviours-general,sexual 
adolescent drug users plus application problem solving therapy orientation,law infringements
161 - 1 Cessation of/adherence  None STDs (HIV) Control – counselling for HIV test only (clinic 1) Age,sex,level of education,marital 
to safer sex in adults  Group 1 – counselling HIV test plus information by  status,actual risk status,health 
with HIV trained counsellors on risk reduction (clinic 2) behaviours-general attitudes
177 - 1 Cessation of drug use  None STDs (HIV) Group 1 – illustrated,leaflet plus verbal information  Age,sex,level of education,social class,
and risky sex in drug  presented by sex worker on HIV risks and prevention  ethnicity,actual risk status,health 
users plus free condoms plus transport to health centre behaviours-general,knowledge,
Group 2 – Group 1 plus additional contact sex  perception of risk
worker and provide feedback on changes
392 - 1 Uptake of safe sex in  None STDs (HIV) Control – routine government family planning project Age,level of education,actual risk 
well,married women Group 1 – information:family planning plus child  status,reproductive history,health 
and parental immunisations plus re-hydration  behaviours-general,perceived 
therapy for diarrhoea satisfaction
791 - 1 Adherence to/cessation  None STDs (HIV) Control – routine care Age,level of education,ethnicity,actual 
of risky sex in adult well  Group 1 – video plus leaflet plus group discussion: risk status,medical history,reproductive 
female sex workers HIV risk factors tailored sex workers plus free  history,knowledge,self-efficacy
condoms plus posters plus feedback
555 - 1 Cessation of/adherence  None STDs (HIV) Control – no additional HIV/STD information Age,sex,actual risk status,living 
to risky sex in well  Group 1 – HIV/STD information given to classes  arrangements,knowledge,attitudes
adolescents by nurse plus skill acquisition plus free condoms
665 - 1 Change in sexual practice  None STDs (HIV) Control – routine leaflets plus posters Age,ethnicity,knowledge,social 
in well gay adult males Group 1 – identify group leaders and train about  reinforcement/norms
HIV risk factor,prevention and skill acquisition plus 
place in clubs to disseminate information
579 - 1 Cessation of risky sex  None STDs (HIV) Control – delayed intervention group Age,level of education,ethnicity,
in adult well women  Group 1 – group plus leaflet plus video information: knowledge
(sex workers) STD and condoms
748 - 1 Utilisation of services  None STDs (HIV) Group 1 – physician actively involved in patient’s  Age,sex,social class,ethnicity,actual 
in adults with HIV health care risk status
Group 2 – physician unaware patient HIV
Group 3 – patients not registered GP
Group 4 – mixed group of motivated patients 
and GPs
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455 - 1 Adherence to  None STDs (HIV) Control – assessment only Age,religion,ethnicity,knowledge,
contraception in well  Group 1 – trained staff on adolescent behaviours  perceived satisfaction
adolescent girls plus introduction consultation protocols
71 - 1 Cessation of cocaine use, None STDs (HIV), Control – routine collection urine samples plus  Level of education,social class,ethnicity,
attendance sessions in  obstetrics  counselling plus coping actual risk status,reproductive history,
adult,pregnant cocaine  and  Group 1 – control plus additional management  attitudes
users gynaecology counselling
(midwifery)
486 - 1 Reduction pregnancies  Conflict  STDs (HIV), Control – baseline measures control group Age,level of education,social class,
in well adolescents theory  obstetrics  Group 1 – counselling (Janis and Mann):decision- marital status,ethnicity,actual risk 
(Janis and  and  making skills plus prenatal care plus adoption plus  status,reproductive history,self-efficacy
Mann) gynaecology future pregnancies
(midwifery)
17 - 1 Cessation of risky sex, Social  STDs (HIV) Control – question and answers on AIDS Knowledge,attitudes
adherence to condoms  cognition  Group 1 – presentation by person with AIDS 
in school children model Group 2 – role-play (feedback) plus skill acquisition
18 - 1 Cessation of steroids, Health  STDs (HIV) Control – delayed intervention Level of education,social class,ethnicity,
male school children promotion  Group 1 – Adolescents Training and Learning to  knowledge,attitudes,self-efficacy
Avoid Steroids (ATLAS) classroom information:diet 
and alternatives to steroids plus skill acquisition plus 
weight room plus incentives
240 - 1 Uptake of condoms/  Social  STDs (HIV) Control – no additional HIV information Age,sex,ethnicity,actual risk status,
cessation of risky sex  cognition  Group 1 – trained teachers skill-based information  health behaviours-general,knowledge,
in well adolescents model plus feedback plus video plus skills acquisition attitudes,perception of risk,intention 
251 - 1 Cessation of drug use  Health  STDs (HIV), Control – no additional information Age,level of education,social class,
in well adolescents promotion  medicine Group 1 – school and community based information  ethnicity,actual risk status,health 
plus acquisition skills plus norms non-drug use plus  behaviours-general,living arrangements
media plus peers volunteers
391 - 1 Uptake of safe sex  Health  STDs (HIV) Control – comparative community
in adult well males promotion Group 1 – male motivation project plus leaflets 
plus radio drama plus group discussion
515 - 1 Cessation of risky sex  Social  STDs (HIV) Control – delayed intervention Age,sex,health behaviours-general,
in well adolescents cognition  Group 1 – trained teachers group information  living arrangements,knowledge,
model (theory planned behaviour) plus feedback plus skill  attitudes,social support/ 
acquisition plus parental involvement plus T-shirts communication,social reinforcement/ 
norms,awareness of intervention
759 - 1 Adherence to safe sex  Social STDs (HIV), Control – routine sex education – matched schools Sex,level of education,social class,actual 
in well adolescents learning medicine Group 1 – verbal group information on puberty, risk status,health behaviours-general,living 
theory contraception,reproduction and relationships and  arrangements,knowledge,attitudes,
empowerment skills usefulness of information,social 
reinforcement/norms
628 - 1 Cessation of/adherence  Health  STDs (HIV) Control – usual information for runaways Age,sex,ethnicity,actual risk status,
to risky sex promotion Group 1 – additional counselling plus video:HIV  sexual orientation
risk and prevention plus feedback plus skills
780 - 1 Cessation of/adherence  Social  STDs (HIV) Control – comparison community  Age,sex,level of education,social class,
to risky/safe sex in  learning  Group 1 – comics plus newsletters plus free  marital status,ethnicity,actual risk 
well adults theory condoms plus house call information on HIV risk  status,reproductive history,knowledge,
factor cessation self-efficacy
463 - 1 Cessation of risky sex  Health  STDs (HIV) Control – delayed onset intervention Age,level of education,marital status,
in gay well males promotion  Group 1 – leaflets plus posters in bars plus  ethnicity,actual risk status,sexual 
university and community areas orientation,self-efficacy,awareness 
of intervention
663 - 1 Adherence to/cessation  Health  STDs (HIV) Control – assessment only Age,sex,level of education,social class,
of risky/safe sex in well  promotion Group 1 – trained teachers group lessons plus  religion,health behaviours-general,
adolescents leaflet plus audio-tape plus skill acquisition knowledge,attitudes,reasons
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373 - 1 Change sexual activity  Social  STDs (HIV) Control – routine sex information Age,sex,ethnicity,reproductive history,
in well adolescents cognition  Group 1 – verbal plus leaflet plus group information  knowledge,attitudes,perception of 
model (HBM/SLT) plus skill acquisition plus feedback susceptibility,reasons,self-efficacy,
operationalised model
453 - 1 Cessation of drug use  Social  STDs (HIV), Control – assessment only  Age,sex,ethnicity,actual risk status,
in well adolescents learning  medicine Group 1 – peer volunteer verbal information plus  living arrangements,health behaviours-
theory skill acquisition general,knowledge,attitudes,social 
Group 2 – Group 1 plus booster sessions reinforcement/norms
822 - 1 Cessation of risky sex  Social  STDs (HIV) Group 1 – brief verbal information about safe sex  Age,sex,reasons,awareness 
in well adolescents cognition  (school clinic) intervention
model, Group 2 – peer volunteer verbal information:HIV 
social  and prevention pregnancy (school clinic)
learning  Group 3 – pregnancy prevention information plus 
theory vouchers for contraception (school clinic)
Group 4 – target high-risk groups plus provision 
contraception plus prompt repeat prescriptions 
(school clinic)
Group 5 – pregnancy prevention information plus 
contraception prescribed plus prompt for repeat 
prescription (school clinic)
Group 6 – all sex-related information available plus 
school dispensed contraception
823 - 1 Change CVD/HIV  Health  STDs (HIV), Control – assessment only Age,sex,health behaviours-general 
risk factors in well  promotion medicine Group 1 – school based module on teenage  knowledge,attitudes
adolescents health plus skill acquisition
813 - 1 Change in CVD risk  None Primary  Control – assessment only Age,sex,level of education,actual 
behaviours in elderly  care, Group 1 – letters plus leaflets plus newsletter plus  risk status,health behaviours-general,
adults medicine feedback CVD risk from physician physiological/psychological assessment
146 - 1 Uptake of influenza  None Primary  Control – cases documented before intervention Age,sex,actual risk status,health 
vaccination in well elderly  care Group 1 – cases documented after intervention: behaviours-general
adults with a history  trained physicians plus reimbursed for vaccine plus 
pneumonia patient letter plus media plus leaflet 
257 - 1 Adherence to health  None Primary  Group 1 – letter invitation Age,sex,level of education,medical 
checks in elderly well  care, Group 2 – letter plus phone call history,physiological/psychological 
adults medicine Group 3 – letter plus phone call plus fixed  assessment,health insurance
appointment time
Group 4 – Group 3 plus elicited reasons 
non-attendance plus encouraged attendance
775 - 1 Uptake of immunisation None Primary  Group 1 – children registered with general practice Age,living arrangements
in parents of well children care Group 2 – children registered with health clinics
331 - 1 Uptake of immunisation  None Primary  Control – children attended A&E not immunised Age,sex,actual risk status,physiological/ 
in parents of children  care Group 1 – children attended A&E immunised psychological assessment,health 
attended A&E insurance
95 - 1 Adherence to self- Social  Primary  Control – no additional information Age,sex,level of education,actual 
management in adults  learning  care Group 1 – group counselling information session  risk status,physiological/psychological 
with arthritis theory for over 6 weeks assessment,self-efficacy,disability scale
3 - 1 Uptake of breast feeding  None Obstetrics  Control – no additional information Age,level of education,marital status,
in adult well women and  Group 1 – trained health workers gave verbal  religion,ethnicity,reproductive history,
gynaecology  information breast feeding plus posters plus leaflets  knowledge,perception of risk
(midwifery) at routine post-natal care visits
529 - 1 Uptake of xylitol chewing  None Dentistry Control – no information Sex,knowledge
gum in adolescents Group 1 – xylitol and oral hygiene information 
by dental assistance plus free chewing gum
618 - 1 Uptake of dental services  Marketing  Dentistry Control – no change in dentistry practices  Age,sex,level of education,
in well children and young  model Group 1 – reimbursement costs for children/  health insurance
adults adults under 26 years
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430-1 Reproductive decision in  None Genetics Group 1 – genetic counselling information  Marital status,ethnicity,attitudes,
Tay–Sachs carriers  Tay–Sachs and reproductive options perception of risk,affect,intentions,
autonomy decision making
516 - 1 Uptake of carrier testing  Social  Genetics Group 1 – letter invitation plus if interested  Age,sex,level of education,marital 
in well adults cognition  counsellor appointment plus leaflet status,ethnicity,reproductive history,
model Group 2 – approached patients in health centre  knowledge,attitudes,perception of risk,
plus leaflet plus counselled and tested need cognition/certainty,need cognitive 
closure/ambiguity,intention 
323 - 1 Adherence to  None Infectious  Control – no additional information Age,sex,social class
medication and  disease Group 1 – social network group,researchers 
attendance clinic in  attend community group meetings:information 
symptomatic adults plus offer free health centre treatment
Group 2 – media group:posters plus town criers 
give same information
586 - 1 Adherence to treatment  None Infectious  Group 1 – directly observed preventive therapy  Age,sex,ethnicity
in adolescents with TB disease taken within school
Group 2 – hospital based medication 
(not observed)
452 - 1 Adherence to treatment  None Infectious  Routine – routine patient care for TB Age,sex,actual risk status,medical 
in patients with TB disease Group 1 – staff training and supervision on TB history,living arrangements
124 - 1 Adherence to  None Mental  Control – remained on oral medication  Sex,ethnicity,actual risk status
medication in adults  health Group 1 – patients changed from oral to 
with schizophrenia injecting medication
825 - 1 Adherence to  None Mental  Control – no information about control group Actual risk status,medical history,
medication in adults  health Group 1 – only told group meetings attitudes,reasons
with schizophrenia
335 - 1 Adherence to  None Paediatrics Control – interviewed only  Age,level of education,social class,
medication in parents  Group 1 – posters plus demonstration how to  religion,reproductive history,
of children with  mix salt-sugar solution plus feedback  knowledge
diarrhoea
570 - 1 Adherence to safety  None Other Control – assessment only Age,sex,level of education,actual risk 
in well adolescents Group 1 – peer presented information:accidents, status,medical history,knowledge,
disabilities and risk taking perception of risk,perception of 
Group 2 – Group 1 information given by health  control,reasons,self-efficacy,intention,
professional awareness of intervention
773 - 1 Uptake of bicycle safety  None Other Control – letter to parents and children plus teen  Age,sex,social class,family history,
in well children plus  magazine plus voucher for bike shop health behaviours-general,reasons,
parents Group 1 – control plus high profile in school: knowledge,attitudes,intention,social 
posters,stickers,stunt bike rider demonstration reinforcement/norms
40 - 1 Reporting symptoms in  None Surgery Control – paper-pen diary of symptom recording Age,ethnicity,actual risk status,
adult women with bladder  Group 1 – computer symptom reporting depression,other affect
complaints
75 - 1 Use of health care in  None Surgery Group 1 – medical assistance and no  Age,sex,social class,marital status,
adult well patients health insurance health insurance attitudes
Group 2 – private insuranceAppendix 7
118
TABLE 29  Description of decision,intervention and measures recorded in studies:before/after different samples
Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
34 - 1 Uptake of mammography  None Cancer Group 1 – prompt on patient’s notes
in adult well women
100 - 1 Uptake of mammography  None Cancer Group 1 – letter of invitation Age,actual risk status,health insurance
in well women
192 - 1 Uptake of cervical  None Cancer Age
screening in adult 
well women
383 - 1 Uptake of mammography  None Cancer Group 1 – reduced-fee mammogram plus media  Age,ethnicity,social class,level of 
in well based adult  plus presentations in workplaces/health centres education,medical history,knowledge,
women awareness of intervention
421 - 1 Uptake of mammography/ None Cancer Group 1 – health professional encouragement plus  Age,level of education,social 
BSE in well women monthly clinics plus calendar prompts plus self- class,attitude
referral contact number
575 - 1 Uptake of cervical  None Cancer Group 1 – introduction mobile screening unit  Age,marital status,level of education,
screening in well  plus information social class,knowledge
women
401 - 1 Uptake of mammography  None Cancer Group 1 – trained staff plus reminder system  Age
in well women implemented plus prompt sheet in reviewed notes 
plus noted women’s breast cancer history
765 - 1 Adherence to sun  Social  Cancer Group 1 – poster plus leaflet:skin cancer and 
protective behaviours  learning  protection plus feedback plus peer volunteers plus 
in well adults theory raffle plus free sunscreen
495 - 1 Uptake of living will in  None Medicine Group 1 – leaflet on patient self-determination act  Age,sex,level of education,social class,
recently hospitalised  and information on living will ethnicity,knowledge,attitudes
adults
340 - 1 Cessation of smoking  None Medicine Group 1 – community intervention:media plus  Age,sex,level of education,ethnicity,
in well adults posters plus leaflets plus volunteers plus free  knowledge,awareness of intervention
cessation classes plus prize-draw
423 - 1 Cessation of smoking in  None Medicine, Group 1 – change in hospital policy to no-smoking 
drug dependent adults STDs (HIV) zone plus patients sign no-smoking contract
550 - 1 Cessation of drug use  None Medicine, Group 1 – introduction no-smoking ban in hospital Age,level of education,social class,
in elderly substance  STDs (HIV) marital status,actual risk status,medical 
using men history,health behaviours-general
514 - 1 Cessation of smoking in  None Medicine, Group 1 – media campaign plus trained  Age,social class,level of education,
pregnant well women obstetrics  professionals plus quitline:emphasis quitting  reproductive history,knowledge,
and  not cutting down attitudes,awareness of intervention
gynaecology 
(midwifery)
461 - 1 Cessation of drink-  None Medicine, Group 1 – media campaigns increase seat belt use, Awareness of intervention
driving in well adults other maintain speed limits,reduce drunk driving,fines
462 - 1 Cessation of/adherence  Social  Medicine Group 1 – information based social learning theory: Age,sex,level of education,ethnicity
to CVD risk factors in  cognition  group leaders plus increase exercise clubs plus health 
well adults model, fairs plus health checks plus school competitions
social 
learning 
theory
670 - 1 Uptake of HIV screening  None STDs (HIV) Group 1 – all media campaigns over 4-year period Sexual orientation
in well adults
680 - 1 Uptake of safe sex/  None STDs (HIV) Group 1 – media campaigns advocating  Sex,ethnicity,sexual orientation,
cessation of risky sex  condom use medical history,social class
in adults with STDs
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TABLE 29 contd  Description of decision,intervention and measures recorded in studies:before/after different samples
Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
662 - 1 Adherence to safer sex  None STDs (HIV) Group 1 – announcement ‘magic johnson’  Age,sex,level of education,marital 
in adults with STDs (basketball player) as HIV positive status,ethnicity,actual risk status,health 
behaviours-general,reasons,living 
arrangements knowledge,attitudes,
perception of risk,perceived satisfaction
142 - 1 Change HIV risks in adult  None STDs (HIV) Group 1 – introduction of sale syringes in  Age,sex,level of education,social class,
substance users pharmacies within France marital status,ethnicity,actual risk 
status,medical history,reproductive 
history,health behaviours-general,living 
arrangements,knowledge
619 - 1 Change HIV behaviours  None STDs (HIV) Group 1 – media plus posters plus group  Age,social class,reasons,living 
in well adult men information and feedback sessions arrangements,sexual orientation
647 - 1 Cessation of risky sex  Health  STDs (HIV) Group 1 – ‘trend-setter’ peer trained to give  Age,sex,ethnicity,knowledge,
in well gay men promotion information in clubs,identified by eye-catching  social norms
badge to start conversations
193 - 1 Uptake of immunisation  None Primary care, Control – noted attendance at clinics Age,level of education,social class,
in mothers of new-borns paediatrics Group 1 – leaflets about childhood immunisations ethnicity,reproductive history,health 
behaviours-general,memory,reasons
767 - 1 Uptake of immunisation  None Primary care Group 1 – region-based intervention:feedback  Deprivation indices
in parents of well children non attendees to health professional plus trained 
health professionals
413 - 1 Uptake of immunisation  None Primary care Group 1 – introduction of immunisation status  Reasons
in well adults (high-risk  in notes
influenza)
623 - 1 Uptake of breast feeding  None Obstetrics  Group 1 – introduction new staff position for baby  Perceived satisfaction
in well women and  feeding and changes on ward
gynaecology 
(midwifery)
26 - 1 Breast feeding in adult  Marketing Obstetrics  Group 1 – trained health professionals plus leaflets  Age,social class,religion,reproductive 
well women model and  and video in clinic increased profile breast screening  history,health insurance,perception of 
gynaecology  plus prompts in notes risk,reasons
(midwifery)
97 - 1 Adherence to dental  None Dentistry Group 1 – large public campaign media plus  Knowledge
hygiene in well adults posters plus leaflets
737 - 1 Attendance for dental  None Dentistry Group 1 – verbal information on importance 
check ups in well adults periodontal care plus made fixed appointments
563 - 1 Utilisation of services and  None Dentistry Group 1 – changed examination/treatment from  Age,ethnicity
uptake of dental treatment  attending fixed clinic to attending mobile unit
in well children
239 - 1 Adherence to sleeping  None Paediatrics Group 1 – home visit midwife information plus  Age,marital status,level of education,
position baby in  feedback plus telephone contact social class,health behaviour,
adolescent mothers physiological/psychological assessment,
reasons,knowledge
294 - 1 Utilisation of services  None Genetics Group 1 – dissemination fragile X video and leaflet  Usefulness information
plus testing for fragile X  information by agencies
in well adults
674 - 1 Attendance for surgery  None Surgery Group 1 – introduction nurse information at  Satisfaction,anxiety
in women undergoing  pre-operative assessment clinic
hysterectomies
149 - 1 Uptake of bicycle helmet  None Other Group 1 – media plus posters plus leaflets plus  Age,sex
in school children community events plus verbal information plus 
feedback plus reduction price helmets plus changing 
roads for bike pathsAppendix 7
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TABLE 30  Description of decision,intervention and measures recorded in studies:before/after same sample
Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
99 - 1 Uptake of mammography  None Cancer Group counselling with feedback and ways to over- Age,knowledge,attitudes
in adult well women come barriers to screening (devised a board game)
266 - 1 Adherence to safe sun  None Cancer Verbal plus leaflet information on sun protection  Age,sex,ethnicity,medical history,
in adults with skin cancer following removal of non-melanoma skin cancer  actual risk
plus feedback own behaviour
746 - 1 Uptake of breast and  None Cancer Trained volunteers plus community workshops plus  Age,sex,ethnicity,knowledge,reasons
cervical screening in  posters plus media plus video
well adult women
815 - 1 Uptake of testicular  None Cancer Leaflet plus lecture from health professional on  Knowledge,attitudes
self-examination in  testicular self-examination
well adolescents
795 - 1 Uptake of cervical  None Cancer GP contract plus computerised systems Age
screening in well women
809 - 1 Uptake of mammography  None Cancer One-to-one counselling plus trained health  Age,health insurance
in well women professional plus posters plus leaflets plus media 
plus prompt on notes plus reminders
133 - 1 Adherence to/cessation  None Cancer, Schools funded projects,trained teachers  Actual risk status,health behaviours-
of healthy lifestyle in  medicine information:heart disease,cancer nutrition  general,physiological/psychological 
school children and exercise programmes assessment,knowledge,attitudes
466 - 1 Uptake of screening/ None Cancer, Group 1 – prompt in notes for GP:screenings  Age,sex,ethnicity,health insurance
immunisation in  primary care, and immunisations
well adults medicine 
46 - 1 Uptake of  Self- Cancer Group 1 – targeted women family history breast  Knowledge,attitudes,perception of risk
mammography in  regulation  cancer:diet,BSE,and mammography
adult well women  theory
(family history 
breast cancer)
126 - 1 Uptake of  Expected  Cancer Group 1 – leaflets about mammography and BSE Age,level of education,ethnicity,
mammography and  utility  attitudes,perception of susceptibility,
BSE in well women theory efficacy
198 - 1 Adherence to safe  Social  Cancer Group 1 – trained volunteer plus leaflet  Age,sex,level of education,social class,
sun in adults with  cognition  information skin care  health behaviour,knowledge,attitudes,
skin cancer model self-esteem,perception of control,
perception of risk
42 - 1 Utilisation of services  None Medicine Patient chart with personalised medication details, Actual risk status,health 
and adherence to  symptoms and course of action behaviours-general
medication
74 - 1 Adherence to  None Medicine Self-management educational control programme Age,sex,physiological/psychological 
medication adult patients  assessment knowledge
with medicine
79 - 1 Adherence to lifestyle  None Medicine Video information:diet,exercise,smoking cessation  Age,sex,level of education,ethnicity,
in school children plus additional exercise activities actual risk status,family history,health 
behaviours-general,physiological/ 
psychological assessment,attitudes,
perception of risk,stress
111 - 1 Completion advance  None Medicine Leaflet on advance directives plus opportunity to  Age,sex,level of education,marital 
directives in patients  talk with nurse status,religion,ethnicity,actual risk 
with haemodialysis status,medical history,knowledge,
attitudes,reasons
244 - 1 Uptake of exercise  None Medicine Trained physicians plus leaflet plus verbal  Age,sex,level of education,social class,
in well adults information exercise plus follow-up phone call  marital status,living arrangement,health 
plus note prompt insurance,social norms,self-efficacy
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TABLE 30 contd  Description of decision,intervention and measures recorded in studies:before/after same sample
Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
270 - 1 Smoking cessation of  None Medicine Group 1 – verbal information plus group sessions  Age,sex,ethnicity,level of education,
in well adults plus self-monitoring plus skill acquisition social class,affect,reasons,perceived 
satisfaction
355 - 1 Uptake of exercise in  None Medicine Group 1 – free exercise classes plus group activities  Age,level of education,social class,
well men (worksite) plus feedback plus prize for weight loss ethnicity,marital status,health 
behaviour,physiological/ 
psychological assessment
384 - 1 Uptake of screening, None Medicine Group 1 – free screening plus health professional  Age,sex,ethnicity,social class,family 
cessation of/adherence  feedback on blood pressure,cholesterol levels and  history,medical history,physiological/ 
to healthy lifestyle in  lifestyles changes psychological assessment
well adults (workplace)
521 - 1 Self-care in elderly adults  None Medicine Group 1 – group counselling plus self care skill  Physiological/psychological assessment,
with medicine acquisition for medicine knowledge,affect,coping
676 - 1 Self-management in  None Medicine Group 1 – self-management ‘credit card’ to record  Age,sex,ethnicity,actual risk status,
adults with asthma peak flow rates and other self-management  physiological/ psychological assessment
behaviours
522 - 1 Adherence to self- None Medicine Group 1 – asthma action plan:checklist for  Age,sex,physiological/psychological 
management in adults  patients and GPs to assess together plus media assessment
with asthma
544 - 1 Adherence to self- None Medicine Group 1 – self-monitoring skills plus information  Age,sex,social class,actual risk status,
management in adults  asthma plus summary management plan medical history,knowledge
with asthma
262 - 1 Smoking cessation of  None Medicine Group 1 – smoking cessation information plus  Age,sex,social class,ethnicity,
in well adults (workplace) buddy system plus gum actual risk status,physiological/ 
psychological assessment
449 - 1 Adherence to medication  None Medicine Group 1 – leaflet plus diary card plus feedback  Age,sex,medical history
in children with asthma on medication within daily routine
798 - 1 Change in CVD  None Medicine Group 1 – information about CVD risks  Age,actual risk status,health 
behaviours in well  and screening behaviours-general,physiological/ 
adult males psychological assessment
821 - 1 Uptake of exercise/ None Medicine Group 1 – information CVD risk and prevention  Age,sex,actual risk status,medical 
cessation of smoking  plus exercise programme history,physiological/psychological 
in adults with CVD assessment
621 - 1 Uptake of weaning  None Medicine, Group 1 – piloted and culturally appropriate  Age,level of education,social class,
food in children of  obstetrics  information on making weaning food,groups, actual risk status,reproductive history,
well adults and  skill acquisition reasons,knowledge,attitudes,
gynaecology  awareness of intervention
(midwifery)
348 - 1 Uptake of/cessation  None Medicine, Group 1 – leaflet plus opportunity group  Age,level of education,social class,
of lifestyle and osteo- primary care information plus free screening family history,health behaviours,health 
porosis screening  insurance knowledge
in women
162 - 1 Adherence to healthy  None Medicine, Group 1 – nurse education programme plus  Age,sex
diet in elderly,physically  primary care memory prompts plus media plus change menu in 
ill adults residential home plus social reinforcement plus 
incentive game
84 - 1 Cessation of drink-driving  None Medicine, Nurse information on car crashes injuries plus 
in adolescents other interactive sessions on prevention
594 - 1 Adherence to  Framing  Medicine  Group 1 – interactive video,content depends on  Age,sex,level of education,actual risk 
medication in adults  inform- disease type:mild hypertension,alter risk through  status,medical history,physiological/
with hypertension ation, lifestyle change;BPH,encouraging systematic  psychological assessment,worry,atti-
shared  decision making of all alternatives tudes,perception of risk,need cognitive 
consult- closure,autonomy in decision making,
ation usefulness of information
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TABLE 30 contd  Description of decision,intervention and measures recorded in studies:before/after same sample
Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
179 - 1 Cessation of smoking  Health  Medicine Group 1 – counselling sessions advising patients  Actual risk status
in adults with  promotion  risk smoking plus coping strategies
asthmatic children
367 - 1 Cessation of smoking  Social  Medicine Group 1 – up in smoke – no-smoking groups, Age,sex
in well adults learning  lottery incentive,recruited through media
theory
91 - 1 Use of condoms, None STDs (HIV) HIV patients counselled about HIV and  Age,sex,ethnicity,knowledge
cessation of risky sex  high-risk behaviours
in adults with HIV
38 - 1 Uptake of condoms, None STDs (HIV) Introduction health centres at schools plus routine  Age,social class,medical history,
cessation of risky sex  visits scheduled plus information about safer sex reproductive history,health 
in school children behaviours-general
49 - 1 Cessation of risky sex, None STDs (HIV) AIDS information given by medical students plus  Age,sex,knowledge,attitudes,
uptake of condoms in  interactive sessions plus video perception of risk
school children
123 - 1 Adherence to safer sex, None STDs (HIV) Peer volunteer plus video plus group information: Age,level of education,social class,
cessation of drug use in  on safe sex and drug use marital status,ethnicity,actual risk 
adolescent gay males status,health behaviours-general 
knowledge,attitudes
159 - 1 Cessation of/adherence  None STDs (HIV) Group 1 – workshops discussing risky sex plus  Age,ethnicity,level of education,social 
to safer sex in well  skills acquisition class,marital status,sexual orientation,
adult men religion,health behaviours,actual risk 
attitudes,knowledge,self-efficacy,
intentions
480 - 1 Cessation of/adherence  None STDs (HIV) Group 1 – peer volunteer individual counselling  Age,ethnicity,health insurance,level 
to safe sex in well  plus leaflet on HIV risks of education,social class,knowledge
adolescent women
651 - 1 Adherence to safe sex/  None STDs (HIV) Group 1 – video plus Group discussions led by  Age,marital status,actual risk status,
HIV testing in adult well  physician plus free condoms plus spermicides medical history
plus seropostive women 
655 - 1 Uptake of contraception  None STDs (HIV) Group 1 – contraception video plus free  Age,marital status,actual risk status,
in well women contraception reproductive history,reasons
688 - 1 Condom use in sero- None STDs (HIV) Group 1 – counselling couples to use condoms  Age,sex,marital status,medical 
positive adults (work) plus free condoms plus calendar to mark off when  history,reasons
used condoms
729 - 1 Cessation of risky  None STDs (HIV) Group 1 – verbal information on HIV,drug and sex  Age,sex,ethnicity,actual risk
needle behaviour in  behaviour plus clean needles and cleaning kit knowledge
drug using adults
770 - 1 Change HIV behaviours  None STDs (HIV) Group 1 – trained outreach workers plus additional  Age,sex,level of education,social class,
in drug using adults visits to drug users plus free bleach and condoms  actual risk
plus leaflets plus free transport to centre
610 - 1 Cessation of/adherence  None STDs (HIV) Group 1 – use of puppets show:seriousness, Age,sex,ethnicity,worry,knowledge,per-
to risky sex in well adults transmission,avoidance of HIV (shows video) ception of risk,usefulness of information
467 - 1 Adherence to/cessation  None STDs (HIV) Group 1 – video plus leaflet plus group discussion  Age,sex,social class,knowledge,
of HIV risk factors in  about HIV attitudes,perception of risk
well adolescents
723 - 1 Use condoms in female  None STDs (HIV) Group 1 – free condoms plus group discussions  Age,level of education,marital status,
sex workers with STD plus design poster knowledge,living arrangements,efficacy
545 - 1 Cessation of risky sex  None STDs (HIV) Group 1 – HIV counselling and testing plus  Age,sex,ethnicity,actual risk status
in adults with HIV scheduling follow-up visit (no details information)
650 - 1 Cessation of risky HIV  None STDs (HIV), Group 1 – group session HIV/AIDS transmission  Age,marital status,ethnicity,knowledge,
behaviours in pregnant  obstetrics  and testing attitudes,intention 
women and 
gynaecology 
(midwifery)
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TABLE 30 contd  Description of decision,intervention and measures recorded in studies:before/after same sample
Study  Summary decision  Theory Health  Comparison groups Variables referred to
number and area of health area
537 - 1 Attendance clinic in  None STDs (HIV), Group 1 – separate waiting area for women and  Age,sex,ethnicity,actual risk status
adults with HIV primary care children plus increase female staff plus free transport 
plus onsight colposcopy
35 - 1 Uptake of condoms, None STDs (HIV) Group 1 – video plus leaflets plus large and small  Age,sex,ethnicity,actual risk status,
cessation of risky sex  group information plus peer volunteer plus  health behaviours-general,reproductive 
in school children skills training history,attitudes,social reinforcement/ 
norms
364 - 1 Adherence to safer  Social  STDs (HIV) Group 1 – small group plus video social cognition  Age,level of education,religion,
sex in adult well  learning  theory driven information (piloted):skill acquisition  knowledge,attitudes,self-efficacy,
women theory plus exercises plus HIV and condom use perception of norms
526 - 1 Adherence to/  Social  STDs (HIV) Group 1 – video plus small group information plus  Age,actual risk,health behaviour,
cessation of risky  cognition  art plus skill acquisition plus confronting barriers  knowledge,perception of risk,self efficacy,
sex in gay adolescent  model, information plus access to services perception of control,social support,
males social  perception of norms,stress,coping,
learning anxiety,depression
theory
654 - 1 Cessation of/  New  STDs (HIV) Group 1 – Stop AIDS project:group information  Age,ethnicity,knowledge,attitudes,
adherence to HIV  model  HIV and testing plus skill acquisition plus feedback  self-efficacy
behaviours in gay  testing plus ‘contract’ to change behaviour
well adult males
450 - 1 Change HIV risks  Social  STDs (HIV) Group 1 – HIV information plus skill acquisition  Level of education,social class,ethnicity,
in women with  cognition  plus free bleach plus condoms plus incentives actual risk status,reproductive history,
substance using  model, perception of control
partners social 
learning 
theory
573 - 1 Uptake of immunisation  None Primary care Group 1 – lecture plus group discussions  Knowledge,attitudes
in well adults plus leaflet
342 - 1 Uptake of immunisation  None Primary care Group 1 – information by physician at day health  Social class,attitudes,reasons
(influenza) in well adults centre plus free vaccine
132 - 1 Uptake of breast feeding  None Obstetrics  Trained health professionals on breast feeding and  Reasons
in well women and  skills plus encourage ‘rooming in’ in hospital plus 
gynaecology encourage  support  groups
(midwifery)
163 - 1 Adherence to  None Obstetrics  Group 1 – information on transmission of  Age
handwashing in pregnant  and  cytomegalovirus and affects fetus plus provision 
women with children gynaecology  latex gloves plus liquid soap
(midwifery)
361 - 1 Adherence to behavioural  None Mental  Group 1 – discussion of patient targets within  Age,sex,marital status,level of 
therapy programme in  health group plus problem solving education,actual risk
mentally ill adultsHealth Technology Assessment 1999; Vol. 3: No.1
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TABLE 31  Description of the quality of the study and summary results:RCTa
Study  Intervention  Sample size Summary of results
number level
23 - 1 Patient ? / 69 / ? Intervention associated with increase in amount of self-care behaviours
Convenience sample
39 - 1 Patient 878 / 659 / ? Signed letter by GP more likely to increase self-report smear attendance than letter sent 
Total sample available by clinic or information alone
41 - 1 Patient ? / 465 / 450 Signed letter by GP increased uptake of refusers from 10% to 21%
Total sample available
52 - 1 Patient 151 / 151 / 151 Uptake of mammography greater with telephone call reminder irrespective of identity caller.
Total sample available Medical assistant group most cost-effective
85 - 1 Patient 907 / 722 / 722 Authors claim prompt on contraceptive packet increased performance of BSE (57% vs.49% at 
Total sample available 6 months).Both interventions increased adherence to BSE after intervention.Note:large 
attrition and only a random sample of women’s results reported
108 - 1 Patient ? / 283 / 283 Uptake of FOB testing not associated with manipulation of stools or simplification of 
Convenience sample screening technique
122 - 1 Patient ? / 1842 / 1842 Uptake of colorectal cancer screening not associated with type of screening method
Not adequately described
316 - 1 Patient 1455 / 278 / 212 No significant increase in attendance for colorectal screening following the letter-based 
Systematic sample information intervention (4% vs.9%)
509 - 1 Patient 153 / 119 / 105 Voucher intervention increased attendance for mammography (44% vs.10%)
Total sample available
101 - 1 Patient 150 / 150 / 150 Intervention not associated with uptake of mammography.Note:positively framed message 
Total sample available associated with greater intention to attend than the routine letter
117 - 1 Other 228 / 171 / 171 Elderly educator and modified information was associated with increased adherence to screening 
Total sample available
197 - 1 Patient 100 / 81 / 81 Supplying screening kit plus information increased uptake of colorectal screening from 
Systematic sample 0% to 51%.HBM operationalised
275 - 1 Patient 2076 / 2076 / 1476 Interventions not associated with differential uptake rates (49%,41%,42%,45%)
Total sample available
53 - 1 Patient ? / 267 / ? Adherence to self-report medication improved from 12% to 18% with use of the 
Total sample available computerised telephone (p = 0.03)
50 - 1 Patient 184 / 184 / ? Counselling group reported changes in exercise uptake (16% vs.50%),diet (19% vs.33%) but no 
Total sample available changes for smoking or alcohol intake.Biophysical markers not associated with changes
64 - 1 Patient 5282 / 4195 / 1098 Trend towards significance for smoking cessation but no significant difference on alcohol use 
Total sample available and exercise uptake
118 - 1 Other 92 / 72 / 72 Intervention associated with increase in number of quit attempts and a trend towards significance 
Systematic sample for smoking outside the home
216 - 2 Not recorded ? / ? / ? Flat fee intervention had higher uptake than refundable deposit intervention (p < 0.0001)
Not adequately described
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TABLE 31 contd  Description of the quality of the study and summary results:RCTa
Study  Intervention  Sample size Summary of results
number level
229 - 1 Patient 386 / 106 / 106 No differences in number people quitting smoking.Note,increasing cost of nicotine gum associated 
Total sample available with decreasing attempts at obtaining gum and quit attempts
350 - 1 Patient ? / 647 / 647 Both physician-based information intervention groups associated with the same rate of 
Convenience sample cessation (approximately 11%)
483 - 1 Other 762 / 410 / 352 No association between training pharmacists and patient adherence
Convenience sample
648 - 1 Patient ? / 504 / 398 No differential effects groups on smoking cessation (56% vs.66% vs.68%).Caution:two 
Convenience sample work-site samples differed at baseline
793 - 1 Patient 1772 / 1686 / 1686 Additional information not associated with smoking cessation.Nicotine patch associated with 
Not adequately described increase in cessation (11% to 19%)
781 - 1 Patient ? / 122 / 115 Self-management associated with reduction in use of antibiotics,ambulatory care and days taken off 
Systematic sample work (p < 0.05)
755 - 1 Not recorded 1600 / 1381 / 1053 Analysis performed control 2 and Group 4:Group 4 associated changes in alcohol and fat 
Systematic sample consumption,increase fruit and vegetables (p < 0.01) but no change in smoking or exercise
67 - 1 Patient 1581 / 661 / ? Information intervention not associated with changes in preferences for CPR. Analysis suggested know-
Systematic sample ledge Alzheimer’s disease,age,income and ethnicity were associated with reduced rates of resuscitation
196 - 1 Patient 221 / 131 / 122 Telephone support associated with adherence to more regular meals and use of community 
Total sample available resources but no change in smoking cessation
714 - 1 Patient 190 / 190 / 184 Intervention associated with fewer missed appointments and increased adherence to 
Total sample available treatment (p < 0.01)
200 - 1 Patient ? / 535 / 520 Intervention associated with increase in physical activity and reductions in CVD risk factors
Total sample available
724 - 1 Patient 1171 / 994 / 814 Intervention associated with increase in smoking cessation (9% vs.14%;p < 0.01).
Total sample available Cost calculation provided
581 - 1 Patient ? / 363 / 326 Information intervention not associated with changes in smoking cessation (8% vs.10%)
Convenience sample
542 - 1 Patient ? / 100 / 100 Positive frame associated with increased consent to study (67% vs.42%;p < 0.01).Interaction with 
Convenience sample reasons for choice
120 - 1 Other 3989 / 3704 / 2082 Participants in control group less likely to respond.No association between the intervention and 
Total sample available self-report of alcohol use.Note:little description of control group so difficult to interpret findings
301 - 1 Patient 46 / 41 / 28 Increased information on side-effects not associated with changes in adherence to medication.
Total sample available Caution:small sample size
325 - 1 Patient 74 / 54 / 54 No reliable differential effects between intervention groups on increased uptake of exercise.
Convenience sample Both interventions increased uptake over time (p < 0.001)
202 - 1 Patient 80 / 80 / 80 Intervention not associated with increased attendance (68% vs.53%).However,those failing to 
Total sample available attend first appointment more likely to respond to a reminder phone call (84% vs.52%)
393 - 1 Patient 97 / 90 / 83 Intervention not associated with changes in risky or safe sex
Total sample available
741 - 1 Patient 500 / 256 / 186 Attendance at STD clinic associated with reduction in sexual partners,HIV testing intervention and 
Total sample available associated increased use condoms (p = 0.05).Purpose of study to assess impact of offering HIV testing
107 - 1 Other ? / 1213 / 808 Intentions to engage in safer sex greater in intervention group (p < 0.0001).
Systematic sample Operationalising social cognitive framework
585 - 1 Other 383 / 138 / 98 Authors claim intervention associated with increase in condom use
Convenience sample
799 - 1 Patient ? / 128 / 100 Social skills and culturally appropriate information associated with increase in safer sex (p < 0.05)
Convenience sample
299 - 1 Other 8069 / 5242 / ? All reminders associated with increase in attendance for tetanus immunisation (p < 0.0001).
Total sample available Letter reminder produced greater attendance than physician or nurse reminder
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TABLE 31 contd  Description of the quality of the study and summary results:RCTa
Study  Intervention  Sample size Summary of results
number level
378 - 1 Patient 1068 / 1068 / 1068 Postcard reminder increased immunisation rates from 9% to 25%
Total sample available
638 - 1 Patient ? / 497 / 434 Telephone intervention associated with less utilisation of primary and hospital care,shorter stays 
Not adequately described in hospital,less medication.Cost calculation provided
387 - 1 Patient 163 / 120 / 120 Intervention associated with greater question-asking by patient.Results presented with 
Total sample available socio-economic status interaction
333 - 1 Patient 5132 / 254 / 254 Intervention associated with increase in immunisation and need for physician,decrease in use of 
Systematic sample medication (p < 0.01)
425 - 1 Patient 3252 / 2794 / ? Intervention associated with fewer scans,day admissions and decreased satisfaction with service
Total sample available
778 - 1 Patient 3368 / 1691 / 1691 Individual information increased attendance for serum screening.General information reduced 
Total sample available attendance for CF carrier testing.Note:low attendance at classes (52%)
678 - 1 Patient 854 / 814 / 814 Team care intervention associated with increased attendance to ante-natal clinic and perception of 
Total sample available more informed choice for patient decision making
606 - 1 Patient 516 / 516 / 516 Nurse intervention associated with greater attendance at follow-up (51% vs.40%) and reduced number
Total sample available of attempted suicides (11% vs.17%)
427 - 1 Patient 68 / 47 / ? Adherence to medication more likely to be achieved in medication group
Total sample availableAppendix 8
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TABLE 32  Description of the quality of the study and summary results:RCTb
Study  Intervention  Sample size Summary of results
number level
352 - 1 Patient 187 / 187 / 187 Small incentive not associated with increased uptake of mammography
Total sample available
352 - 2 Patient 184 / 184 / 184 No differential effect of telephone and postcard reminder with uptake of mammography
Total sample available
352 - 3 Patient 63 / 63 / 63 Signed physician letter associated with increased attendance for mammography and breast screening 
Total sample available clinic (p < 0.05)
353 - 1 Other ? / 769 / 594 Phone call reminders by acquaintances associated with increased uptake of mammography 
Convenience sample (49% vs.34%;p < 0.001)
420 - 1 Patient ? / 2201 / 2201 Intervention associated with increased uptake of colorectal screening (Group 3 significantly greater 
Systematic sample than other groups:48% vs.27%,37%,37%).Gain/loss framing of messages not associated with uptake of 
colorectal screening
482 - 1 Patient ? / 2201 / 1565 Interventions not associated with increase adherence to colorectal screening
Systematic sample
653 - 1 Patient ? / 3726 / 3726 Informing women about research project not associated with uptake of breast cancer screening 
Systematic sample (53% vs.53%)
675 - 1 Patient 153 / 153 / 153 Completion colorectal screening not associated with length of time to take samples (3 or 6 days).
Total sample available Adherence associated with dietary restrictions (28% vs.53%)
683 - 1 Patient ? / 966 / 966 Differential effects in uptake rate (Group 1:48%;Group 2:55%;Group 3:46%;Group 4:31%:
Total sample available Group 523%).Cost–benefit analysis carried out
491 - 1 Patient ? / 614 / 439 Interventions not associated with differential effect self-report BSE.Increase in self-report over time.
Convenience sample Inappropriate statistics and erroneous exclusion of subjects
533 - 1 Patient ? / 614 / 479 Differential effects associated with intervention,individual feedback on own breast associated with 
Convenience sample better BSE technique (p < 0.01)
566 - 1 Patient ? / 325 / 325 Stamped addressed envelope increased return rate from 61% to 74%.Interaction reported with 
Convenience sample whether insured or not
705 - 1 Other ? / 543 / 262 Interventions not associated with changes in safe-sun behaviour
Total sample available
728 - 1 Patient 1143 / 834 / 834 Differential effects in increasing uptake of cervical smear (5%;11%;30%;26%).Personal visit associated 
Systematic sample with increased attendance rather than video
630 - 1 Patient 799 / 799 / 782 No differential effect interventions on women’s attendance for breast screening (11% vs.8% vs.13%)
Total sample available
285 - 1 Not recorded ? / ? / ? Poor explanation study,results reported only for refund vs.free test.Free test increased 
Not adequately described screening (42% vs.56%)
727 - 1 Patient 437771 / 2266 / 2266 Fixed appointment associated with increase in attendance (27% vs.40%).Second intervention study 
Systematic sample not reported as unclear explanation
543 - 1 Patient 2131 / 1912 / 1912 Intervention associated increase cervical smear attendance (28% vs.13%).Higher in those attending 
Total sample available breast screening (42% vs.20%)
587 - 1 Patient 669 / 205 / 205 Increased information associated with decreased interest in prostrate screening (p < 0.05)
Total sample available
713 - 1 Patient ? / 125 / 108 Intervention associated with increased attendance at follow-up clinic (75% vs.46%).Note:little 
Systematic sample information on attrition
48 - 1 Other 995 / 553 / ? Women already in hospital had greater uptake of cervical smears (72%).No difference in uptake of 
Total sample available smears between information only and control group (24% vs 20%)
488 - 1 Patient 169 / 102 / 100 Interactive computer screen associated with increased intention to take part in clinical trial compared 
Total sample available with audio-taped information.Concerned with informed patient decision making
86 - 1 Other ? / ? / ? Intervention associated with increase in cervical and mammography uptake
Not adequately described
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114 - 1 Patient ? / 1104 / 405 Patients belief interventions were twice as effective as routine information
Systematic sample
232 - 1 Patient ? / 802 / 626 Intensive education intervention not associated with a differential effect uptake of mammography.
Systematic sample Operationalised HBM
438 - 1 Patient ? / 181 / 133 Intervention associated with a trend towards significance (gain 52%,loss 66%;p = 0.07).
Convenience sample Operationalised prospect theory
784 - 1 Patient 3291 / 3291 / 3290 Authors claim attendance increased to 70% if woman interviewed (42% overall). Actual uptake by 
Total sample available group unclear as analysis to assess predictors of uptake
700 - 1 Patient ? / 142 / 92 Question-based intervention increased question asking (35% vs.16%). Assessed preference of 
Not adequately described consultation style 
789 - 1 Patient ? / 250 / 197 Information framed using internal responsibility associated with increased uptake of mammography 
Convenience sample (55% vs.66% vs.57%;p < 0.01)
207 - 1 Other ? / ? / 117 Smoking and smoking/diet group associated with reduction in smoking;diet and smoking/diet 
Convenience sample intervention associated with changes in diet
288 - 1 Patient 1927 / 647 / 390 No differential effect of interventions on number kits ordered or intention to test. Assessed changes 
Convenience sample in perceptions of risk
690 - 1 Patient 2822 / 1404 / 511 Belief and information group associated with greater increase in BSE than other groups (p < 0.05)
Systematic sample
458 - 1 Other 1703 / 1703 / 1270 Intervention associated with trend towards intention to change behaviour (p < 0.01)
Total sample available
307 - 1 Patient 875 / 175 / 157 No differential effect in interventions.BSE improved over time
Convenience sample
140 - 1 Patient ? / 186 / 114 Intervention not associated with changes in smoking cessation
Convenience sample
757 - 1 Patient 535 / 535 / 446 No differential effects from framing information but additional information associated with increased 
Total sample available uptake of mammography (66% vs.53%;p < 0.01)
434 - 1 Patient 264 / 96 / 90 Framing information not associated with willingness to enter trial
Convenience sample
816 - 1 Patient 218 / 180 / 180 Intervention not associated with increase or decrease in participation (13% control vs.24% 
Total sample available intervention). Analysis looked at predictors of attendance
667 - 1 Patient 64 / 60 / 60 Intervention not associated with changes in participation consultation or final decision
Total sample available
671 - 1 Patient ? / 100 / 81 Additional information not associated with cancellation of procedure.Note:small sample size and 
Not adequately described non-validated measures
1 - 1 Patient ? / 681 / 626 No change in exercise behaviour,though reduction in anxiety
Not adequately described
10 - 1 Patient 200 / 160 / 140 No association between care plan group and hospital attendance.Main results between intervention,
Not adequately described patient satisfaction and mortality
28 - 1 Patient 50 / 46 / 46 Intervention not associated with change in use of healthcare services
Not adequately described
63 - 1 Patient 430 / 391 / 294 Nurse intervention associated with increased uptake of exercise.Exercise uptake not associated 
Total sample available with routine and routine plus information group
47 - 1 Patient ? / 2441 / ? Physician group more likely to eat more healthily and be immunised than hospital-based group.
Convenience sample No association with smoking behaviour
55 - 1 Other ? / 267 / 267 Intervention not associated with intention to stop smoking
Not adequately described
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55 - 2 Other ? / 450 / 220 Intervention not associated with intention to stop smoking
Not adequately described
57 - 1 Not recorded 427 / 320 / 213 Adherence decreased if medication taken twice a day (95% vs.82%)
Total sample available
88 - 1 Patient 71 / 60 / 60 Intervention not associated with changes in adherence.Presented results of demographic associations 
Total sample available with adherence
102 - 1 Other 1425 / 1097 / 770 Intervention not associated with cessation of smoking.Interaction between level education 
Convenience sample and treatment condition
105 - 1 Patient 74 / 36 / 31 Modified information associated with increase in adherence to medication (79%,83%,93%).
Total sample available Small sample size
110 - 1 Other 4712 / 4712 / 1452 Intervention associated with decrease in self-report alcohol use,increase in healthy eating but 
Systematic sample no change in smoking or exercise.Caution in interpreting the results as inappropriate use of statistics 
and potential confounders between randomised groups
147 - 1 Patient ? / 70 / 61 Intervention group associated with reduction in fatty food intake
Convenience sample
155 - 1 Patient ? / 128 / 128 Patients less likely to sign consent form if given information about videotaping consultation
Systematic sample
183 - 1 Patient ? / 453 / 290 No association with information group and cessation of alcohol
Not adequately described
216 - 1 Patient 6000 / 3257 / 140 One-stage intervention had a higher uptake rate than the two-stage approach 3% vs.2% (p < 0.05)
Systematic sample
217 - 1 Other 7351 / 2577 / ? No changes in smoking behaviour either before/after intervention or between varying amounts 
Total sample available and types of information groups
249 - 1 Patient ? / 179 / 155 No association between counselling and cessation of smoking
Not adequately described
259 - 1 Patient ? / 338 / 336 Control group drinking twice as much as either intervention group (p < 0.001).No difference 
Convenience sample between intervention groups
279 - 1 Other 1005 / 1005 / 766 Intervention associated with reduced uptake of smoking (17% vs.26%).No baseline measure of 
Total sample available smoking in intervention group
356 - 1 Other 2002 / 1001 / 1001 Blood pressure and diet monitoring by nurse not associated with change in salt intake/diet change
Systematic sample
574 - 1 Patient ? / 44 / 22 No differences in cessation between groups (68% vs.71% vs.60%).High cessation rates indicate 
Not adequately described that sample not representative
652 - 1 Patient ? / 1975 / 1948 Authors suggest intervention associated with increase in attendance (46%,61%,58%)
Convenience sample
679 - 1 Other ? / 1274 / 1274 Intervention not associated with changes in exercise behaviour
Systematic sample
489 - 1 Patient ? / 36 / 36 Interventions not associated with any changes to lifestyle behaviours
Convenience sample
772 - 1 Patient ? / 44 / 42 No differential effect of patient-centred and directive style with cessation of drinking.Counselling 
Convenience sample better than no counselling (p < 0.02)
807 - 1 Patient ? / 204 / ? Intervention associated with increase in self-management of diabetes
Convenience sample
447 - 1 Patient ? / 224 / 209 Intervention associated with increased clinic attendance (p < 0.001).Note:interaction analysis 
Not adequately described performed between ‘new’ hypertensives and known infrequent attendees
783 - 1 Patient 2021 / 2021 / 1877 Telephone support counselling increased cessation rates (16% vs.15% vs.14% vs.23%)
Convenience sample
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336 - 1 Other 2753 / 2202 / 1652 Interventions not associated with changes in diet and smoking.Curriculum plus screening associated 
Total sample available with increase in aerobic exercise (p < 0.05)
530 - 1 Patient 192 / 116 / 116 Intervention associated with increase adherence at follow-up (p < 0.05)
Convenience sample
564 - 1 Not recorded 371 / 227 / 227 No differences in treatment adherence by group (14%,12%,10%).Differential effects of groups on 
Total sample available other drinking outcomes:hospitalisation > choice > AA
702 - 1 Patient 70 / 70 / 70 Information plus phone call associated with greater increase in adherence behaviour (p < 0.01)
Total sample available
213 - 1 Other ? / ? / 659 Intervention associated with increased rates of cessation (18% vs.9%)
Convenience sample
327 - 1 Patient ? / 52 / 52 No association between computer group and increase in house-mite reduction activities.Both groups 
Convenience sample increased house-mite reduction activities over time
328 - 1 Patient ? / 102 / 102 Intervention associated with increase in healthy diet and self-monitoring of glucose.No association 
Convenience sample between exercise and medication adherence
612 - 1 Patient ? / 27 / 25 Type of device not associated with adherence therapy
Convenience sample
629 - 1 Patient 200 / 190 / 190 Intervention associated with increase in completion healthcare proxy (48% vs.6%,p < 0.001)
Total sample available
268 - 1 Patient ? / 5354 / 3122 Presentation results by men,wives and children.Intervention associated with changes in diet 
Total sample available (p < 0.01).No change in smoking cessation
395 - 1 Other 7397 / 7397 / 7397 Differential effects by group. Authors claim greatest increase associated with physician and 
Total sample available patient reminder group (p < 0.01)
396 - 1 Patient ? / 105 / 105 Computer group associated changes in fat and calorie intake (p < 0.05)
Not adequately described
398 - 1 Patient ? / 93 / 75 Results not reported for exercise/diet adherence by group.Analysis reporting differences between 
Convenience sample black/white participants.Exercise uptake but not diet intake improved over time
402 - 1 Patient ? / 211 / 211 Randomisation of patients resulted in lower uptake treatment (71% vs.56%;p < 0.05)
Not adequately described
439 - 1 Patient 5281 / 4195 / 3097 No data provided for uptake of screening in control group.Intervention a predictor for better health 
Total sample available at 2-year follow-up
527 - 1 Patient ? / 241 / 231 Feedback intervention associated with increased adherence with inhaler (p < 0.01)
Convenience sample
168 - 1 Patient 122 / 102 / 102 Telephone intervention not associated with adherence to medication (34% vs.29%)
Total sample available
265 - 1 Patient ? / 229 / 169 Interventions not associated with exercise or smoking behaviours.Control group increased intake of 
Total sample available cholesterol,early intervention associated with greater decrease in cholesterol intake than late group 
(p < 0.05)
365 - 1 Patient 321 / 253 / 231 Intervention aimed at women associated with change in diet in men (p < 0.05).Note:excluded men 
Convenience sample no longer living in marital home
372 - 1 Patient ? / 207 / 173 Intervention not associated with consultation attendance or changes to lifestyle
Convenience sample
263 - 1 Patient ? / 303 / 264 Intervention associated with reduction of fat in diet (17% vs.36%)
Convenience sample
693 - 1 Patient ? / 52 / 42 Authors claim that medication schedule associated with increased compliance but sample size small 
Total sample available
137 - 1 Patient ? / 181 / 138 Intervention not associated with adherence to medication
Convenience sample
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139 - 1 Patient 307 / 275 / 275 Analysis performed by risk group:intervention,obese patients more likely to make appointment 
Total sample available with dietician;intervention,smoking group more likely to report quitting (though not confirmed 
by cotinine level)
143 - 1 Patient ? / 1745 / 1745 No differential effects of intervention on smoking cessation (16% vs.17%)
Convenience sample
668 - 1 Patient ? / 870 / 602 Differential effects of intervention over time.Personalised feedback plus stage of change leaflet 
Convenience sample associated with greater cessation. Applied transtheoretical model
332 - 1 Patient ? / 201 / 201 Differential effects for way medical interventions described:31% cases positively described,
Convenience sample 12% negatively described and 19% medical guideline accepted treatment
20 - 1 Patient 85 / 64 / 43 Intervention not associated with change in use of healthcare service
Convenience sample
27 - 1 Patient 500 / 329 / 303 Association between groups and use of services by disease:osteoporosis,counselling group fewer 
Convenience sample clinic visits than other groups;rheumatoid arthritis no association by groups
104 - 1 Patient ? / 156 / 156 Different associations by different behaviours:behavioural strategy group more likely to monitor 
Convenience sample glucose level;attention group lower adherence to smoking cessation and medication but better diet 
and weight behaviours
220 - 1 Other 8565 / 7795 / ? Adherence to healthy diet associated with intervention (p < 0.001)
Systematic sample
233 - 1 Patient ? / 1800 / 1381 Significant group by time interactions for adherence exercise and cessation fat and caffeine intake
Not adequately described
241 - 1 Patient ? / 125 / 114 Intervention associated with increased duration and frequency of exercise.Path analysis assessed 
Convenience sample relationship self-efficacy and exercise adherence
276 - 1 Other 1013 / 570 / 570 Intervention not associated with changes in smoking cessation
Total sample available
295 - 1 Patient ? / 66 / 56 Interventions not associated with self-reported changes in diet at 3 months
Not adequately described
305 - 1 Patient ? / 293 / 177 Both theory-based groups associated with cessation of fatty diet and adherence to exercise.No 
Convenience sample changes for smoking,use of health professional,and adherence to medication
321 - 1 Patient ? / 26 / 22 Intervention not associated with differences in adherence (no figures provided)
Convenience sample
157 - 1 Other 2332 / 933 / 583 Information group not associated with infant smoke exposure reduction.Both control and 
Convenience sample intervention groups increased smoking over time (53% vs.46%)
376 - 1 Patient 1387 / 1378 / 1378 Intervention associated with increased attendance at smoking cessation programme (after GP advice,
Total sample available 1%;after recruitment 9%)
469 - 1 Patient ? / 453 / 453 Intervention associated with increased adherence to medication in both new and existing patients
Not adequately described
502 - 1 Patient ? / 84 / 58 Intervention not associated with changes in self-management of illness
Not adequately described
503 - 1 Patient ? / 66 / 48 Intervention associated with changes in lifestyle behaviours (p = 0.04).Behaviours not noted and 
Not adequately described percentages not stated.Regression analyses performed looking at knowledge
707 - 1 Patient ? / 585 / 585 No difference in adherence to therapies (11% vs.9%).Biochemical assessment smoking,diet 
Not adequately described and exercise suggest changes by group
158 - 1 Patient 72 / 51 / 51 Intervention associated with increased cessation in moderate smokers (31% vs.7%)
Total sample available
158 - 2 Patient 410 / 296 / 197 Intervention associated with smoking cessation in moderate smokers (p < 0.05 adjusted for 
Convenience sample non-responders)
210 - 1 Patient 686 / 507 / 347 Tailored intervention associated with self-reported changes in diet (p < 0.01)
Not adequately described
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211 - 1 Other ? / 340 / 292 No differential effects of interventions on smoking cessation (27% vs.22%).Operationalised stages 
Convenience sample of change model
644 - 1 Other 488 / 431 / 364 Analysis reported by group and collapsed groups:behavioural counselling associated with higher 
Not adequately described cigarette cessation rate than information-feedback groups (18% vs.3%,p < 0.01)
269 - 1 Patient ? / 345 / 139 Differential effect of intervention on fibre consumption (29% vs.88% vs.66%,p < 0.01).
Convenience sample Cost–benefit analysis
291 - 1 Patient ? / 290 / 225 Education intervention associated with increase in self-management for parents and children
Convenience sample
541 - 1 Patient 524 / 290 / 196 Intervention associated with reduction in fat intake (p < 0.001)
Total sample available
255 - 2 Other 8992 / 8992 / 7180 No differential effects of interventions on smoking behaviour
Systematic sample
145 - 1 Other ? / 5589 / 3884 Intervention not associated with cessation of smoking. Analysis assessed rebelliousness,norms 
Convenience sample and smoking status
264 - 1 Patient ? / 208 / 169 Intervention associated with increased exercise uptake for control and Group 3,a decrease in fat 
Not adequately described consumption for Group 2
659 - 1 Patient ? / 550 / 304 Women’s intervention associated with reduction in men’s consumption of fat (p < 0.01) but no 
Not adequately described increase in eating healthy foods
622 - 1 Patient ? / ? / 842 No differential effects of intervention groups,both increased adherence over control group (p < 0.01).
Not adequately described Operationalised HBM
814 - 1 Patient ? / 136 / 120 Intervention associated with greater adherence to exercise programme (p < 0.01)
Convenience sample
490 - 1 Patient 133 / 88 / 80 Intervention leaflet associated with increase in rehabilitation exercises (p < 0.001).Main analysis 
Total sample available assessed gender differences and anxiety
22 - 1 Other ? / 2271 / ? Results presented by gender.Males and females in intervention group showed increase in intention 
Systematic sample to use condoms
732 - 1 Other 14749 / 12537 / 8845 Intervention not associated with changes in risky sex behaviour.Purpose of study to look at 
Systematic sample prevalence of HIV
736 - 1 Patient ? / 313 / 218 Authors claim intervention not associated with change in behaviours but sample group highly selective 
Convenience sample and attrition
341 - 1 Patient 313 / 313 / 218 Intervention not associated with changes in drug use or sexual behaviour.Sub-group analysis between 
Total sample available used vs.not used alcohol
156 - 1 Patient ? / 99 / 61 High reward associated with increase in attendance,decrease ‘drug’ behaviours.No difference in low 
Not adequately described reward intervention over time
212 - 1 Other ? / ? / ? Intervention not associated with any changes in cigarette,alcohol or marijuana over 5-year period
Not adequately described
639 - 1 Patient 243 / 217 / 217 Video group associated with greater intention to reduce risk behaviour immediately after information.
Total sample available No effect at 2 months
289 - 1 Patient ? / 107 / 77 Acquisition of condoms associated with intervention (38% vs.77% vs.75%).No differential effects 
Convenience sample between intervention groups
465 - 1 Patient ? / 214 / 97 Results on behaviour not clearly reported,no reported change in behaviour
Convenience sample
733 - 1 Patient ? / 70 / 60 Intervention associated with trend towards drug cessation and attendance for health appointments 
Convenience sample (p = 0.06,0.07)
4 - 1 Patient 184 / 184 / 184 Contact therapy not associated with greater decrease in cocaine use. Authors looked at predictors of 
Convenience sample cocaine use
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24 - 1 Patient ? / 20 / ? Alcohol was associated with reduced discussion of condoms.No change in intention to use condoms
Convenience sample
223 - 1 Patient ? / ? / 296 Social skills intervention no more effective than routine information in increasing cessation of drug use
Convenience sample
226 - 1 Other 3011 / 2416 / 2416 Groups confronting beliefs and normative behaviours associated with reduced drug use.Control and 
Total sample available resistance training alone not useful in reducing drug use behaviour
247 - 1 Other 5070 / 3549 / ? Authors claim psycho-social interventions associated with changes in alcohol,smoking and marijuana 
Total sample available use. Analysis performed by gender
277 - 1 Other ? / ? / ? No association of theory-based interventions and changes in alcohol,smoking and marijuana use,
Total sample available 2 years after intervention. Analysis performed on process measures
424 - 1 Other ? / ? / ? Authors claim intervention associated with increased safer sex practices.Note:analysis only on 
Convenience sample sexually active sub-group
478 - 1 Other ? / 1033 / 758 Intervention associated with greater contraceptive discussions with parents.In female,first-time sexual 
Total sample available encounters intervention associated with safer sex practices
600 - 1 Other 387 / 220 / 208 Directive intervention associated with lower recruitment rates (65% vs.52%).No association between 
Total sample available intervention and attendance at counselling sessions.No demographic results presented although 
reported
685 - 1 Patient ? / 291 / 291 Theory-based information associated with increase in attainment of free condoms (p < 0.01).
Not adequately described Assessed relationship experience and attitude formation (Fazio)
742 - 1 Patient ? / ? / 206 Analysis suggests AIDS information group more likely to use condoms
Not adequately described
492 - 1 Patient ? / 89 / 81 Intervention not associated with changes in risky behaviour
Convenience sample
766 - 1 Patient 246 / 246 / 225 Intervention associated with increased use of condoms over time (p < 0.01),reduction in the initiation 
Total sample available of sexual activity (31% vs.12%)
776 - 1 Patient ? / 187 / 93 Intervention associated with increased use of condoms (p < 0.001)
Convenience sample
165 - 1 Patient ? / 1770 / 994 Intervention not associated with cessation of risky drug behaviours although a time effect 
Convenience sample
632 - 1 Patient 55 / 50 / 47 Analysis of safe sex/drug use not reported.Intervention associated with skill acquisition for condom 
Convenience sample and needle sterilisation use
632 - 2 Patient ? / 98 / 60 Intervention not associated with behaviour change
Not adequately described
635 - 1 Patient 176 / 152 / 106 Risky sex/drug behaviour decreased over time (p < 0.001).No reliable differential effects by 
Total sample available intervention but for sex/ drugs more in information group increased risk behaviour (11% vs.4%)
636 - 1 Patient ? / 497 / 407 Enhanced intervention associated with cessation of cocaine use and risky drug use
Not adequately described
525 - 1 Patient ? / 200 / 88 No differential effect between groups on drug use,risky sex and study attrition.Over time,reduction 
Convenience sample in risky drug use but not sex
660 - 1 Other 1315 / 1201 / 867 Intervention associated with adherence to safer sex (p < 0.01)
Systematic sample
454 - 1 Patient ? / 916 / 858 Decreased risky behaviours for both groups over time,traditional group associated with greater 
Convenience sample cessation of behaviours than intensive group
706 - 1 Patient 465 / 419 / 419 Intervention associated with mixed findings:reduction in home visits for coughs,colds,fevers but 
Total sample available increase for diarrhoea and vomiting
6 - 1 Patient 10 / 10 / ? Adherence to medication not associated with taste of medication
Convenience sample
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6 - 2 Not recorded 15 / 12 / ? Adherence to medication not associated with taste of medication
Not adequately described
6 - 3 Patient 10 / 10 / ? Adherence to medication not associated with taste of medication
Convenience sample
32 - 1 Patient 201 / 194 / 174 Intervention associated with differences in attendance and adherence.Stimulus group had lower attendance 
Total sample available than regular class;weight-dependence group had better adherence than time-dependent group 
51 - 1 Patient ? / 400 / 385 Medication provided with precise unit of measurement in liquid form associated with increase in 
Not adequately described adherence to medication
174 - 1 Patient ? / 44 / 39 Intervention associated with adherence to exercise programme but not with diet
Convenience sample
302 - 1 Other ? / 100 / 98 Leaflet associated with fewer home visits and physician appointments and more self-treatments of 
Not adequately described children’s symptoms (p > 0.01)
589 - 1 Patient ? / 325 / 159 No difference between two methods of invitation (72% vs.66%)
Systematic sample
572 - 1 Patient 239 / 239 / 103 Intervention associated with increased uptake of immunisation (p < 0.001)
Total sample available
747 - 1 Patient ? / 1200 / 1200 Differential effect of interventions on uptake (75% vs.69% vs.54%)
Systematic sample
769 - 1 Not recorded 4641 / 855 / 567 No differential effects of interventions on attendance at general practice. Article reports costs 
Systematic sample of each alternative
520 - 1 Patient 3913 / 3404 / 3404 Leaflet associated with lower utilisation of services.Interaction with perception of health risk
Total sample available
234 - 1 Patient ? / 3884 / 1989 Free vaccination increased uptake of flu immunisation more than the control group.
Not adequately described Uptake of immunisation increased over time.Note:less than a 40% response rate
337 - 1 Other 2624 / 2624 / 2624 Attendance increased in intervention group,particularly for ‘alarming’ coughs
Total sample available
796 - 1 Other 548 / 548 / 548 Intervention associated with adherence to cough care treatment (30% vs.56%;p < 0.01)
Total sample available
414 - 1 Patient ? / 43 / 32 No association of intervention and therapy adherence,diet or exercise changes
Convenience sample
553 - 1 Patient ? / 120 / 86 No association between groups and changes in exercise behaviour.Predictors of behaviour analysis 
Not adequately described only reported
408 - 1 Patient 229 / 229 / 222 Telephone reminder not associated with increase in immunisation
Total sample available
19 - 1 Patient ? / 236 / 236 Choice of treatments associated with presentation data:fewer patients chose immediate survival 
Not adequately described when data presented as a curve rather than point estimates
167 - 1 Patient ? / 288 / 288 Interventions associated with increased attendance at well-baby clinic (p < 0.05).No differential effects 
Not adequately described interventions (68%,75%,74%)
357 - 1 Patient ? / 66 / 62 Illustrated leaflet not associated with increased adherence to medication (p = 0.07)
Not adequately described
426 - 1 Patient 299 / 299 / 299 Fixed appointment increased uptake from 27%– 59%.Operationalised HBM
Total sample available
506 - 1 Patient 141 / 67 / 67 Intervention not associated with increase in patient participation consultation
Total sample available
633 - 1 Patient 422 / 422 / 359 Intervention not associated with uptake of vaccination
Total sample available
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369 - 1 Patient 587 / 439 / 439 Intervention not associated with adherence to medication
Total sample available
620 - 1 Patient 299 / 254 / 121 No differential effect in uptake of health check by group. Fewer people in opportunistic group 
Not adequately described approached,resulting in differences in uptake (79% vs.33%;p < 0.01)
135 - 1 Patient 68 / 68 / 55 Authors suggest intervention group associated with increase in exclusively breast feeding for 
Convenience sample 3 months (p < 0.02).(published again Journal of The American Dietetic Association 1995;95:323–8.)
698 - 1 Patient 300 / 210 / 210 Adherence trial associated with effectiveness of HRT in controlling menopausal symptoms 
Not adequately described (47% vs.49% vs.73%)
634 - 1 Patient ? / 800 / 800 Fixed appointment letter associated with increased attendance (75% vs.54%)
Not adequately described
768 - 1 Patient 270 / 216 / 87 Breast pump rather than formula associated with increased breast feeding only if women perceived 
Total sample available bottle to make night-time feed easier (p < 0.05)
616 - 1 Patient ? / 194 / 175 Intervention associated with increased breast-feeding (38% vs.70%;p < 0.001)
Convenience sample
403 - 1 Patient ? / ? / 180 No association between interventions and uptake or duration of breast feeding
Total sample available
562 - 1 Patient 232 / 232 / 186 Feedback and information group associated with increase in dental hygiene (76% vs.67% vs.90%;
Total sample available p < 0.01)
576 - 1 Patient ? / 20 / 20 Interventions associated with increase in dental hygiene (additional feedback plus checklist)
Not adequately described
758 - 1 Patient 700 / 167 / 91 Intervention not associated with changes in dental hygiene behaviour.Operationalised the theory of 
Convenience sample reasoned action
371 - 1 Other ? / 119 / 98 Intervention not associated with changes in self-reported dental behaviour,but changes in plaque level
Not adequately described
457 - 1 Patient ? / 84 / 84 Group 2 associated increase in dental hygiene activities (36% vs.41% vs.100%;p < 0.01)
Not adequately described
304 - 1 Patient 392 / 318 / ? Differential attendance rates for final visit (65% vs.94% vs.95% vs.78%).Despite inappropriate 
Convenience sample statistics,nurse home-based interventions associated with increased attendance (p < 0.05)
308 - 1 Other ? / 200 / 179 Intervention group more likely to clear mosquito breeding sites (82% vs.25%)
Systematic sample
96 - 1 Patient ? / 191 / 172 Intervention not associated with adherence to medication
Not adequately described
479 - 1 Patient ? / 77 / 77 Family intervention associated with increased adherence to treatment.Results indicate patient’s 
Not adequately described clinical state improved
511 - 1 Patient 400 / 322 / 290 Intervention associated with exercise uptake (p < 0.001) and trend towards decreased physician visits 
Total sample available (p = 0.06)
494 - 1 Not recorded ? / 206 / 199 Intervention associated with fewer referrals to nursing homes (p < 0.05).Main analysis between social 
Convenience sample support,health and behaviour
554 - 1 Patient ? / 816 / 783 Pre-paid plans not associated with Medicaid beneficiaries utilisation services
Systematic sample
794 - 1 Patient 281 / 217 / 177 Authors claim intervention associated with increased adherence to medication (76% vs.50%;p < 0.01)
Total sample available
493 - 1 Patient ? / 102 / 91 Computer associated with increased confidence in decision making but not decision skill.
Convenience sample Computer used for information and not as a decision aid
176 - 1 Patient 511 / 492 / 470 57% patients chose medication phrased in relative-risk terms,15% when phrased in absolute-risk 
Total sample available terms.Good experimental design but no control over order effects
150 - 1 Patient 400 / 234 / 205 Use of cartoons plus leaflet increased adherence to wound care
Total sample availableHealth Technology Assessment 1999; Vol. 3: No.1
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37 - 1 Patient ? / 1744 / ? Video intervention associated with increased uptake of rate cervical smear
Total sample available
154 - 1 Patient 511 / 369 / 369 Intervention associated with increased mammography screening.Note:women ‘dropped out’ perceived 
Total sample available themselves to be less susceptible to breast cancer and perceived mammography to be less effective 
than those who took part
296 - 1 Patient 527 / 395 / 179 Free test by physician increased adherence to screening (p < 0.05). Addition of reminder letter not 
Not adequately described associated with increase in adherence
377 - 1 Patient 621 / 204 / 202 No differential effect in uptake of either intervention (55% vs.67%)
Total sample available
412 - 1 Patient ? / 146 / 146 Stamped addressed envelope associated with higher return rate for hemoccult cards (37% vs.57% vs.
Not adequately described 71%;p < 0.01).Calculated cost intervention
695 - 1 Not recorded 527 / 498 / 147 Uptake of mammography not associated intervention
Systematic sample
712 - 1 Patient 220 / 220 / 178 Differential effects of interventions by experimental group (73% vs.72% vs.44% vs.36%;p < 0.01)
Total sample available
310 - 1 Other ? / 1618 / 603 No differential effects associated with any interventions on smoking cessation. Analysis carried out for 
Convenience sample number of quit attempts and differences in participants/non-participants
752 - 1 Other 1588 / 1588 / 1588 Sending hemoccult by post associated with greater uptake (26% vs.32% vs.21%;P < 0.01).Hemoccult 
Total sample available screening not associated with invitation to attend health check
691 - 1 Other 89 / 82 / 82 No differential effect in uptake irradiation therapy by group (95%:96%:93%).Differences with 
Total sample available decision-making process:consultation less directive and more involved in decision process
248 - 1 Patient 170 / 161 / 161 Leaflet not associated with increased attendance at appointment (P = 0.097).No evidence leaflet 
Total sample available readable
354 - 1 Other 752 / 616 / 412 Theory-based intervention associated with increased uptake of mammography (45% vs.12%;
Systematic sample p < 0.001).Operationalised HBM
380 - 1 Patient 90 / 90 / 90 Telephone counselling confronting barriers to attendance increased attendance at clinic 
Total sample available (67% vs.43%,p < 0.05)
484 - 1 Other 2044 / 2044 / 2044 Free transportation associated with highest attendance at clinic,letter only with lowest.Logistic 
Total sample available regression analysis,so no percentages
507 - 1 Patient 3035 / 3035 / 963 Interventions not associated with increased uptake rates (89%,90%,90%).Note all uptake rates very 
Total sample available high
508 - 1 Other 541 / 541 / 541 Intervention associated with increased cervical screening.Logistic regression presented,interaction 
Total sample available with type of cervical abnormality
303 - 1 Other 268 / 219 / 219 Information intervention not associated increased with adherence.Interactions showed least 
Total sample available compliant patients improved following intervention (55% vs.32%) 
320 - 1 Patient 379 / 287 / 287 Information intervention associated with decreased attendance at clinic p < 0.05),no change in diet,
Total sample available smoking and alcohol behaviour
381 - 1 Patient ? / 313 / 238 Additional information and letter prompt not associated with increased referral to physician 
Convenience sample (25% vs.24%) or self-reported changes in diet,exercise or smoking
471 - 1 Patient ? / 139 / 96 No results reported evaluating impact interventions alone.Results analysed by gender
Convenience sample group interaction
473 - 1 Patient ? / 921 / 570 Interventions not associated with any changes in smoking cessation
Convenience sample
475 - 1 Patient ? / 36 / 27 Intervention associated with increase in checking blood glucose,diet,exercise,service utilisation
Convenience sample
485 - 1 Patient 371 / 227 / 200 Hospitalisation associated with greatest cessation of drinking after 2 years (37% vs.17% vs.16%)
Total sample available
763 - 1 Other ? / 88 / 79 Intervention associated with increase adherence (95% vs.83%;p = 0.02)
Not adequately described
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459 - 1 Other ? / 873 / 630 No differential effects of cessation smoking by group (10% vs.9% vs.10%)
Convenience sample
754 - 1 Patient 924 / 342 / 305 Both intervention groups associated with changes in diet (p < 0.05). Assessed knowledge
Convenience sample
708 - 1 Other ? / 580 / 510 Intervention not associated with changes in smoking
Not adequately described
711 - 1 Other ? / 309 / 309 Follow-up phone call decreased drop-out rate for 6 months only after treatment (p < 0.01)
Not adequately described
170 - 1 Patient 1142 / 1015 / 747 Information intervention associated with small change in preventive behaviour in better educated 
Not adequately described parents.Likely some group contamination and no evidence leaflet readable
343 - 1 Other 309 / 149 / 137 Information intervention not associated with increase in advance directives.Note:questionnaire only 
Total sample available offered to intervention group,no self-report data for controls
56 - 1 Other 2452 / 1272 / 1260 Attendance twice as high when free service provision (66% vs.37%)
Systematic sample
472 - 1 Other 67 / 61 / 61 Intervention patients asked more questions at discharge (7.8 vs.3.1;p < 0.01).An association between 
Total sample available perception of physical and psychological functioning and intervention
72 - 1 Other ? / 446 / 218 Results for both groups at all time points not reported.No differences in smoking cessation by 
Convenience sample group across all time points.Operationalised stages of change model
242 - 1 Patient 482 / 375 / 268 Stages of change intervention associated with increased smoking cessation and more quitting 
Convenience sample attempts.Note:only two groups reported although three randomised
254 - 1 Patient 3161 / 2707 / 2707 Prompts plus skill acquisition group increased cessation smoking twice as much as advice only 
Total sample available or group session (from 6% to 12%)
375 - 1 Patient ? / 28 / 28 Intervention not associated with greater attendance at exercise classes.Purpose of study to assess 
Convenience sample increase in knowledge
792 - 1 Other ? / 5458 / 2540 Theory-based intervention associated with increase in smoking cessation (p < 0.01)
Total sample available
640 - 1 Other 3655 / 3655 / 2688 Intervention not associated with changes in tobacco use
Total sample available
287 - 1 Patient 1119 / 1119 / 996 Intervention associated with increased smoking cessation (11% vs.16%;p < 0.009)
Total sample available
169 - 1 Patient 1383 / 719 / 706 Intervention associated with increased adherence (p < 0.001)
Total sample available
405 - 1 Other ? / 146 / 146 Intervention not associated with changes in tobacco use
Not adequately described
442 - 1 Other ? / 2791 / 1222 Intervention not associated with changes in CVD risk factors
Convenience sample
360 - 1 Other ? / 511 / 434 Intervention not associated with changes in children’s intention to change drug use behaviour.
Not adequately described Reports changes in process measures
115 - 1 Patient 328 / 328 / 225 Study operationalised the theory of planned behaviour and results analysed accordingly.Interventions 
Total sample available not associated with differential adherence to diet.No control group
329 - 1 Patient 193 / 193 / 109 No differential effect on cessation of smoking (42% vs.38% vs.48% quit)
Total sample available
80 - 1 Patient 131 / 91 / 86 No association between intervention and changes in self-report smoking cessation (too few smokers),
Total sample available dietary change or uptake of exercise.Both groups changed diet and uptake of exercise
649 - 1 Other 337 / 337 / 240 Intervention not associated with changes in safer sex practices
Total sample available
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684 - 1 Patient ? / 407 / 301 No differential effects of interventions on condom use
Convenience sample
720 - 1 Other ? / 385 / 243 Analysis assessed relationship between social network and behaviour.Unclear relationship 
Total sample available between intervention and behaviour
407 - 1 Other ? / 2144 / 1866 Intervention associated with decreased in risky drug use (p < 0.05)
Convenience sample
181 - 1 Patient 60 / 51 / 39 Authors suggest intervention associated with greater adherence (p < 0.05).Unclear sample size in 
Total sample available final analysis,large attrition
762 - 1 Patient ? / 106 / 76 Interventions associated with increased acquisition of condoms and initiation of HIV conversations 
Convenience sample (p < 0.01).Interventions not associated with self-reported behaviour change safer sex
528 - 1 Patient 907 / 693 / 381 Authors claim intensive information associated with safer drug practices
Convenience sample
646 - 1 Other ? / 233 / 213 Intervention not associated with cessation of drug/ sex behaviours
Convenience sample
696 - 1 Other 3348 / 3226 / 1665 Interventions associated with differential effect on uptake of free condoms (21% vs.27% vs.41%)
Total sample available
817 - 1 Other 567 / 411 / 339 No differential effect of interventions and risky behaviour.Both interventions associated with 
Total sample available decreased risky behaviours
749 - 1 Patient ? / 157 / 157 HIV risk intervention associated with appropriate change in sex behaviours (p < 0.01)
Convenience sample
777 - 1 Other ? / 1417 / 1417 Intervention associated with increase in facewashing (p < 0.05)
Total sample available
172 - 1 Other ? / 1303 / 1303 Postcard reminders not associated with increased attendance.Predictors of non-attendance analysis 
Total sample available carried out
363 - 1 Patient ? / 238 / 238 Intervention not associated with change in immunisation uptake (31% vs.33%)
Not adequately described
470 - 1 Patient 207 / 177 / 157 Intervention associated with fewer problems but more health supervision surgery visits.No change in 
Total sample available late and emergency visits
512 - 1 Other 8002 / 8002 / 6623 Odds ratios reported:intervention associated with increased immunisation of children;specific 
Total sample available message more impact than general;invitation call greater impact than reminder
98 - 1 Patient 140 / 75 / 57 Intervention associated with changes in self-management of arthritis but not exercise
Convenience sample
601 - 1 Patient ? / 129 / 129 Intervention increased request for information from 10% to 27%.No change in self-report of 
Convenience sample behaviour
601 - 2 Patient ? / 163 / 163 Nurse intervention associated with increased question asking 8% to 54%
Convenience sample
83 - 1 Patient 1566 / 549 / 401 Intervention group associated with fewer prenatal visits and ultrasounds.No differences in uptake 
Total sample available serum screening or perinatal outcomes
106 - 1 Patient ? / 240 / 240 Provision of toy associated with greater attendance post-partum.It is likely that the ‘toy’ group had 
Not adequately described more contact with health professional
788 - 1 Other 251 / 251 / 226 Additional information not associated with postpartum healthcare utilisation
Total sample available
481 - 1 Other 2008 / 2008 / 2008 Interventions not associated with differential effect attendance.Before/after analysis suggest reminder 
Total sample available call increased attendance from 53% to 62%
411 - 1 Patient ? / 40 / 40 Intervention associated with greater adherence TB medication (64% vs.11%;p < 0.001)
Not adequately described
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743 - 1 Patient ? / 2002 / 1908 Uptake of CF carrier screening not associated with type of screening technique.Purpose of study 
Not adequately described to assess impact testing
790 - 1 Patient 5529 / 5529 / 5529 Differential effects of interventions on uptake CF carrier testing (12% vs.9% vs.17% vs.70% vs.25% 
Not adequately described vs.4%)
293 - 1 Other 210 / 93 / 93 No differential effects between groups on use of car seats.Note:majority of sample using car seats
Total sample available
349 - 1 Patient 202 / 93 / 61 Questionnaire plus leaflet reduced number of missed initial appointments and increased attendance 
Total sample available for therapy at 6 months (p < 0.05)
58 - 1 Other 5600 / ? / ? No baseline figures,statistical tests or indication sample size.Twice as likely to sign donor card if 
Systematic sample ‘intensive package’ than information only or control group (5%,5%,12%,13%)
324 - 1 Patient ? / 149 / 98 Illustrated leaflet associated with increased intention to check heat of water (p < 0.0001)
Convenience sample
717 - 1 Patient 74 / 74 / 74 Intervention associated with increased attendance (57% vs.82%;p < 0.05)
Total sample availableHealth Technology Assessment 1999; Vol. 3: No.1
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44 - 1 Other 1750 / ? / ? No significant difference between sampled women’s uptake of breast screening.Difficult to interpret 
Systematic sample results as an additional intervention conducted within the communities at the same time
61 - 1 Other ? / ? / ? Results from medical records by age.Difficult to assess significance association intervention 
Total sample available with uptake rates (71% vs.65%)
203 - 1 Other 1937 / 1697 / 1697 Intervention not associated with differential effects on uptake by group.Interaction between age and 
Total sample available uptake of screening
243 - 1 Other ? / ? / ? Community and physician intervention associated with increased attendance for mammography
Systematic sample
246 - 1 Other ? / 1405 / 875 Both intervention groups associated with increase in BSE
Systematic sample
385 - 1 Other ? / 1200 / ? No significant differences in tobacco use between intervention groups (18% vs.20% vs.15%)
Not adequately described
686 - 1 Other ? / 970 / 970 Intervention associated with increased mammography (from 35% to 55% vs.30% to 40%)
Systematic sample
171 - 1 Other ? / 1500 / 966 Information intervention not associated with changes in smoking,sun-tanning or breast 
Systematic sample examination behaviours
205 - 1 Other 1346 / 1346 / 559 Community-based intervention associated with greater uptake than media intervention (50% vs.32%)
Total sample available
205 - 2 Other 1013 / 1013 / 1013 GP intervention associated with greater attendance at breast cancer screening than community 
Total sample available intervention (64% vs.49%)
397 - 1 Other ? / ? / ? Results not reported for uptake cervical and mammography screening by group.Note:awareness 
Convenience sample programme increased in both groups so contamination groups
546 - 1 Other 1616 / 1332 / 1332 Personalised invitation associated with greater attendance at cervical screening than national 
Total sample available rate (55% vs.41%)
448 - 1 Other 225 / 135 / 135 Skills group associated with increased uptake of colorectal cancer (65% vs.41% vs.94%);p < 0.05)
Total sample available
418 - 1 Other ? / 294 / 294 Intervention not associated with change in uptake of sigmoidoscopy examinations,immunisations,
Not adequately described cholesterol screening or installation of smoke detectors
386 - 1 Other ? / 189 / 179 Uptake and maintenance of BSE improved in both intervention groups (p < 0.001).No differential 
Not adequately described effect between intervention groups
760 - 1 Other ? / 615 / 295 Differential effects of interventions on attendance for mammography (10% vs.30% vs.34%;p < 0.01).
Convenience sample Operationalised HBM
608 - 1 Other 1194 / 628 / 628 Media-based intervention associated with increase in mammography uptake (15% vs.24%;p < 0.05)
Convenience sample
404 - 1 Other ? / 1857 / 1857 Women within the intervention community more likely to report having a mammogram (30% vs.19% 
Total sample available increase;p < 0.05). Analysis carried out to assess predictors attendance
446 - 1 Other ? / 2724 / 2724 Intervention associated with changes in mammography uptake (10% vs.27%;p < 0.01)
Systematic sample
136 - 1 Other 648 / 648 / 612 Group 2 associated with increased sun protection behaviours over time (p < 0.01)
Systematic sample
237 - 1 Other 2000 / 1506 / 1231 Intervention associated with a decreased fat intake over time (p < 0.01).No change in smoking habits
Systematic sample
180 - 1 Other ? / ? / ? Self-report hat wearing and sunscreen increased,no change in covering up after intervention.
Not adequately described Less change in men’s behaviour
45 - 1 Other ? / ? / ? Self-report attending cholesterol checks higher in white intervention than control population.
Systematic sample No increase amongst black respondents.Sample randomly selected by phone
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82 - 1 Patient ? / 84 / 84 Patients within intervention group fewer emergency visits and days off work than matched controls.
Convenience sample No differences between number hospitalisations.Note:data suggest non-parametric analysis 
more appropriate
218 - 1 Other 2812 / 1506 / 1093 Intervention not associated with reliable differences in smoking cessation
Total sample available
222 - 1 Other 286 / 209 / 125 Screening teachers associated with uptake of exercise but no change in smoking behaviour
Total sample available
235 - 1 Other 1052 / 966 / 931 Prevalence of smoking not associated with type of work policy;daily rate cigarette consumption 
Not adequately described associated with type of work policy
245 - 1 Patient ? / 62 / ? Intervention groups not associated with smoking cessation at 6 months follow-up.Caution:hospital 
Convenience sample had a no-smoking policy
256 - 1 Patient 1946 / 1286 / 997 Cessation rates:advice only (13%),counselling only (24%),counselling and gum (30%).Logistic 
Total sample available regression analysis modelling demographic variables and cessation
258 - 1 Other 3558 / 708 / 708 Authors suggest intervention associated with changes in CVD risk factors.Caution:low response 
Convenience sample rate over large period of time
260 - 1 Patient ? / 8184 / 8184 Special care intervention reported greater change in smoking cessation than usual care (43% vs.14%).
Not adequately described Little information about intervention or process measures of change
280 - 1 Other 16089 / 3382 / 2972 Participation in survey greater in North Karelia (0.6% vs.0.3%,0.3%).Reported change cessation 
Convenience sample smoking higher in North Karelia (25% vs.20%,19%)
283 - 1 Other 5445 / 56 / 56 Competition intervention associated with greater interest in programme (2% vs.0.6%).Maintenance 
Convenience sample abstinence greater in competition intervention (p < 0.05)
284 - 1 Other ? / 2147 / 1220 Cessation of smoking greater within intervention group (32% vs.17%;p < 0.05)
Convenience sample
315 - 1 Other 96 / 84 / 55 Packaging pills in foil holders with ‘date to take’ increased compliance up to 3 months after 
Total sample available discharge (49% vs.23%)
390 - 1 Other ? / ? / 1880 Authors claim counselling and exercise compatible with daily life is effective in increasing exercise 
Convenience sample uptake.Note:results not clearly reported and unclear 
504 - 1 Other ? / 46 / 46 Intervention associated with fewer GP contacts and emergency visits (p < 0.01) but no change in 
Total sample available referrals to specialists
657 - 1 Patient ? / 4487 / 2767 Intervention group three times more likely to quit smoking (6% vs.2%)
Systematic sample
731 - 1 Other ? / 5078 / 4538 Interventions not associated with changes in smoking behaviour
Systematic sample
740 - 1 Other ? / ? / ? Authors claim that smoking cessation greater within intervention community but analysis not 
Not adequately described carried out to illustrate this
779 - 1 Other 1087 / 1036 / 1036 Intervention village greater long-term smoking cessation rate (p = 0.01) but no difference in 
Total sample available short-term cessation rates
206 - 1 Other ? / ? / ? Intervention associated with increased smoking cessation in men only (8% vs.3%).Results presented 
Not adequately described for physiological estimates CVD risk
215 - 1 Other ? / 1500 / ? Authors claim Group 1 associated diet change.However,small sub-section of sample.Group 2 
Systematic sample and 3 not associated with changes
409 - 1 Other ? / ? / 1863 No differential effect of information on children’s report of diet.Note:differences between trained/not 
Convenience sample trained teachers,e.g.funding schools;inappropriate statistics
312 - 1 Other ? / ? / ? Intervention associated with reduction in fatty diet (p < 0.05)
Systematic sample
273 - 1 Other ? / 4270 / 2605 Intervention not associated with cessation of smoking,though there was a time effect (p < 0.01)
Systematic sample
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394 - 1 Patient ? / 1024 / 860 Intervention not associated with change in ophthalmic specialist use
Convenience sample
194 - 1 Other 203 / 184 / ? Authors present changes in intention to behave more safely for:seat-belt use as a driver and 
Total sample available passenger,speeding and drink-driving.Intervention associated with increased intention of passenger 
seat-belt use
89 - 1 Patient 738 / 227 / 227 Authors suggest post-intervention group had greater intention to change exercise behaviour than 
Convenience sample pre-intervention group (p < 0.05).Operationalise the theory planned behaviour
184 - 1 Other 276 / 232 / 146 Interventions not associated with differential effect of smoking cessation but reduction in overall 
Total sample available pre-/post-intervention
253 - 1 Other ? / 465 / 346 Parent information associated with greater increase of intention and actual food buying than 
Convenience sample child/control groups.Operationalised SLT
345 - 1 Other 252 / 252 / 187 Intervention not associated with increased smoking cessation rates.Operationalised stages of 
Total sample available change theory
416 - 1 Patient ? / 48 / 48 Interventions not associated with changes in self-report behaviour
Convenience sample
440 - 1 Other ? / 2500 / ? Behavioural-based intervention assessed mainly by physiological changes.There was no association 
Systematic sample with smoking cessation
209 - 1 Other 407 / 255 / 212 Stages of change intervention associated with increased exercise uptake (p < 0.01)
Convenience sample
631 - 1 Other ? / ? / 6814 Intervention not associated with reliable changes in self-report of diet change at 5 years
Systematic sample
464 - 1 Other ? / 907 / 907 Intervention not associated with exercise adherence but effects reported for subsidiary analysis
Systematic sample
658 - 1 Other ? / 2136 / 1674 Intervention increased attendance at lifestyle change activities
Systematic sample
726 - 1 Other ? / ? / ? Little association between intervention and self-reports of smoking or exercise behaviour
Systematic sample
255 - 1 Other ? / ? / ? Intervention not associated with changes in tobacco use
Systematic sample
313 - 1 Other 625 / 558 / 516 Both interventions associated with increased medication adherence and self-monitoring (p < 0.05).
Total sample available Neither intervention associated with changes in diet and exercise
367 - 2 Patient ? / 341 / 119 Differential attrition (56% vs.48%) and smoking cessation rates (14% vs.57%).Difficult to draw 
Convenience sample any conclusions as poor design
370 - 1 Other ? / 5356 / 3833 Intervention associated with decreased self-report of alcohol use (p < 0.01)
Total sample available
238 - 1 Other ? / ? / ? Intervention not associated with changes in smoking behaviour
Systematic sample
261 - 1 Other 171 / 171 / 157 Intervention associated with favourable changes in smoking,diet and dental health (p < 0.01)
Total sample available
456 - 1 Other 405 / 155 / 55 Intervention associated with changes in diet (p < 0.05) but not smoking or uptake exercise
Not adequately described
709 - 1 Other ? / ? / ? Intervention not associated with changes in diet,smoking,exercise.Interaction between social support 
Systematic sample and intervention
311 - 1 Other ? / ? / 2863 Authors claim social intervention associated with lower onset substance use than control,whereas 
Not adequately described the affective intervention group was associated with increased substance use
125 - 1 Patient ? / 117 / 77 Intervention associated with intention to practice safer sex.No association with drug or alcohol use
Convenience sample
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161 - 1 Other ? / 600 / 600 Intervention associated with increased condom use and reduced number of sexual partners (p < 0.001)
Convenience sample
177 - 1 Patient ? / 2624 / 1616 Results not reported for comparison interventions but as before/ after design,predictors of behaviour 
Convenience sample change.Cessation of risky needle use and adherence to safer sex in males after intervention
392 - 1 Other ? / 7946 / 7946 Uptake of contraception use in intervention area over time greater than control community 
Systematic sample (57% vs.27%)
791 - 1 Patient ? / 541 / 524 Intervention associated with increased use of condoms and raising issue of condom use with clients 
Convenience sample (p < 0.01)
555 - 1 Other ? / 1398 / 1398 Authors claim intervention not associated with use of condoms but increase in intention to use 
Convenience sample condoms
665 - 1 Other ? / 1267 / 1267 Authors claim reduction in self-report of risky sex practices within intervention city only
Convenience sample
579 - 1 Other 1226 / 442 / 442 Information intervention not associated with changes in condom use
Convenience sample
748 - 1 Patient ? / 209 / 20 Group 1 associated with reduced length of hospital stay and fewer outpatient visits (p < 0.01) but 
Convenience sample increased GP visits for Groups 1 and 4
455 - 1 Other ? / 1261 / 1256 Control group associated with increased utilisation of care (p < 0.01),intervention group less likely 
Not adequately described to change method of contraception (85% vs.92%,p < 0.01)
71 - 1 Not recorded 29 / 22 / 22 Those with lower addiction (baseline group 1) were more likely to attend antenatal classes.Those 
Convenience sample with a higher addiction (intensive Group 2) expressed more intention to quit.Design of study unable 
to evaluate intervention
486 - 1 Patient ? / 248 / 113 Intervention associated with greater number of children adopted (43% vs.0%),less sexually active 
Not adequately described (57% vs.75%) at 24 months.Low response rate and samples significantly different at beginning of study
17 - 1 Other 738 / 734 / 520 Authors suggest intention to use condoms and practice safer sex increased after role play.
Total sample available Carried out attitude-behaviour analysis
18 - 1 Other 173 / 120 / 80 Intervention associated with less intention to use steroids.Operationalised model
Systematic sample
240 - 1 Other ? / 2844 / 1477 Theory-based (skills) intervention associated with increased use of condoms,reduction in number of 
Not adequately described partners and behavioural intentions.Operationalised theory of reasoned action
251 - 1 Other ? / 5378 / 3875 Authors claim programme associated with increased smoking cessation in intervention school
Not adequately described
391 - 1 Patient ? / 763 / 763 Authors suggest intervention associated with increased condom use (42% vs.30%).Unclear 
Systematic sample description of design either before/after or concurrent
515 - 1 Other ? / 2026 / 1785 Intervention associated with greater intention to practice safer sex.Operationalisation theory 
Systematic sample planned behaviour
759 - 1 Other ? / 6573 / 6573 Intervention not associated with changes in behaviour,though control schools increased sexual activity and 
Not adequately described intervention group remained the same. Analysis looked at predictors of sexual activity
628 - 1 Other ? / 197 / 145 Authors claim intervention associated with increased consistent condom use (p < 0.01)
Convenience sample
780 - 1 Other ? / 2239 / 2239 Intervention not associated with changes in risky sex
Systematic sample
463 - 1 Other ? / 298 / 191 Intervention community decreased number of risky sex behaviours,not changed in 
Convenience sample comparison community
663 - 1 Other 880 / 845 / 804 Intervention not associated with intention to change behaviour (p = 0.07)
Systematic sample
373 - 1 Other ? / 1444 / 888 Intervention not associated with sexual activity. Analysis operationalised HBM
Convenience sample
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453 - 1 Other ? / 377 / 161 Both intervention groups associated with changes in alcohol use but not cigarette or marijuana 
Convenience sample use (p < 0.05)
822 - 1 Other ? / ? / ? Differential effects between groups and in comparison with intervention groups for safer sex
Convenience sample
823 - 1 Other ? / ? / 4806 Intervention associated with changes in smoking and drug use (p < 0.05)
Not adequately described
813 - 1 Other 5686 / 3779 / 1786 Intervention associated with changes in seat belt use and diet (p < 0.01).No changes for smoking,
Total sample available exercise or alcohol
146 - 1 Other 2978 / 2978 / 2978 Authors suggest intervention associated with increased uptake of influenza vaccination (40% to 56%).
Total sample available Main analysis was predictors uptake
257 - 1 Other ? / ? / 3884 More aggressive recruitment associated with greater attendance for health check (14%,21%,
Total sample available 32%,37%)
775 - 1 Other 3616 / 3616 / 3616 Children more likely to be immunised in general practice than in health centre (80% vs.68%).Analysis 
Total sample available assessed differences between rural and inner city locations
331 - 1 Patient ? / 80 / 80 Adherence to routine health/immunisation screenings was not associated with immunisation in A&E
Not adequately described
95 - 1 Patient ? / 175 / ? No improvement in self-management behaviours by intervention group.Main outcomes were 
Not adequately described knowledge and satisfaction
3 - 1 Other ? / 256 / 206 Intervention associated with an increase in breast feeding
Not adequately described
529 - 1 Other ? / 2610 / 2508 Intervention associated with increased chewing of xylitol (p < 0.05)
Systematic sample
618 - 1 Other ? / ? / ? Intervention not associated with increased use of reimbursed dental service
Convenience sample
430 - 1 Patient ? / ? / 230 Differences in reproductive choices found between counselled/not counselled.Note:not a 
Not adequately described controlled sample
516 - 1 Patient ? / 1607 / 1607 Health centre intervention higher uptake than letter invitation (24% vs.4%). Assessed 
Total sample available process variables
323 - 1 Other 9150 / 1265 / 551 Both information interventions associated with higher recruitment to study and adherence at 
Total sample available 6 months,no differential effect between intervention groups
586 - 1 Patient 161 / 127 / 127 Observation of medication taking associated with greater adherence (88% vs.50%)
Convenience sample
452 - 1 Other 1300 / 1300 / 1300 Intervention associated with increased completion treatment (65% vs.78%;p < 0.05)
Total sample available
124 - 1 Patient ? / 93 / 93 Whether drug was taken orally or injected had no impact on medication adherence post-discharge
Convenience sample
825 - 1 Not recorded ? / ? / ? Authors claim intervention associated with increased adherence
Not adequately described
335 - 1 Other ? / ? / 334 Intervention women more likely to assemble rehydration solution accurately
Convenience sample
570 - 1 Other ? / 106 / 106 Intervention not associated with any changes in risk taking behaviours
Not adequately described
773 - 1 Other 1620 / 1168 / 1043 No association between intensive intervention and increased adherence to helmet use
Total sample available
40 - 1 Not recorded ? / 72 / ? More symptoms noted when using computer also preferred method
Convenience sample
75 - 1 Patient ? / 108 / 108 Insured patients more likely to keep appointments,less likely to make appointments and willing 
Convenience sample to pay more for insuranceAppendix 8
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34 - 1 Other ? / ? / ? Mammography uptake improved over 5 years
Not adequately described
100 - 1 Patient ? / ? / ? Uptake rate for mammography increased from 47% to 72% a year
Convenience sample
192 - 1 Other 410 / 316 / ? Cervical screening increased from 51% to 78%
Total sample available
383 - 1 Other ? / 516 / 516 Intervention not associated with uptake of mammography (47% vs.41%:aware intervention vs.
Systematic sample not aware)
421 - 1 Other ? / ? / ? Actual results not reported but authors claim intervention associated with increased BSE
Not adequately described
575 - 1 Patient ? / 2972 / 2972 Intervention associated with increased smear uptake (20% to 58%)
Systematic sample
401 - 1 Other 985 / 656 / 656 Trained health professionals and provision prompts increased referral and attendance in women 
Total sample available for mammography (55% to 88%)
765 - 1 Patient 618 / 109 / 109 Authors claim intervention associated increase sun protective behaviours (6.5% to 27%)
Convenience sample
495 - 1 Patient ? / 533 / 533 Intervention not associated with increase in making living wills. Analysis looked at predictors of living 
Systematic sample will completion
340 - 1 Other ? / 7667 / 7667 Authors claim smoking decreased over a 4-year period. Actual percentages not reported and likely 
Systematic sample self-selecting sample bias
423 - 1 Patient 912 / 706 / 706 Authors claim media interventions associated with increase testing for HIV but no increase in 
Total sample available number of positives
550 - 1 Other 344 / 314 / 314 No-smoking policy not associated changes marijuana and alcohol use.Associated with cessation of 
Total sample available cigarette use (p = 0.02)
514 - 1 Not recorded ? / 1232 / 1232 Intervention not associated cessation smoking
Systematic sample
461 - 1 Other ? / 15188 / 15188 Self report increase seat belt use (17% more) and reduction drunk driving (40% less) greater 
Systematic sample in intervention city
462 - 1 Other ? / 2016 / 2016 Intervention community associated increase physical activity and cholesterol checks (p < 0.05),
Systematic sample no change smoking cessation or fruit consumption
670 - 1 Patient ? / ? / ? Analysis suggests greatest change in testing after television campaigns
Convenience sample
680 - 1 Patient ? / ? / ? Authors claim interventions associated with decreased risky sexual behaviours.Interactions with 
Convenience sample ethnicity and sexual orientation
662 - 1 Patient ? / 276 / 266 Announcement associated with greater intention to test for HIV (p < 0.01)
Convenience sample
142 - 1 Other ? / ? / ? Authors claim changes in risky sex and safe drug taking practices
Convenience sample
619 - 1 Other ? / 1515 / 1515 Surveys demonstrated no change in behaviour over the two time points.Behaviour change probably 
Convenience sample made before first survey
647 - 1 Other ? / 1469 / 1469 Intervention associated reduction high risk behaviours in all three cities
Not adequately described
193 - 1 Patient ? / ? / ? Intervention not associated with an increase in childhood immunisations
Systematic sample
767 - 1 Other ? / ? / ? Intervention associated increase immunisation (53% to 78%). Analysis assessed uptake by 
Total sample available deprivation indices
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TABLE 35 contd  Description of the quality of the study and summary results:before/after different samples
Study  Intervention  Sample size Summary of results
number level
413 - 1 Other ? / 299 / 299 Intervention associated increase vaccination from 50% to 73%
Total sample available
623 - 1 Other ? / 652 / 524 Intervention not associated changes in breast feeding behaviour
Not adequately described
26 - 1 Other 167 / 167 / 167 Intervention associated increase breast feeding in hospital,not maintained at home
Total sample available
97 - 1 Other ? / ? / ? More people reported brushing teeth and buying toothbrushes /fluorinated toothpaste.No reduction 
Convenience sample in those that do not attend a health professional
737 - 1 Patient ? / 604 / 604 Adherence to treatment increased between two time points
Not adequately described
563 - 1 Patient ? / 928 / 928 Use of mobile clinic increased completion of examination forms and adherence to treatment 
Not adequately described (from 9% to 91%)
239 - 1 Other 6168 / 5925 / 5385 Risky child sleep position decreased from 30% to 5%
Total sample available
294 - 1 Other ? / ? / ? Authors claim 523 people requested fragile X information,no increase uptake diagnostic tests.
Convenience sample Note:no baseline,post intervention or population figures given to support authors claims
674 - 1 Patient ? / 1339 / 1339 Introduction clinic associated with fewer non-attendees (0.3% vs.4.3%)
Total sample available
149 - 1 Other ? / 783 / 783 Authors claim helmet use increased
Convenience sampleAppendix 8
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TABLE 36  Description of the quality of the study and summary results:before/after same sample
Study  Intervention  Sample size Summary of results
number level
99 - 1 Patient 1087 / 727 / 526 Intention to attend for mammography increased (60% vs.51%;p < 0.01). Analysis performed by 
Convenience sample intention to have vs.not to have
266 - 1 Patient 1592 / 1592 / 1022 Increased sun protective behaviours were observed over 6 years.Unable to attribute to 
Total sample available clinic intervention alone
746 - 1 Patient 1628 / 1000 / 100 Intervention associated with increased uptake of cervical and mammography screening.However,less 
Systematic sample than target rates
815 - 1 Patient ? / 127 / 127 Authors claim increased uptake of testicular cancer screening over three years (p < 0.01)
Not adequately described
795 - 1 Other 9650 / 9650 / 9650 Cervical smear uptake increased from 78% to 85% (80% target rate)
Total sample available
809 - 1 Other ? / 268 / 268 Intervention associated with increased mammography uptake.Results presented by age group
Systematic sample
133 - 1 Other ? / 11600 / ? Intervention not associated with changes in health behaviours over time
Systematic sample
466 - 1 Other ? / ? / ? Prompt on notes associated with increased attendance for screening and immunisations
Total sample available
46 - 1 Patient ? / 10 / ? Study designed to compare a psycho-educational programme and control but no measure of 
Not adequately described behaviour.Before/after results associated with increased BSE and mammography 
126 - 1 Patient 3686 / 1585 / 948 Authors suggest intervention associated with uptake of mammography.Results analysed using age and 
Total sample available income interactions
198 - 1 Patient 320 / 200 / 178 Intervention associated with increased safer sun practices (p < 0.05)
Total sample available
42 - 1 Not recorded ? / 110 / 102 Intervention associated with decreased GP visits,increased use of prevention medication,decreased 
Not adequately described use of other medication
74 - 1 Patient ? / 15 / 15 Actual results not reported,authors claim participants more likely to test blood and adjust 
Not adequately described insulin level after programme (p = 0.01)
79 - 1 Other ? / 70 / 54 Claimed to be comparative design but only results of before/after measures intervention group 
Convenience sample reported.Intervention associated with changes in diet adherence but not exercise
111 - 1 Patient 57 / 43 / 31 Receipt of information on living wills increased patients completion of wills and discussions with family 
Convenience sample members and health professionals
244 - 1 Patient ? / 396 / 257 Intervention associated with increased exercise uptake
Convenience sample
270 - 1 Patient 111 / 89 / 89 Intervention associated with 25% smoking cessation rate. Analysis assessed predictors of cessation
Total sample available
355 - 1 Patient ? / 94 / 38 Intervention associated with increased exercise uptake. Analysis assessed attendees vs.non-attendees
Convenience sample
384 - 1 Patient ? / 2244 / 338 Intervention associated with changes in diet and exercise uptake but not smoking
Convenience sample
521 - 1 Patient 208 / 186 / 148 Intervention associated with increased self-management behaviours (p < 0.01)
Total sample available
676 - 1 Patient 223 / 38 / 30 Intervention associated with fewer emergency visits,improved useof inhalers and appropriate 
Convenience sample self-administration of steroids
522 - 1 Patient 2500 / 588 / 300 Intervention not associated with changes in medication use or utilisation of health services
Convenience sample
544 - 1 Not recorded 142 / 142 / 132 Authors report adherence to medication increased,reduction in visits by health professionals 
Total sample available (p < 0.001)
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TABLE 36 contd  Description of the quality of the study and summary results:before/after same sample
Study  Intervention  Sample size Summary of results
number level
262 - 1 Patient 2215 / 1113 / 1097 Intervention associated with 13% cessation rate.Only 5% of smokers who did not take part in 
Convenience sample intervention quit
449 - 1 Patient ? / 78 / 53 Intervention associated with increased adherence from 73% to 83% (p < 0.01)
Convenience sample
798 - 1 Patient 1006 / 526 / 520 Self-reported changes at follow-up:exercise (11%),smoking (15%),alcohol (24%),diet (less fat 46%)
Total sample available
821 - 1 Patient ? / 68 / 45 Authors claim intervention associated with implementation of exercise programme at home and 
Not adequately described smoking cessation
621 - 1 Other ? / 937 / 596 Participants more likely to adopt new diet (16% vs.1%).Poor design but looked at predictors 
Convenience sample of uptake
348 - 1 Patient 2324 / 771 / 512 Authors claim intervention associated with changes in osteoporosis prevention activities. Analysis 
Total sample available assessed differences in attendees/non-attendees
162 - 1 Patient 160 / 3 / 3 Authors claim intervention associated with increased healthy diet choice
Not adequately described
84 - 1 Patient ? / ? / 274 Intervention associated with changes in self-report of car safety
Convenience sample
594 - 1 Patient ? / 83 / 64 Interactive video associated with uptake of medication from 0% to 25% of patients.Study assessed 
Convenience sample several decision-making process measures
179 - 1 Patient ? / 7 / 5 Sample selection of before/after design too small to draw any conclusions
Convenience sample
367 - 1 Patient ? / 112 / 78 15% sample quit after the programme
Convenience sample
91 - 1 Patient ? / 20 / ? Intervention associated with increased self-report of safe sex behaviours,cessation of risky sex
Convenience sample
38 - 1 Not recorded ? / 143 / 56 Intervention associated with increased use of condoms and decreased risky sex encounters
Convenience sample
49 - 1 Not recorded 1180 / 1161 / ? Intervention associated with intentions to engage in safer sex,in one of the two schools.No 
Total sample available association in the other school
123 - 1 Patient ? / 239 / 139 Intervention associated with increased self-report use of condoms and decreased anal intercourse
Convenience sample
159 - 1 Patient 202 / 193 / 147 Intervention not associated with changes in risky sexual behaviours. Assessed predictors of behaviour
Convenience sample
480 - 1 Patient 414 / 414 / 241 Intervention associated with reduction in sexual activity (33% to 25%)
Total sample available
651 - 1 Patient 3702 / 1458 / 1385 Use of condoms increased from 7% to 22% after intervention
Systematic sample
655 - 1 Patient ? / 586 / 502 Intervention associated with increased uptake of hormonal contraception
Convenience sample
688 - 1 Patient ? / 195 / 149 Intervention associated with increased condom use (62% to 82%,p = 0.01)
Convenience sample
729 - 1 Patient ? / 659 / 402 Authors claim intervention associated with some change in drug use behaviours
Convenience sample
770 - 1 Patient ? / 1113 / 983 Authors claim a mixed association between intervention and drug use behaviours
Convenience sample
610 - 1 Patient ? / ? / 208 Authors claim intervention associated with increased intention to use condom (44% vs.65%) and 
Convenience sample reduce number of partners (43% vs.53%)
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TABLE 36 contd  Description of the quality of the study and summary results:before/after same sample
Study  Intervention  Sample size Summary of results
number level
467 - 1 Other ? / 2378 / 1688 Intervention associated with greater intention to engage in safe sex
Total sample available
723 - 1 Patient ? / 292 / 134 Intervention associated with increased use condom (64% to 70%)
Not adequately described
545 - 1 Patient ? / 755 / 61 Authors claim association between counselling and reduction risky sex
Not adequately described
650 - 1 Patient 814 / ? / 614 Clinic information not associated with changes in risk behaviours
Total sample available
537 - 1 Patient ? / 700 / 700 Intervention not associated with increased attendance at clinic.No differences in attendance between 
Total sample available sexes
35 - 1 Other 97 / 77 / 31 Small sample size and self-selected.Self-report of condom use increased and discussions of safer 
Total sample available sex increased after the intervention
364 - 1 Patient ? / 109 / 109 Intervention associated with increased intention to use condoms.Operationalised social cognitive 
Convenience sample theory
526 - 1 Patient 141 / 138 / 119 Intervention associated with changes in risky sex behaviours.Analysis assessed predictors behaviour 
Total sample available change,operationalised five models
654 - 1 Patient ? / 327 / 327 Authors claim intervention associated with intention to change sex practices (p < 0.01)
Convenience sample
450 - 1 Patient ? / 93 / 69 Authors claim intervention associated with risk-reducing behaviours
Convenience sample
573 - 1 Patient ? / 1915 / 1145 Intervention associated with 20% increased uptake of Hepatitis B vaccination (p < 0.01)
Total sample available
342 - 1 Patient ? / 195 / 195 Uptake of immunisation increased from 8% to 46%
Total sample available
132 - 1 Patient 893 / 893 / 893 Breast feeding increased from 18% to 52%
Total sample available
163 - 1 Patient ? / 11 / 11 Authors claim intervention associated with increased hygiene activities
Convenience sample
361 - 1 Patient ? / 11 / 11 Authors claim intervention associated with increased appropriate behaviour (library visit)
Not adequately describedHealth Technology Assessment 1999; Vol. 3: No.1
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